Cayman公司成立于1980年，在過去20多年的發(fā)展過程中，始終保持著為科研工作者提供高質(zhì)、優(yōu)價研究產(chǎn)品的宗旨。該公司目前可以提供2,138 多種生化和免疫試劑，涉及腫瘤、氧化氮、神經(jīng)學(xué)、凋亡、氧化性損傷、內(nèi)分泌學(xué)等研究領(lǐng)域。非常有特色的檢測試劑盒包括類花生酸類物質(zhì)、游離的生物標(biāo)志、環(huán)核苷、激素及氧化氮等。此外，還提供多種高質(zhì)量試劑，如類花生酸類物質(zhì)、氧化氮試劑及許多相關(guān)脂質(zhì)、脂肪酸、酶和抗體等。Cayman非常愿意接受各地客戶的要求，合成復(fù)雜和不穩(wěn)定分子。
品牌商名稱：Cayman Chemical
：(734) 971-3335
地址：1180 East Ellsworth Road Ann Arbor, Michigan 48108 USA
公司：http://www.caymanchem。。ｃｏｍ/
世界*實(shí)驗(yàn)材料供應(yīng)商Cayman正式授權(quán)上海起發(fā)為其中國代理，Cayman在一直是行業(yè)的*,一直為廣大科研客戶提供zui為的產(chǎn)品和服務(wù),上海起發(fā)一直秉承為中國科研客戶帶來的產(chǎn)品，的服務(wù)， 簽約Cayman就是為了給廣大科研客戶帶來更加完善的產(chǎn)品和服務(wù),您的滿意將是我們zui大的收獲
Cayman中國代理，Cayman上海代理，Cayman北京代理，Cayman廣東代理，Cayman江蘇代理 Cayman湖北代理, Cayman天津, Cayman黑龍江代理, Cayman內(nèi)蒙古代理, Cayman吉林代理, Cayman福建代理, Cayman江蘇代理, Cayman浙江代理, Cayman四川代理,
部分報價1
| 品牌 | 目錄號 | 產(chǎn)品 | 規(guī)格 | 2015目錄價 |
| Cayman2015 | 10000 | Cyclopentenone Prostaglandin HPLC Mixture | 1 ea | 938 |
| Cayman2015 | 100000 | Optineurin (C-Term) Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 100000 | Optineurin (C-Term) Polyclonal Antibody | 1 Trial | 1386 |
| Cayman2015 | 100002 | Optineurin (INT) Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 10001 | Primary Eicosanoid HPLC Mixture | 1 ea | 938 |
| Cayman2015 | 100011 | CD36 Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 100012 | Vilogenin (Japanese medaka) Monoclonal Antibody (Clone CK-4B3) | 100 μL | 4580 |
| Cayman2015 | 100012 | Vilogenin (Japanese medaka) Monoclonal Antibody (Clone CK-4B3) | 500 μL | 20620 |
| Cayman2015 | 100017 | Zona Radiata (salmon) Monoclonal Antibody (Clone MN-8C4) | 100 μL | 4580 |
| Cayman2015 | 100017 | Zona Radiata (salmon) Monoclonal Antibody (Clone MN-8C4) | 500 μL | 20620 |
| Cayman2015 | 100018 | Zona Radiata (salmon) Monoclonal Antibody (Clone MN-7F2) | 100 μL | 4580 |
| Cayman2015 | 100018 | Zona Radiata (salmon) Monoclonal Antibody (Clone MN-7F2) | 500 μL | 20620 |
| Cayman2015 | 100019 | BLT1 Receptor Polyclonal Antiserum | 1 ea | 2996 |
| Cayman2015 | 10002 | Prostaglandin HPLC Mixture | 1 ea | 938 |
| Cayman2015 | 100020 | Zona Radiata (salmon) Monoclonal Antibody (Clone MN-2B4) | 100 μL | 4580 |
| Cayman2015 | 100020 | Zona Radiata (salmon) Monoclonal Antibody (Clone MN-2B4) | 500 μL | 20620 |
| Cayman2015 | 100022 | Hepsin Polyclonal Antibody (aa 241-260) | 1 ea | 3206 |
| Cayman2015 | 100023 | Prostaglandin I Synthase (mouse) Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 100024 | Hepsin Blocking Peptide (aa 241-260) | 1 ea | 1498 |
| Cayman2015 | 100025 | 5-OxoETE Receptor Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 100027 | SOAT-2/ACAT-2 Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 100028 | SOAT-1/ACAT-1 Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 100029 | β-Catenin Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 10003 | Vasoactive Eicosanoid HPLC Mixture | 1 ea | 1106 |
| Cayman2015 | 100030 | Endothelial Lipase Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 100033 | Vilogenin (Japanese medaka) Monoclonal Antibody (Clone CK-1H11) | 100 μL | 4580 |
| Cayman2015 | 100033 | Vilogenin (Japanese medaka) Monoclonal Antibody (Clone CK-1H11) | 500 μL | 20620 |
| Cayman2015 | 100034 | Goat Anti-COX-2 (human) Affinity-Purified Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 100035 | Monoacylglycerol Lipase Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 10004023 | Thromboxane B2 Express EIA Kit - Monoclonal | 480 Solid | 14182 |
| Cayman2015 | 10004023 | Thromboxane B2 Express EIA Kit - Monoclonal | 480 Well | 14182 |
| Cayman2015 | 10004023 | Thromboxane B2 Express EIA Kit - Monoclonal | 96 Solid | 3780 |
| Cayman2015 | 10004023 | Thromboxane B2 Express EIA Kit - Monoclonal | 96 Well | 3780 |
| Cayman2015 | 10004110 | TP Receptor (mouse) Blocking Peptide | 1 ea | 1498 |
| Cayman2015 | 10004111 | Endothelial Lipase (human) Blocking Peptide | 1 ea | 1498 |
| Cayman2015 | 10004161 | Luteolin | 10 mg | 266 |
| Cayman2015 | 10004161 | Luteolin | 100 mg | 1064 |
| Cayman2015 | 10004161 | Luteolin | 50 mg | 602 |
| Cayman2015 | 10004161 | Luteolin | 500 mg | 4662 |
| Cayman2015 | 10004174 | 4-oxo 2-Nonenal-d3 | 1 mg | 15288 |
| Cayman2015 | 10004174 | 4-oxo 2-Nonenal-d3 | 100 μg | 2072 |
| Cayman2015 | 10004174 | 4-oxo 2-Nonenal-d3 | 50 μg | 1092 |
| Cayman2015 | 10004174 | 4-oxo 2-Nonenal-d3 | 500 μg | 8736 |
| Cayman2015 | 10004177 | CAY10443 | 10 mg | 1036 |
| Cayman2015 | 10004177 | CAY10443 | 25 mg | 2464 |
| Cayman2015 | 10004177 | CAY10443 | 5 mg | 546 |
| Cayman2015 | 10004177 | CAY10443 | 50 mg | 4424 |
| Cayman2015 | 10004184 | NESS 0327 | 1 mg | 2436 |
| Cayman2015 | 10004184 | NESS 0327 | 10 mg | 19488 |
| Cayman2015 | 10004184 | NESS 0327 | 5 mg | 11032 |
| Cayman2015 | 10004185 | 3,4',5-Trismethoxybenzophenone | 10 mg | 378 |
| Cayman2015 | 10004185 | 3,4',5-Trismethoxybenzophenone | 100 mg | 3024 |
| Cayman2015 | 10004185 | 3,4',5-Trismethoxybenzophenone | 25 mg | 896 |
| Cayman2015 | 10004185 | 3,4',5-Trismethoxybenzophenone | 50 mg | 1708 |
| Cayman2015 | 10004197 | Prostaglandin E2-1-glyceryl ester-d5 | 100 μg | 2100 |
| Cayman2015 | 10004197 | Prostaglandin E2-1-glyceryl ester-d5 | 50 μg | 1106 |
| Cayman2015 | 10004197 | Prostaglandin E2-1-glyceryl ester-d5 | 500 μg | 8848 |
| Cayman2015 | 10004207 | (S)-Flurbiprofen | 1 g | 8624 |
| Cayman2015 | 10004207 | (S)-Flurbiprofen | 100 mg | 1078 |
| Cayman2015 | 10004207 | (S)-Flurbiprofen | 250 mg | 2562 |
| Cayman2015 | 10004207 | (S)-Flurbiprofen | 500 mg | 4858 |
| Cayman2015 | 10004219 | SC-236 | 1 mg | 350 |
| Cayman2015 | 10004219 | SC-236 | 10 mg | 1750 |
| Cayman2015 | 10004219 | SC-236 | 5 mg | 1050 |
| Cayman2015 | 10004219 | SC-236 | 50 mg | 7882 |
| Cayman2015 | 10004224 | trans-EKODE-(E)-Ib | 100 μg | 1960 |
| Cayman2015 | 10004224 | trans-EKODE-(E)-Ib | 25 μg | 546 |
| Cayman2015 | 10004224 | trans-EKODE-(E)-Ib | 50 μg | 1036 |
| Cayman2015 | 10004224 | trans-EKODE-(E)-Ib | 500 μg | 8736 |
| Cayman2015 | 10004235 | cis-Resveratrol | 10 mg | 1596 |
| Cayman2015 | 10004235 | cis-Resveratrol | 100 mg | 11760 |
| Cayman2015 | 10004235 | cis-Resveratrol | 5 mg | 840 |
| Cayman2015 | 10004235 | cis-Resveratrol | 50 mg | 6720 |
| Cayman2015 | 10004236 | Fluprostenol serinol amide | 1 mg | 672 |
| Cayman2015 | 10004236 | Fluprostenol serinol amide | 10 mg | 5376 |
| Cayman2015 | 10004236 | Fluprostenol serinol amide | 5 mg | 3024 |
| Cayman2015 | 10004237 | 17-phenyl trinor Prostaglandin F2α serinol amide | 1 mg | 826 |
| Cayman2015 | 10004237 | 17-phenyl trinor Prostaglandin F2α serinol amide | 10 mg | 6608 |
| Cayman2015 | 10004237 | 17-phenyl trinor Prostaglandin F2α serinol amide | 5 mg | 3724 |
| Cayman2015 | 10004237 | 17-phenyl trinor Prostaglandin F2α serinol amide | 50 mg | 28910 |
| Cayman2015 | 10004257 | trans-4,5-epoxy-2(E)-Decenal | 1 mg | 1568 |
| Cayman2015 | 10004257 | trans-4,5-epoxy-2(E)-Decenal | 10 mg | 12544 |
| Cayman2015 | 10004257 | trans-4,5-epoxy-2(E)-Decenal | 5 mg | 7056 |
| Cayman2015 | 10004259 | CAY10429 | 1 mg | 280 |
| Cayman2015 | 10004259 | CAY10429 | 10 mg | 2240 |
| Cayman2015 | 10004259 | CAY10429 | 25 mg | 4900 |
| Cayman2015 | 10004259 | CAY10429 | 5 mg | 1260 |
| Cayman2015 | 10004281 | R-1 Methanandamide Phosphate | 1 mg | 770 |
| Cayman2015 | 10004281 | R-1 Methanandamide Phosphate | 10 mg | 5558 |
| Cayman2015 | 10004281 | R-1 Methanandamide Phosphate | 5 mg | 3472 |
| Cayman2015 | 10004301 | Goat Anti-Rabbit IgG HRP | 1 ea | 756 |
| Cayman2015 | 10004302 | Goat Anti-Mouse IgG HRP | 1 ea | 910 |
| Cayman2015 | 10004303 | 11β-Hydroxysteroid Dehydrogenase (Type 1) Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 10004303 | 11β-Hydroxysteroid Dehydrogenase (Type 1) Polyclonal Antibody | 1 Trial | 1386 |
| Cayman2015 | 10004337 | Prostaglandin D Synthase (hematopoietic-type; human) Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 10004342 | Prostaglandin D Synthase (lipocalin-type; human) Monoclonal Antibody (Clone 10A5) | 1 ea | 2786 |
| Cayman2015 | 10004344 | Prostaglandin D Synthase (lipocalin-type; mouse) Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 10004345 | Prostaglandin D Synthase (hematopoietic-type; human) Monoclonal Antibody (Clone 2A5) | 1 ea | 3150 |
| Cayman2015 | 10004348 | Prostaglandin D Synthase (hematopoietic-type; mouse) Polyclonal Antiserum | 1 ea | 2926 |
| Cayman2015 | 10004349 | Prostaglandin D Synthase (hematopoietic-type; mouse) Monoclonal Antibody (Clone 7H4) | 1 ea | 3206 |
| Cayman2015 | 10004350 | Prostaglandin E Synthase-1 (microsomal) Monoclonal Antibody (Clone 6C6) | 1 ea | 3206 |
| Cayman2015 | 10004372 | (±)-Nutlin-3 | 1 mg | 406 |
| Cayman2015 | 10004372 | (±)-Nutlin-3 | 10 mg | 2282 |
| Cayman2015 | 10004372 | (±)-Nutlin-3 | 5 mg | 1232 |
| Cayman2015 | 10004372 | (±)-Nutlin-3 | 50 mg | 5642 |
| Cayman2015 | 10004377 | Aldosterone EIA Kit - Monoclonal | 480 Solid | 13160 |
| Cayman2015 | 10004377 | Aldosterone EIA Kit - Monoclonal | 480 Well | 13160 |
| Cayman2015 | 10004377 | Aldosterone EIA Kit - Monoclonal | 96 Solid | 3500 |
| Cayman2015 | 10004377 | Aldosterone EIA Kit - Monoclonal | 96 Well | 3500 |
| Cayman2015 | 10004380 | PAF Acetylhydrolase Inhibitor Screening Assay Kit | 1 ea | 3444 |
| Cayman2015 | 10004381 | Aldosterone EIA Monoclonal Antibody | 100 dtn | 882 |
| Cayman2015 | 10004381 | Aldosterone EIA Monoclonal Antibody | 500 dtn | 3304 |
| Cayman2015 | 10004382 | Aldosterone AChE Tracer | 100 dtn | 2478 |
| Cayman2015 | 10004382 | Aldosterone AChE Tracer | 500 dtn | 9296 |
| Cayman2015 | 10004383 | Aldosterone EIA Standard | 1 ea | 392 |
| Cayman2015 | 10004384 | 16(S)-HETE | 100 μg | 6048 |
| Cayman2015 | 10004384 | 16(S)-HETE | 25 μg | 1680 |
| Cayman2015 | 10004384 | 16(S)-HETE | 50 μg | 3192 |
| Cayman2015 | 10004385 | 16(R)-HETE | 100 μg | 6048 |
| Cayman2015 | 10004385 | 16(R)-HETE | 25 μg | 1680 |
| Cayman2015 | 10004385 | 16(R)-HETE | 50 μg | 3192 |
| Cayman2015 | 10004386 | Sulindac | 1000 mg | 126 |
| Cayman2015 | 10004386 | Sulindac | 10000 mg | 1008 |
| Cayman2015 | 10004386 | Sulindac | 5000 mg | 574 |
| Cayman2015 | 10004386 | Sulindac | 50000 mg | 4410 |
| Cayman2015 | 10004387 | Sulindac sulfide | 1 mg | 350 |
| Cayman2015 | 10004387 | Sulindac sulfide | 10 mg | 980 |
| Cayman2015 | 10004387 | Sulindac sulfide | 25 mg | 2100 |
| Cayman2015 | 10004387 | Sulindac sulfide | 5 mg | 560 |
| Cayman2015 | 10004412 | Reversine | 1 mg | 392 |
| Cayman2015 | 10004412 | Reversine | 10 mg | 3136 |
| Cayman2015 | 10004412 | Reversine | 25 mg | 6860 |
| Cayman2015 | 10004412 | Reversine | 5 mg | 1764 |
| Cayman2015 | 10004413 | 4-hydroperoxy 2-Nonenal | 1 mg | 1120 |
| Cayman2015 | 10004413 | 4-hydroperoxy 2-Nonenal | 10 mg | 8232 |
| Cayman2015 | 10004413 | 4-hydroperoxy 2-Nonenal | 5 mg | 4704 |
| Cayman2015 | 10004413 | 4-hydroperoxy 2-Nonenal | 500 μg | 588 |
| Cayman2015 | 10004442 | Vilogenin (stickleback) Polyclonal Antibody (GA-306) | 100 μL | 4580 |
| Cayman2015 | 10004442 | Vilogenin (stickleback) Polyclonal Antibody (GA-306) | 500 μL | 20620 |
| Cayman2015 | 10004452 | TP Receptor (human) Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 10004454 | 15-Lipoxygenase-2 Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 10004457 | 15-Lipoxygenase-2 Blocking Peptide | 1 ea | 1498 |
| Cayman2015 | 10004549 | 11β-Hydroxysteroid Dehydrogenase (Type 2) Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 10004597 | CD45 Monoclonal Antibody (Clone BRA-55) | 1 ea | 3206 |
| Cayman2015 | 10004599 | CD4 Monoclonal Antibody (Clone RIV7) | 1 ea | 3206 |
| Cayman2015 | 10004600 | Cytokeratin Monoclonal Antibody (Clone C-11) | 1 ea | 3206 |
| Cayman2015 | 10004604 | CD95 Monoclonal Antibody (Clone IPO-4) | 1 ea | 3206 |
| Cayman2015 | 10004675 | NADP+ (sodium salt hydrate) | 1 g | 2436 |
| Cayman2015 | 10004675 | NADP+ (sodium salt hydrate) | 100 mg | 644 |
| Cayman2015 | 10004675 | NADP+ (sodium salt hydrate) | 250 mg | 910 |
| Cayman2015 | 10004675 | NADP+ (sodium salt hydrate) | 50 mg | 406 |
| Cayman2015 | 10004715 | CD8 Monoclonal Antibody (Clone RIV11) | 1 ea | 3206 |
| Cayman2015 | 10004716 | CD19 Monoclonal Antibody (Clone CB19) | 1 ea | 3206 |
| Cayman2015 | 10004718 | CD37 Monoclonal Antibody (Clone IPO-24) | 1 ea | 2912 |
| Cayman2015 | 10004722 | RSV Microsomal Immunoblot Control | 1 ea | 364 |
| Cayman2015 | 10004800 | PAF-AH Inhibitor Screening Assay Buffer (10X) | 1 ea | 140 |
| Cayman2015 | 10004801 | PAF-AH Inhibitor Screening Assay DTNB | 1 ea | 98 |
| Cayman2015 | 10004802 | 2-thio-PAF-AH Inhibitor Screening Assay (substrate) | 1 ea | 644 |
| Cayman2015 | 10004803 | Inhibitor Screening Human Plasma PAF-AH | 1 ea | 994 |
| Cayman2015 | 10004804 | CD150 Monoclonal Antibody (Clone IPO-3) | 1 ea | 2828 |
| Cayman2015 | 10004805 | PCNA Monoclonal Antibody (Clone IPO-38) | 1 ea | 2548 |
| Cayman2015 | 10004806 | p53 Monoclonal Antibody (Clone BP53-12) | 1 ea | 3206 |
| Cayman2015 | 10004807 | p53 (Phospho-Ser392) Polyclonal Antibody | 1 ea | 4580 |
| Cayman2015 | 10004835 | CD34 Monoclonal Antibody (Clone ICO-115) | 1 ea | 2982 |
| Cayman2015 | 10004837 | CD27 Monoclonal Antibody (Clone 203.6) | 1 ea | 3556 |
| Cayman2015 | 10004840 | LPA3 Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 10004872 | Antioxidant Assay Buffer (10X) | 1 ea | 196 |
| Cayman2015 | 10004873 | Antioxidant Assay Chromogen | 1 ea | 434 |
| Cayman2015 | 10004875 | Antioxidant Assay Metmyoglobin | 1 ea | 588 |
| Cayman2015 | 10004876 | Antioxidant Assay Trolox | 1 ea | 266 |
| Cayman2015 | 10004877 | Antioxidant Assay Hydrogen Peroxide | 1 ea | 266 |
| Cayman2015 | 10004883 | sPLA2 (Type V) Inhibitor Screening Assay Kit | 96 Well | 4872 |
| Cayman2015 | 10004884 | CRTH2/DP2 Receptor (N-Term) Blocking Peptide | 1 ea | 1498 |
| Cayman2015 | 10004886 | CRTH2/DP2 Receptor (N-Term) Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 10004888 | FMOC-L-Leucine | 100 g | 756 |
| Cayman2015 | 10004888 | FMOC-L-Leucine | 25 g | 210 |
| Cayman2015 | 10004888 | FMOC-L-Leucine | 50 g | 406 |
| Cayman2015 | 10004910 | Mouse Macrophage Microsomal Immunoblot Control | 1 ea | 896 |
| Cayman2015 | 10004913 | sPLA2 Assay (human Type V) | 1 ea | 2394 |
| Cayman2015 | 10004914 | O-1918 | 1 mg | 322 |
| Cayman2015 | 10004914 | O-1918 | 10 mg | 1932 |
| Cayman2015 | 10004914 | O-1918 | 25 mg | 3626 |
| Cayman2015 | 10004914 | O-1918 | 5 mg | 1288 |
| Cayman2015 | 10004942 | Nod2 Monoclonal Antibody (Clone 2D9) | 1 ea | 3206 |
| Cayman2015 | 10004943 | PEPCK Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 10004944 | FABP4 Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 10004946 | 14,15-EE-5(Z)-E | 100 μg | 1764 |
| Cayman2015 | 10004946 | 14,15-EE-5(Z)-E | 25 μg | 490 |
| Cayman2015 | 10004946 | 14,15-EE-5(Z)-E | 50 μg | 938 |
| Cayman2015 | 10004946 | 14,15-EE-5(Z)-E | 500 μg | 7840 |
| Cayman2015 | 10004970 | (+)-5-trans Cloprostenol | 1 mg | 784 |
| Cayman2015 | 10004970 | (+)-5-trans Cloprostenol | 10 mg | 6272 |
| Cayman2015 | 10004970 | (+)-5-trans Cloprostenol | 25 mg | 13720 |
| Cayman2015 | 10004970 | (+)-5-trans Cloprostenol | 5 mg | 3528 |
| Cayman2015 | 10004971 | N,N'-Dicyclohexylurea | 10 g | 210 |
| Cayman2015 | 10004971 | N,N'-Dicyclohexylurea | 25 g | 350 |
| Cayman2015 | 10004974 | Ionomycin | 1 mg | 266 |
| Cayman2015 | 10004974 | Ionomycin | 10 mg | 2128 |
| Cayman2015 | 10004974 | Ionomycin | 25 mg | 4662 |
| Cayman2015 | 10004974 | Ionomycin | 5 mg | 1204 |
| Cayman2015 | 10004976 | Leptomycin B | 10 μg | 602 |
| Cayman2015 | 10004976 | Leptomycin B | 25 μg | 1316 |
| Cayman2015 | 10004976 | Leptomycin B | 5 μg | 350 |
| Cayman2015 | 10004985 | Caylin-1 | 1 mg | 700 |
| Cayman2015 | 10004985 | Caylin-1 | 10 mg | 5600 |
| Cayman2015 | 10004985 | Caylin-1 | 5 mg | 3150 |
| Cayman2015 | 10004993 | Vilogenin (carp) EIA Kit | 480 WEL | 52960 |
| Cayman2015 | 10004993 | Vilogenin (carp) EIA Kit | 96 WEL | 14120 |
| Cayman2015 | 10004994 | Vilogenin (rainbow trout) EIA Kit | 480 Well | 52960 |
| Cayman2015 | 10004994 | Vilogenin (rainbow trout) EIA Kit | 96 Well | 14120 |
| Cayman2015 | 10004995 | Vilogenin (zebrafish) EIA Kit | 480 Well | 52960 |
| Cayman2015 | 10004995 | Vilogenin (zebrafish) EIA Kit | 96 WEL | 14120 |
| Cayman2015 | 10005 | Prostaglandin Metabolite HPLC Mixture | 1 ea | 1106 |
| Cayman2015 | 10005000 | Stearidonic Acid methyl ester | 1 mg | 966 |
| Cayman2015 | 10005000 | Stearidonic Acid methyl ester | 10 mg | 7728 |
| Cayman2015 | 10005000 | Stearidonic Acid methyl ester | 5 mg | 4354 |
| Cayman2015 | 10005002 | Caylin-2 | 1 mg | 700 |
| Cayman2015 | 10005002 | Caylin-2 | 10 mg | 5600 |
| Cayman2015 | 10005002 | Caylin-2 | 5 mg | 3150 |
| Cayman2015 | 10005019 | CAY10433 | 1 mg | 644 |
| Cayman2015 | 10005019 | CAY10433 | 10 mg | 5152 |
| Cayman2015 | 10005019 | CAY10433 | 25 mg | 11270 |
| Cayman2015 | 10005019 | CAY10433 | 5 mg | 2898 |
| Cayman2015 | 10005020 | Protein Carbonyl Colorimetric Assay Kit | 96 Well | 3850 |
| Cayman2015 | 10005031 | L-NMMA (acetate) | 100 mg | 2352 |
| Cayman2015 | 10005031 | L-NMMA (acetate) | 25 mg | 756 |
| Cayman2015 | 10005031 | L-NMMA (acetate) | 5 mg | 168 |
| Cayman2015 | 10005031 | L-NMMA (acetate) | 50 mg | 1344 |
| Cayman2015 | 10005032 | 5(S),6(R)-7-trihydroxymethyl Heptanoate | 1 mg | 630 |
| Cayman2015 | 10005032 | 5(S),6(R)-7-trihydroxymethyl Heptanoate | 10 mg | 5040 |
| Cayman2015 | 10005032 | 5(S),6(R)-7-trihydroxymethyl Heptanoate | 5 mg | 2842 |
| Cayman2015 | 10005033 | CAY10444 | 10 mg | 1120 |
| Cayman2015 | 10005033 | CAY10444 | 25 mg | 2646 |
| Cayman2015 | 10005033 | CAY10444 | 5 mg | 588 |
| Cayman2015 | 10005033 | CAY10444 | 50 mg | 4704 |
| Cayman2015 | 10005056 | Eicosapentaenoic Acid-d5 | 1 mg | 8876 |
| Cayman2015 | 10005056 | Eicosapentaenoic Acid-d5 | 100 μg | 1386 |
| Cayman2015 | 10005056 | Eicosapentaenoic Acid-d5 | 50 μg | 728 |
| Cayman2015 | 10005056 | Eicosapentaenoic Acid-d5 | 500 μg | 5544 |
| Cayman2015 | 10005057 | Docosahexaenoic Acid-d5 | 1 mg | 4536 |
| Cayman2015 | 10005057 | Docosahexaenoic Acid-d5 | 100 μg | 1008 |
| Cayman2015 | 10005057 | Docosahexaenoic Acid-d5 | 50 μg | 630 |
| Cayman2015 | 10005057 | Docosahexaenoic Acid-d5 | 500 μg | 3780 |
| Cayman2015 | 10005059 | PTEN Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 10005064 | Thromboxane B2 Express AChE Tracer | 100 dtn | 2114 |
| Cayman2015 | 10005064 | Thromboxane B2 Express AChE Tracer | 500 dtn | 7784 |
| Cayman2015 | 10005065 | Thromboxane B2 Express EIA Monoclonal Antibody | 100 dtn | 714 |
| Cayman2015 | 10005065 | Thromboxane B2 Express EIA Monoclonal Antibody | 500 dtn | 2674 |
| Cayman2015 | 10005066 | Thromboxane B2 Express EIA Standard | 1 ea | 308 |
| Cayman2015 | 10005067 | CAY10434 | 1 mg | 266 |
| Cayman2015 | 10005067 | CAY10434 | 10 mg | 2128 |
| Cayman2015 | 10005067 | CAY10434 | 5 mg | 1204 |
| Cayman2015 | 10005067 | CAY10434 | 50 mg | 9310 |
| Cayman2015 | 10005072 | CAY10455 | 1 mg | 5040 |
| Cayman2015 | 10005072 | CAY10455 | 100 μg | 630 |
| Cayman2015 | 10005072 | CAY10455 | 500 μg | 2842 |
| Cayman2015 | 10005090 | SOAT-1/ACAT-1 Blocking Peptide | 1 ea | 1498 |
| Cayman2015 | 10005091 | SOAT-2/ACAT-2 Blocking Peptide | 1 ea | 1498 |
| Cayman2015 | 10005092 | LPA3 Blocking Peptide | 1 ea | 1498 |
| Cayman2015 | 10005098 | AMC Arachidonoyl Amide | 10 mg | 1736 |
| Cayman2015 | 10005098 | AMC Arachidonoyl Amide | 25 mg | 4102 |
| Cayman2015 | 10005098 | AMC Arachidonoyl Amide | 5 mg | 910 |
| Cayman2015 | 10005098 | AMC Arachidonoyl Amide | 50 mg | 7280 |
| Cayman2015 | 10005099 | 17(R)-HDoHE | 100 μg | 4634 |
| Cayman2015 | 10005099 | 17(R)-HDoHE | 25 μg | 1288 |
| Cayman2015 | 10005099 | 17(R)-HDoHE | 250 μg | 10304 |
| Cayman2015 | 10005099 | 17(R)-HDoHE | 50 μg | 2450 |
| Cayman2015 | 10005102 | CAY10435 | 1 mg | 1148 |
| Cayman2015 | 10005102 | CAY10435 | 10 mg | 8428 |
| Cayman2015 | 10005102 | CAY10435 | 5 mg | 4816 |
| Cayman2015 | 10005102 | CAY10435 | 500 μg | 602 |
| Cayman2015 | 10005166 | Daidzein | 100 mg | 140 |
| Cayman2015 | 10005166 | Daidzein | 1000 mg | 1120 |
| Cayman2015 | 10005166 | Daidzein | 500 mg | 630 |
| Cayman2015 | 10005166 | Daidzein | 5000 mg | 4900 |
| Cayman2015 | 10005167 | Genistein | 100 mg | 518 |
| Cayman2015 | 10005167 | Genistein | 1000 mg | 4144 |
| Cayman2015 | 10005167 | Genistein | 250 mg | 1232 |
| Cayman2015 | 10005167 | Genistein | 500 mg | 2338 |
| Cayman2015 | 10005169 | Quercetin | 10 g | 322 |
| Cayman2015 | 10005169 | Quercetin | 100 g | 2352 |
| Cayman2015 | 10005169 | Quercetin | 50 g | 1344 |
| Cayman2015 | 10005169 | Quercetin | 5000 mg | 168 |
| Cayman2015 | 10005174 | Matairesinol | 1 mg | 420 |
| Cayman2015 | 10005174 | Matairesinol | 10 mg | 2520 |
| Cayman2015 | 10005174 | Matairesinol | 25 mg | 4732 |
| Cayman2015 | 10005174 | Matairesinol | 5 mg | 1680 |
| Cayman2015 | 10005186 | CAY10441 | 1 mg | 714 |
| Cayman2015 | 10005186 | CAY10441 | 10 mg | 5712 |
| Cayman2015 | 10005186 | CAY10441 | 25 mg | 12502 |
| Cayman2015 | 10005186 | CAY10441 | 5 mg | 3220 |
| Cayman2015 | 10005188 | DAUDA | 100 mg | 1260 |
| Cayman2015 | 10005188 | DAUDA | 25 mg | 350 |
| Cayman2015 | 10005188 | DAUDA | 50 mg | 672 |
| Cayman2015 | 10005190 | EAF2 Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 10005191 | FABP4 (mouse recombinant) | 100 μg | 4984 |
| Cayman2015 | 10005191 | FABP4 (mouse recombinant) | 25 μg | 1386 |
| Cayman2015 | 10005191 | FABP4 (mouse recombinant) | 50 μg | 2632 |
| Cayman2015 | 10005196 | FAAH Inhibitor Screening Assay Kit | 96 Well | 3920 |
| Cayman2015 | 10005198 | Cytochrome P450 Control Yeast Reductase | 10 mg | 3900 |
| Cayman2015 | 10005199 | Cytochrome P450 Control Human Reductase | 10 mg | 5100 |
| Cayman2015 | 10005223 | AM1172 | 10 mg | 1862 |
| Cayman2015 | 10005223 | AM1172 | 100 mg | 13720 |
| Cayman2015 | 10005223 | AM1172 | 5 mg | 980 |
| Cayman2015 | 10005223 | AM1172 | 50 mg | 7840 |
| Cayman2015 | 10005228 | S1P1 Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 10005228 | S1P1 Polyclonal Antibody | 1 Trial | 1428 |
| Cayman2015 | 10005229 | 2,3-DCPE (hydrochloride) | 10 mg | 770 |
| Cayman2015 | 10005229 | 2,3-DCPE (hydrochloride) | 5 mg | 406 |
| Cayman2015 | 10005229 | 2,3-DCPE (hydrochloride) | 50 mg | 3248 |
| Cayman2015 | 10005254 | AFMK | 1 mg | 252 |
| Cayman2015 | 10005254 | AFMK | 10 mg | 1512 |
| Cayman2015 | 10005254 | AFMK | 5 mg | 1008 |
| Cayman2015 | 10005254 | AFMK | 50 mg | 5040 |
| Cayman2015 | 10005256 | GPx4 Blocking Peptide | 1 ea | 1498 |
| Cayman2015 | 10005257 | Prostaglandin I Synthase (mouse) Blocking Peptide | 1 ea | 1498 |
| Cayman2015 | 10005258 | GPx4 Polyclonal Antibody | 1 ea | 3780 |
| Cayman2015 | 10005260 | Serine Palmitoyltransferase Polyclonal Antibody | 1 ea | 3780 |
| Cayman2015 | 10005263 | TOFA | 10 mg | 770 |
| Cayman2015 | 10005263 | TOFA | 100 mg | 5684 |
| Cayman2015 | 10005263 | TOFA | 5 mg | 406 |
| Cayman2015 | 10005263 | TOFA | 50 mg | 3248 |
| Cayman2015 | 10005270 | (±)-C75 | 1 mg | 616 |
| Cayman2015 | 10005270 | (±)-C75 | 10 mg | 2590 |
| Cayman2015 | 10005270 | (±)-C75 | 5 mg | 1848 |
| Cayman2015 | 10005272 | Cortisol AChE Tracer | 100 dtn | 1750 |
| Cayman2015 | 10005272 | Cortisol AChE Tracer | 500 dtn | 6566 |
| Cayman2015 | 10005276 | DL-threo-PDMP (hydrochloride) | 10 mg | 504 |
| Cayman2015 | 10005276 | DL-threo-PDMP (hydrochloride) | 100 mg | 3724 |
| Cayman2015 | 10005276 | DL-threo-PDMP (hydrochloride) | 5 mg | 266 |
| Cayman2015 | 10005276 | DL-threo-PDMP (hydrochloride) | 50 mg | 2128 |
| Cayman2015 | 10005280 | LPA1 Polyclonal Antibody | 1 ea | 3374 |
| Cayman2015 | 10005291 | p53 Product Pack | 1 ea | 7182 |
| Cayman2015 | 10005292 | Atherosclerosis Product Pack | 1 ea | 6230 |
| Cayman2015 | 10005314 | Creatinine Standard | 1 ea | 168 |
| Cayman2015 | 10005314 | Creatinine Standard | 5 ea | 630 |
| Cayman2015 | 10005315 | Creatinine Color Reagent | 1 ea | 728 |
| Cayman2015 | 10005315 | Creatinine Color Reagent | 5 ea | 2730 |
| Cayman2015 | 10005316 | Creatinine Sodium Hydroxide | 1 ea | 140 |
| Cayman2015 | 10005316 | Creatinine Sodium Hydroxide | 5 ea | 532 |
| Cayman2015 | 10005317 | Creatinine Acid Solution | 1 ea | 168 |
| Cayman2015 | 10005317 | Creatinine Acid Solution | 5 ea | 630 |
| Cayman2015 | 10005368 | Fenofibrate | 1000 mg | 126 |
| Cayman2015 | 10005368 | Fenofibrate | 10000 mg | 1008 |
| Cayman2015 | 10005368 | Fenofibrate | 5000 mg | 574 |
| Cayman2015 | 10005368 | Fenofibrate | 50000 mg | 4410 |
| Cayman2015 | 10005371 | 384-Well Solid Plate (black; non-binding) | 1 ea | 238 |
| Cayman2015 | 10005371 | 384-Well Solid Plate (black; non-binding) | 5 ea | 896 |
| Cayman2015 | 10005372 | 96-Well Solid Plate (black; non-binding) | 1 ea | 238 |
| Cayman2015 | 10005372 | 96-Well Solid Plate (black; non-binding) | 5 ea | 896 |
| Cayman2015 | 10005375 | Lysophospholipase D Polyclonal Antibody | 1 ea | 3374 |
| Cayman2015 | 10005388 | Prostaglandin Transporter Blocking Peptide | 1 ea | 1498 |
| Cayman2015 | 10005395 | Hydrogen Peroxide Assay (urinary) Catalase | 1 ea | 490 |
| Cayman2015 | 10005426 | Orlistat | 100 mg | 644 |
| Cayman2015 | 10005426 | Orlistat | 250 mg | 1512 |
| Cayman2015 | 10005426 | Orlistat | 50 mg | 336 |
| Cayman2015 | 10005426 | Orlistat | 500 mg | 2688 |
| Cayman2015 | 10005428 | JWH 133 | 1 mg | 490 |
| Cayman2015 | 10005428 | JWH 133 | 10 mg | 2800 |
| Cayman2015 | 10005428 | JWH 133 | 25 mg | 6132 |
| Cayman2015 | 10005428 | JWH 133 | 5 mg | 1722 |
| Cayman2015 | 10005432 | DDA | 10 mL | 742 |
| Cayman2015 | 10005432 | DDA | 25 mL | 1764 |
| Cayman2015 | 10005432 | DDA | 5 mL | 392 |
| Cayman2015 | 10005432 | DDA | 50 mL | 3136 |
| Cayman2015 | 10005439 | Tafluprost (free acid) | 1 mg | 1302 |
| Cayman2015 | 10005439 | Tafluprost (free acid) | 10 mg | 10416 |
| Cayman2015 | 10005439 | Tafluprost (free acid) | 25 mg | 22792 |
| Cayman2015 | 10005439 | Tafluprost (free acid) | 5 mg | 5866 |
| Cayman2015 | 10005440 | Tafluprost | 1 mg | 1274 |
| Cayman2015 | 10005440 | Tafluprost | 10 mg | 10192 |
| Cayman2015 | 10005440 | Tafluprost | 25 mg | 15932 |
| Cayman2015 | 10005440 | Tafluprost | 5 mg | 5740 |
| Cayman2015 | 10005455 | N-Arachidonoyl-L-Serine | 1 mg | 210 |
| Cayman2015 | 10005455 | N-Arachidonoyl-L-Serine | 10 mg | 840 |
| Cayman2015 | 10005455 | N-Arachidonoyl-L-Serine | 25 mg | 1820 |
| Cayman2015 | 10005455 | N-Arachidonoyl-L-Serine | 5 mg | 560 |
| Cayman2015 | 10005459 | Oleoyl Ethyl Amide | 1 mg | 154 |
| Cayman2015 | 10005459 | Oleoyl Ethyl Amide | 10 mg | 1232 |
| Cayman2015 | 10005459 | Oleoyl Ethyl Amide | 25 mg | 2702 |
| Cayman2015 | 10005459 | Oleoyl Ethyl Amide | 5 mg | 700 |
| Cayman2015 | 10005516 | Doppel Blocking Peptide | 1 ea | 1498 |
| Cayman2015 | 10005517 | Doppel Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 10005518 | IP Receptor (human) Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 10005519 | IP Receptor (human) Blocking Peptide | 1 ea | 1498 |
| Cayman2015 | 10005537 | N-Arachidonoyl Taurine | 1 mg | 910 |
| Cayman2015 | 10005537 | N-Arachidonoyl Taurine | 10 mg | 6664 |
| Cayman2015 | 10005537 | N-Arachidonoyl Taurine | 5 mg | 3808 |
| Cayman2015 | 10005537 | N-Arachidonoyl Taurine | 500 μg | 476 |
| Cayman2015 | 10005583 | Y-27632 (hydrochloride) | 1 mg | 630 |
| Cayman2015 | 10005583 | Y-27632 (hydrochloride) | 10 mg | 2212 |
| Cayman2015 | 10005583 | Y-27632 (hydrochloride) | 5 mg | 1582 |
| Cayman2015 | 10005583 | Y-27632 (hydrochloride) | 50 mg | 7560 |
| Cayman2015 | 10005609 | N-Oleoyl Taurine | 1 mg | 910 |
| Cayman2015 | 10005609 | N-Oleoyl Taurine | 10 mg | 6664 |
| Cayman2015 | 10005609 | N-Oleoyl Taurine | 5 mg | 3808 |
| Cayman2015 | 10005609 | N-Oleoyl Taurine | 500 μg | 476 |
| Cayman2015 | 10005610 | N-Stearoyl Taurine | 1 mg | 938 |
| Cayman2015 | 10005610 | N-Stearoyl Taurine | 10 mg | 7504 |
| Cayman2015 | 10005610 | N-Stearoyl Taurine | 5 mg | 4228 |
| Cayman2015 | 10005611 | N-Palmitoyl Taurine | 1 mg | 938 |
| Cayman2015 | 10005611 | N-Palmitoyl Taurine | 10 mg | 7504 |
| Cayman2015 | 10005611 | N-Palmitoyl Taurine | 5 mg | 4228 |
| Cayman2015 | 10005615 | PtdIns-(4,5)-P2 (1,2-dipamitoyl)-d62 (sodium salt) | 100 μg | 3780 |
| Cayman2015 | 10005615 | PtdIns-(4,5)-P2 (1,2-dipamitoyl)-d62 (sodium salt) | 25 μg | 1050 |
| Cayman2015 | 10005615 | PtdIns-(4,5)-P2 (1,2-dipamitoyl)-d62 (sodium salt) | 50 μg | 2002 |
| Cayman2015 | 10005616 | PtdIns-(3)-P1 (1,2-dipalmitoyl)-d62 (ammonium salt) | 100 μg | 3780 |
| Cayman2015 | 10005616 | PtdIns-(3)-P1 (1,2-dipalmitoyl)-d62 (ammonium salt) | 25 μg | 1050 |
| Cayman2015 | 10005616 | PtdIns-(3)-P1 (1,2-dipalmitoyl)-d62 (ammonium salt) | 50 μg | 2002 |
| Cayman2015 | 10005633 | CAY10448 | 1 mg | 224 |
| Cayman2015 | 10005633 | CAY10448 | 10 mg | 1792 |
| Cayman2015 | 10005633 | CAY10448 | 5 mg | 1008 |
| Cayman2015 | 10005633 | CAY10448 | 50 mg | 7840 |
| Cayman2015 | 10005647 | Cerulenin | 10 mg | 1750 |
| Cayman2015 | 10005647 | Cerulenin | 5 mg | 910 |
| Cayman2015 | 10005647 | Cerulenin | 50 mg | 7280 |
| Cayman2015 | 10005673 | HU-331 | 1 mg | 672 |
| Cayman2015 | 10005673 | HU-331 | 10 mg | 5376 |
| Cayman2015 | 10005673 | HU-331 | 25 mg | 11760 |
| Cayman2015 | 10005673 | HU-331 | 5 mg | 3024 |
| Cayman2015 | 10005705 | NO-Indomethacin | 1 mg | 224 |
| Cayman2015 | 10005705 | NO-Indomethacin | 10 mg | 1792 |
| Cayman2015 | 10005705 | NO-Indomethacin | 5 mg | 1008 |
| Cayman2015 | 10005705 | NO-Indomethacin | 50 mg | 7840 |
| Cayman2015 | 10005707 | (2S)-OMPT | 1 mg | 1512 |
| Cayman2015 | 10005707 | (2S)-OMPT | 10 mg | 11172 |
| Cayman2015 | 10005707 | (2S)-OMPT | 5 mg | 6384 |
| Cayman2015 | 10005707 | (2S)-OMPT | 500 μg | 798 |
| Cayman2015 | 10005728 | DL-α-Lipoic Acid | 1 g | 98 |
| Cayman2015 | 10005728 | DL-α-Lipoic Acid | 10 g | 784 |
| Cayman2015 | 10005728 | DL-α-Lipoic Acid | 25 g | 1722 |
| Cayman2015 | 10005728 | DL-α-Lipoic Acid | 5 g | 448 |
| Cayman2015 | 10005729 | 11β-Hydroxysteroid Dehydrogenase (Type 1) Blocking Peptide | 1 ea | 1498 |
| Cayman2015 | 10005732 | EAF2 Blocking Peptide | 1 ea | 1498 |
| Cayman2015 | 10005764 | 8-iso Prostaglandin F2α Ethanolamide | 1 mg | 4704 |
| Cayman2015 | 10005764 | 8-iso Prostaglandin F2α Ethanolamide | 100 μg | 588 |
| Cayman2015 | 10005764 | 8-iso Prostaglandin F2α Ethanolamide | 500 μg | 2646 |
| Cayman2015 | 10005765 | Arachidoyl Ethanolamide | 10 mg | 770 |
| Cayman2015 | 10005765 | Arachidoyl Ethanolamide | 100 mg | 5810 |
| Cayman2015 | 10005765 | Arachidoyl Ethanolamide | 25 mg | 1820 |
| Cayman2015 | 10005765 | Arachidoyl Ethanolamide | 5 mg | 406 |
| Cayman2015 | 10005823 | Docosanoyl Ethanolamide | 10 mg | 1302 |
| Cayman2015 | 10005823 | Docosanoyl Ethanolamide | 100 mg | 9604 |
| Cayman2015 | 10005823 | Docosanoyl Ethanolamide | 5 mg | 686 |
| Cayman2015 | 10005823 | Docosanoyl Ethanolamide | 50 mg | 5488 |
| Cayman2015 | 10005836 | bis(7)-Tacrine | 10 mg | 1708 |
| Cayman2015 | 10005836 | bis(7)-Tacrine | 100 mg | 12544 |
| Cayman2015 | 10005836 | bis(7)-Tacrine | 5 mg | 896 |
| Cayman2015 | 10005836 | bis(7)-Tacrine | 50 mg | 7168 |
| Cayman2015 | 10005845 | Protein Carbonyl Hydrochloric Acid | 1 ea | 266 |
| Cayman2015 | 10005846 | Protein Carbonyl DNPH | 1 ea | 434 |
| Cayman2015 | 10005847 | Protein Carbonyl TCA Solution | 1 ea | 350 |
| Cayman2015 | 10005848 | Protein Carbonyl Guanidine Hydrochloride | 1 ea | 350 |
| Cayman2015 | 10005849 | Protein Carbonyl Ethanol | 1 ea | 266 |
| Cayman2015 | 10005850 | Protein Carbonyl Ethyl Acetate | 1 ea | 266 |
| Cayman2015 | 10005851 | N-Decanoyl p-Nitroaniline | 10 mg | 322 |
| Cayman2015 | 10005851 | N-Decanoyl p-Nitroaniline | 25 mg | 756 |
| Cayman2015 | 10005851 | N-Decanoyl p-Nitroaniline | 5 mg | 168 |
| Cayman2015 | 10005851 | N-Decanoyl p-Nitroaniline | 50 mg | 1344 |
| Cayman2015 | 10005913 | CAY10449 | 1 mg | 644 |
| Cayman2015 | 10005913 | CAY10449 | 10 mg | 5152 |
| Cayman2015 | 10005913 | CAY10449 | 25 mg | 11270 |
| Cayman2015 | 10005913 | CAY10449 | 5 mg | 2898 |
| Cayman2015 | 10005983 | Pentafluorobenzenesulfonyl fluorescein | 1 mg | 462 |
| Cayman2015 | 10005983 | Pentafluorobenzenesulfonyl fluorescein | 10 mg | 3696 |
| Cayman2015 | 10005983 | Pentafluorobenzenesulfonyl fluorescein | 25 mg | 8092 |
| Cayman2015 | 10005983 | Pentafluorobenzenesulfonyl fluorescein | 5 mg | 2086 |
| Cayman2015 | 10006045 | (R)-Butaprost (free acid) | 1 mg | 1834 |
| Cayman2015 | 10006045 | (R)-Butaprost (free acid) | 10 mg | 13524 |
| Cayman2015 | 10006045 | (R)-Butaprost (free acid) | 5 mg | 7728 |
| Cayman2015 | 10006045 | (R)-Butaprost (free acid) | 500 μg | 966 |
| Cayman2015 | 10006084 | Hesperetin | 100000 mg | 1610 |
| Cayman2015 | 10006084 | Hesperetin | 25000 mg | 448 |
| Cayman2015 | 10006084 | Hesperetin | 50000 mg | 854 |
| Cayman2015 | 10006084 | Hesperetin | 500000 mg | 7168 |
| Cayman2015 | 10006148 | Leelamine | 10 mg | 770 |
| Cayman2015 | 10006148 | Leelamine | 25 mg | 1834 |
| Cayman2015 | 10006148 | Leelamine | 5 mg | 406 |
| Cayman2015 | 10006148 | Leelamine | 50 mg | 3248 |
| Cayman2015 | 10006170 | DMPO Nitrone Adduct Polyclonal Antiserum | 1 ea | 4116 |
| Cayman2015 | 10006189 | cis-Parinaric Acid methyl ester | 1 mg | 308 |
| Cayman2015 | 10006189 | cis-Parinaric Acid methyl ester | 10 mg | 2464 |
| Cayman2015 | 10006189 | cis-Parinaric Acid methyl ester | 5 mg | 1386 |
| Cayman2015 | 10006189 | cis-Parinaric Acid methyl ester | 50 mg | 10780 |
| Cayman2015 | 10006197 | Leukotriene A4-d5 methyl ester | 100 μg | 4788 |
| Cayman2015 | 10006197 | Leukotriene A4-d5 methyl ester | 25 μg | 1330 |
| Cayman2015 | 10006197 | Leukotriene A4-d5 methyl ester | 50 μg | 2534 |
| Cayman2015 | 10006198 | Leukotriene C4-d5 | 100 μg | 11536 |
| Cayman2015 | 10006198 | Leukotriene C4-d5 | 25 μg | 3206 |
| Cayman2015 | 10006198 | Leukotriene C4-d5 | 50 μg | 6090 |
| Cayman2015 | 10006199 | Leukotriene D4-d5 | 100 μg | 11536 |
| Cayman2015 | 10006199 | Leukotriene D4-d5 | 25 μg | 3206 |
| Cayman2015 | 10006199 | Leukotriene D4-d5 | 50 μg | 6090 |
| Cayman2015 | 10006211 | Silybin | 1000 mg | 112 |
| Cayman2015 | 10006211 | Silybin | 10000 mg | 896 |
| Cayman2015 | 10006211 | Silybin | 5000 mg | 504 |
| Cayman2015 | 10006211 | Silybin | 50000 mg | 3920 |
| Cayman2015 | 10006212 | AN-7 | 1 mg | 350 |
| Cayman2015 | 10006212 | AN-7 | 10 mg | 2100 |
| Cayman2015 | 10006212 | AN-7 | 5 mg | 1134 |
| Cayman2015 | 10006217 | Renin (human recombinant) | 10 μg | 1680 |
| Cayman2015 | 10006217 | Renin (human recombinant) | 25 μg | 3906 |
| Cayman2015 | 10006217 | Renin (human recombinant) | 5 μg | 882 |
| Cayman2015 | 10006217 | Renin (human recombinant) | 50 μg | 7056 |
| Cayman2015 | 10006247 | PPARδ Blocking Peptide | 1 ea | 1498 |
| Cayman2015 | 10006248 | FABP4 Blocking Peptide | 1 ea | 1498 |
| Cayman2015 | 10006270 | Renin Inhibitor Screening Assay Kit | 96 Well | 5908 |
| Cayman2015 | 10006283 | PINK1 Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 10006283 | PINK1 Polyclonal Antibody | 1 Trial | 1386 |
| Cayman2015 | 10006284 | PINK1 Blocking Peptide | 1 ea | 1498 |
| Cayman2015 | 10006292 | FTY720 | 10 mg | 1330 |
| Cayman2015 | 10006292 | FTY720 | 25 mg | 2772 |
| Cayman2015 | 10006292 | FTY720 | 5 mg | 770 |
| Cayman2015 | 10006292 | FTY720 | 50 mg | 4410 |
| Cayman2015 | 10006305 | D-NMAPPD | 1 mg | 252 |
| Cayman2015 | 10006305 | D-NMAPPD | 10 mg | 2016 |
| Cayman2015 | 10006305 | D-NMAPPD | 5 mg | 1134 |
| Cayman2015 | 10006305 | D-NMAPPD | 50 mg | 8820 |
| Cayman2015 | 10006306 | Ghrelin (human acylated) EIA Kit | 1 ea | 9400 |
| Cayman2015 | 10006307 | Ghrelin (rat acylated) EIA Kit | 1 ea | 9400 |
| Cayman2015 | 10006309 | BCTC | 10 mg | 882 |
| Cayman2015 | 10006309 | BCTC | 5 mg | 462 |
| Cayman2015 | 10006309 | BCTC | 50 mg | 3696 |
| Cayman2015 | 10006315 | Estradiol | 1000 mg | 336 |
| Cayman2015 | 10006315 | Estradiol | 10000 mg | 1890 |
| Cayman2015 | 10006315 | Estradiol | 500 mg | 210 |
| Cayman2015 | 10006315 | Estradiol | 5000 mg | 1162 |
| Cayman2015 | 10006317 | Mifepristone | 100 mg | 266 |
| Cayman2015 | 10006317 | Mifepristone | 1000 mg | 2128 |
| Cayman2015 | 10006317 | Mifepristone | 500 mg | 1204 |
| Cayman2015 | 10006317 | Mifepristone | 5000 mg | 9310 |
| Cayman2015 | 10006318 | Levonorgestrel | 100 mg | 266 |
| Cayman2015 | 10006318 | Levonorgestrel | 1000 mg | 2128 |
| Cayman2015 | 10006318 | Levonorgestrel | 500 mg | 1204 |
| Cayman2015 | 10006318 | Levonorgestrel | 5000 mg | 9310 |
| Cayman2015 | 10006319 | Norgestrel | 100 mg | 266 |
| Cayman2015 | 10006319 | Norgestrel | 1000 mg | 2128 |
| Cayman2015 | 10006319 | Norgestrel | 500 mg | 1204 |
| Cayman2015 | 10006319 | Norgestrel | 5000 mg | 9310 |
| Cayman2015 | 10006320 | Quinestrol | 1 g | 3136 |
| Cayman2015 | 10006320 | Quinestrol | 100 mg | 392 |
| Cayman2015 | 10006320 | Quinestrol | 250 mg | 938 |
| Cayman2015 | 10006320 | Quinestrol | 500 mg | 1764 |
| Cayman2015 | 10006321 | Tibolone | 100 mg | 210 |
| Cayman2015 | 10006321 | Tibolone | 1000 mg | 1260 |
| Cayman2015 | 10006321 | Tibolone | 500 mg | 840 |
| Cayman2015 | 10006321 | Tibolone | 5000 mg | 4200 |
| Cayman2015 | 10006329 | EUK 134 | 10 mg | 644 |
| Cayman2015 | 10006329 | EUK 134 | 100 mg | 4872 |
| Cayman2015 | 10006329 | EUK 134 | 5 mg | 406 |
| Cayman2015 | 10006329 | EUK 134 | 50 mg | 2646 |
| Cayman2015 | 10006330 | 2,3-dinor Thromboxane B1 | 100 μg | 4788 |
| Cayman2015 | 10006330 | 2,3-dinor Thromboxane B1 | 25 μg | 1330 |
| Cayman2015 | 10006330 | 2,3-dinor Thromboxane B1 | 50 μg | 2534 |
| Cayman2015 | 10006341 | PDM 11 | 10 mg | 280 |
| Cayman2015 | 10006341 | PDM 11 | 100 mg | 2240 |
| Cayman2015 | 10006341 | PDM 11 | 25 mg | 672 |
| Cayman2015 | 10006341 | PDM 11 | 50 mg | 1260 |
| Cayman2015 | 10006342 | PDM 2 | 10 mg | 490 |
| Cayman2015 | 10006342 | PDM 2 | 100 mg | 3920 |
| Cayman2015 | 10006342 | PDM 2 | 50 mg | 2212 |
| Cayman2015 | 10006350 | HU-211 | 1 mg | 504 |
| Cayman2015 | 10006350 | HU-211 | 10 mg | 4032 |
| Cayman2015 | 10006350 | HU-211 | 25 mg | 8820 |
| Cayman2015 | 10006350 | HU-211 | 5 mg | 2268 |
| Cayman2015 | 10006355 | Melanocortin-4 Receptor Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 10006356 | Melanocortin-4 Receptor Blocking Peptide | 1 ea | 1498 |
| Cayman2015 | 10006371 | Hormone-Sensitive Lipase Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 10006372 | Hormone-Sensitive Lipase Blocking Peptide | 1 ea | 1498 |
| Cayman2015 | 10006373 | S1P3 Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 10006374 | S1P3 Blocking Peptide | 1 ea | 1498 |
| Cayman2015 | 10006389 | HDAC Assay Buffer (10X) | 1 ea | 238 |
| Cayman2015 | 10006391 | HDAC Trichostatin A | 1 ea | 168 |
| Cayman2015 | 10006392 | HDAC Substrate | 1 ea | 1652 |
| Cayman2015 | 10006393 | HDAC Deacetylated Standard | 1 ea | 168 |
| Cayman2015 | 10006394 | HDAC Developer | 1 ea | 238 |
| Cayman2015 | 10006400 | CAY10462 | 1 mg | 266 |
| Cayman2015 | 10006400 | CAY10462 | 10 mg | 2128 |
| Cayman2015 | 10006400 | CAY10462 | 5 mg | 1204 |
| Cayman2015 | 10006400 | CAY10462 | 50 mg | 9310 |
| Cayman2015 | 10006407 | FTY720 (R)-Phosphate | 1 mg | 1302 |
| Cayman2015 | 10006407 | FTY720 (R)-Phosphate | 10 mg | 9604 |
| Cayman2015 | 10006407 | FTY720 (R)-Phosphate | 5 mg | 5488 |
| Cayman2015 | 10006407 | FTY720 (R)-Phosphate | 500 μg | 686 |
| Cayman2015 | 10006408 | FTY720 (S)-Phosphate | 1 mg | 1484 |
| Cayman2015 | 10006408 | FTY720 (S)-Phosphate | 10 mg | 10976 |
| Cayman2015 | 10006408 | FTY720 (S)-Phosphate | 5 mg | 6272 |
| Cayman2015 | 10006408 | FTY720 (S)-Phosphate | 500 μg | 784 |
| Cayman2015 | 10006409 | Adipose Triglyceride Lipase Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 10006410 | 14(15)-EET-d11 | 100 μg | 7308 |
| Cayman2015 | 10006410 | 14(15)-EET-d11 | 25 μg | 2030 |
| Cayman2015 | 10006410 | 14(15)-EET-d11 | 250 μg | 16240 |
| Cayman2015 | 10006410 | 14(15)-EET-d11 | 50 μg | 3864 |
| Cayman2015 | 10006413 | 11(12)-EET-d11 | 10 μg | 1848 |
| Cayman2015 | 10006413 | 11(12)-EET-d11 | 100 μg | 14784 |
| Cayman2015 | 10006413 | 11(12)-EET-d11 | 25 μg | 4396 |
| Cayman2015 | 10006413 | 11(12)-EET-d11 | 50 μg | 8316 |
| Cayman2015 | 10006415 | Ro 48-8071 | 10 mg | 882 |
| Cayman2015 | 10006415 | Ro 48-8071 | 100 mg | 6468 |
| Cayman2015 | 10006415 | Ro 48-8071 | 5 mg | 462 |
| Cayman2015 | 10006415 | Ro 48-8071 | 50 mg | 3696 |
| Cayman2015 | 10006421 | HIF-1α (C-Term) Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 10006426 | RITA | 1 mg | 714 |
| Cayman2015 | 10006426 | RITA | 10 mg | 2352 |
| Cayman2015 | 10006426 | RITA | 5 mg | 1498 |
| Cayman2015 | 10006426 | RITA | 50 mg | 11074 |
| Cayman2015 | 10006427 | Berberine | 1000 mg | 84 |
| Cayman2015 | 10006427 | Berberine | 10000 mg | 672 |
| Cayman2015 | 10006427 | Berberine | 25000 mg | 1470 |
| Cayman2015 | 10006427 | Berberine | 5000 mg | 378 |
| Cayman2015 | 10006435 | DEPMPO | 250 mg | 8610 |
| Cayman2015 | 10006435 | DEPMPO | 50 mg | 2025 |
| Cayman2015 | 10006435 | DEPMPO | 500 mg | 15195 |
| Cayman2015 | 10006436 | DMPO | 1 g | 2002 |
| Cayman2015 | 10006436 | DMPO | 5 g | 8400 |
| Cayman2015 | 10006436 | DMPO | 500 mg | 1050 |
| Cayman2015 | 10006438 | Myeloperoxidase Chlorination Fluorometric Assay Kit | 192 Well | 3066 |
| Cayman2015 | 10006440 | SEW2871 | 10 mg | 238 |
| Cayman2015 | 10006440 | SEW2871 | 25 mg | 574 |
| Cayman2015 | 10006440 | SEW2871 | 5 mg | 126 |
| Cayman2015 | 10006440 | SEW2871 | 50 mg | 1008 |
| Cayman2015 | 10006451 | Pentacosanoic Acid methyl ester | 10 mg | 168 |
| Cayman2015 | 10006451 | Pentacosanoic Acid methyl ester | 100 mg | 1344 |
| Cayman2015 | 10006451 | Pentacosanoic Acid methyl ester | 50 mg | 756 |
| Cayman2015 | 10006451 | Pentacosanoic Acid methyl ester | 500 mg | 5390 |
| Cayman2015 | 10006452 | CAY10486 | 10 mg | 588 |
| Cayman2015 | 10006452 | CAY10486 | 5 mg | 308 |
| Cayman2015 | 10006452 | CAY10486 | 50 mg | 2464 |
| Cayman2015 | 10006452 | CAY10486 | 500 mg | 18480 |
| Cayman2015 | 10006454 | ω-3 Arachidonic Acid methyl ester | 1 mg | 672 |
| Cayman2015 | 10006454 | ω-3 Arachidonic Acid methyl ester | 10 mg | 5600 |
| Cayman2015 | 10006454 | ω-3 Arachidonic Acid methyl ester | 5 mg | 3150 |
| Cayman2015 | 10006454 | ω-3 Arachidonic Acid methyl ester | 500 μg | 350 |
| Cayman2015 | 10006456 | NO-Losartan A | 1 mg | 196 |
| Cayman2015 | 10006456 | NO-Losartan A | 10 mg | 1568 |
| Cayman2015 | 10006456 | NO-Losartan A | 5 mg | 882 |
| Cayman2015 | 10006456 | NO-Losartan A | 50 mg | 6860 |
| Cayman2015 | 10006480 | CAY10487 | 10 mg | 588 |
| Cayman2015 | 10006480 | CAY10487 | 5 mg | 308 |
| Cayman2015 | 10006480 | CAY10487 | 50 mg | 2464 |
| Cayman2015 | 10006480 | CAY10487 | 500 mg | 18480 |
| Cayman2015 | 10006482 | CAY10485 | 10 mg | 742 |
| Cayman2015 | 10006482 | CAY10485 | 100 mg | 5488 |
| Cayman2015 | 10006482 | CAY10485 | 5 mg | 392 |
| Cayman2015 | 10006482 | CAY10485 | 50 mg | 3136 |
| Cayman2015 | 10006484 | Estriol | 100 mg | 126 |
| Cayman2015 | 10006484 | Estriol | 1000 mg | 1008 |
| Cayman2015 | 10006484 | Estriol | 500 mg | 574 |
| Cayman2015 | 10006484 | Estriol | 5000 mg | 4410 |
| Cayman2015 | 10006485 | Estrone | 1000 mg | 210 |
| Cayman2015 | 10006485 | Estrone | 10000 mg | 1568 |
| Cayman2015 | 10006485 | Estrone | 500 mg | 112 |
| Cayman2015 | 10006485 | Estrone | 5000 mg | 896 |
| Cayman2015 | 10006486 | Ethynyl Estradiol | 1000 mg | 630 |
| Cayman2015 | 10006486 | Ethynyl Estradiol | 500 mg | 350 |
| Cayman2015 | 10006486 | Ethynyl Estradiol | 5000 mg | 2100 |
| Cayman2015 | 10006487 | Estradiol Benzoate | 1000 mg | 630 |
| Cayman2015 | 10006487 | Estradiol Benzoate | 500 mg | 350 |
| Cayman2015 | 10006487 | Estradiol Benzoate | 5000 mg | 1932 |
| Cayman2015 | 10006488 | Gestrinone | 100 mg | 1246 |
| Cayman2015 | 10006488 | Gestrinone | 1000 mg | 9968 |
| Cayman2015 | 10006488 | Gestrinone | 500 mg | 5292 |
| Cayman2015 | 10006515 | HAT Inhibitor Screening Assay Kit | 96 Well | 4200 |
| Cayman2015 | 10006518 | S-Nitrosylated Protein Detection Kit | 1 ea | 3710 |
| Cayman2015 | 10006519 | S-Nitrosylation Wash Buffer (10X) | 1 ea | 196 |
| Cayman2015 | 10006520 | S-Nitrosylation Buffer A | 1 ea | 252 |
| Cayman2015 | 10006521 | S-Nitrosylation Buffer B (5X) | 1 ea | 266 |
| Cayman2015 | 10006522 | S-Nitrosylation Reducing Reagent | 1 ea | 938 |
| Cayman2015 | 10006523 | S-Nitrosylation Labeling Reagent | 1 ea | 322 |
| Cayman2015 | 10006524 | S-Nitrosylation Detection Reagent I (HRP) | 1 ea | 784 |
| Cayman2015 | 10006525 | S-Nitrosylation Detection Reagent II (Fluorescein) | 1 ea | 784 |
| Cayman2015 | 10006529 | Oleyl Anilide | 10 mg | 378 |
| Cayman2015 | 10006529 | Oleyl Anilide | 100 mg | 2744 |
| Cayman2015 | 10006529 | Oleyl Anilide | 5 mg | 196 |
| Cayman2015 | 10006529 | Oleyl Anilide | 50 mg | 1568 |
| Cayman2015 | 10006545 | CAY10464 | 10 mg | 238 |
| Cayman2015 | 10006545 | CAY10464 | 100 mg | 1904 |
| Cayman2015 | 10006545 | CAY10464 | 25 mg | 560 |
| Cayman2015 | 10006545 | CAY10464 | 50 mg | 1078 |
| Cayman2015 | 10006546 | CAY10465 | 1 mg | 238 |
| Cayman2015 | 10006546 | CAY10465 | 10 mg | 1904 |
| Cayman2015 | 10006546 | CAY10465 | 5 mg | 1078 |
| Cayman2015 | 10006546 | CAY10465 | 50 mg | 8330 |
| Cayman2015 | 10006556 | Latanoprost-d4 | 1 mg | 6958 |
| Cayman2015 | 10006556 | Latanoprost-d4 | 100 μg | 938 |
| Cayman2015 | 10006556 | Latanoprost-d4 | 50 μg | 490 |
| Cayman2015 | 10006556 | Latanoprost-d4 | 500 μg | 3920 |
| Cayman2015 | 10006577 | Normal Goat Serum | 1 ea | 602 |
| Cayman2015 | 10006579 | γ-Linolenic Acid methyl ester | 100 mg | 672 |
| Cayman2015 | 10006579 | γ-Linolenic Acid methyl ester | 1000 mg | 4200 |
| Cayman2015 | 10006579 | γ-Linolenic Acid methyl ester | 250 mg | 1582 |
| Cayman2015 | 10006579 | γ-Linolenic Acid methyl ester | 50 mg | 350 |
| Cayman2015 | 10006580 | Dihomo-γ-Linolenic Acid methyl ester | 10 mg | 280 |
| Cayman2015 | 10006580 | Dihomo-γ-Linolenic Acid methyl ester | 100 mg | 1652 |
| Cayman2015 | 10006580 | Dihomo-γ-Linolenic Acid methyl ester | 50 mg | 854 |
| Cayman2015 | 10006588 | Goat Anti-Rabbit IgG FITC | 1 ea | 756 |
| Cayman2015 | 10006590 | CB1 Receptor (C-Term) Polyclonal Antibody | 1 ea | 3710 |
| Cayman2015 | 10006590 | CB1 Receptor (C-Term) Polyclonal Antibody | 1 Trial | 1680 |
| Cayman2015 | 10006591 | CB1 Receptor (C-Term) Blocking Peptide | 1 ea | 1498 |
| Cayman2015 | 10006593 | Prostaglandin D Synthase (hematopoietic-type; human recombinant) | 100 μg | 1568 |
| Cayman2015 | 10006593 | Prostaglandin D Synthase (hematopoietic-type; human recombinant) | 250 μg | 3724 |
| Cayman2015 | 10006593 | Prostaglandin D Synthase (hematopoietic-type; human recombinant) | 50 μg | 826 |
| Cayman2015 | 10006594 | Losartan (potassium salt) | 10 mg | 168 |
| Cayman2015 | 10006594 | Losartan (potassium salt) | 100 mg | 1344 |
| Cayman2015 | 10006594 | Losartan (potassium salt) | 50 mg | 756 |
| Cayman2015 | 10006594 | Losartan (potassium salt) | 500 mg | 5880 |
| Cayman2015 | 10006595 | Prostaglandin D Synthase Inhibitor Screening Assay Kit | 96 Well | 5908 |
| Cayman2015 | 10006606 | Retreversine | 1 mg | 742 |
| Cayman2015 | 10006606 | Retreversine | 10 mg | 5488 |
| Cayman2015 | 10006606 | Retreversine | 5 mg | 3136 |
| Cayman2015 | 10006606 | Retreversine | 500 μg | 392 |
| Cayman2015 | 10006607 | Arachidonic Acid (sodium salt) | 100 mg | 1610 |
| Cayman2015 | 10006607 | Arachidonic Acid (sodium salt) | 25 mg | 448 |
| Cayman2015 | 10006607 | Arachidonic Acid (sodium salt) | 50 mg | 854 |
| Cayman2015 | 10006607 | Arachidonic Acid (sodium salt) | 500 mg | 7168 |
| Cayman2015 | 10006610 | Thromboxane B1 | 1 mg | 1540 |
| Cayman2015 | 10006610 | Thromboxane B1 | 10 mg | 12320 |
| Cayman2015 | 10006610 | Thromboxane B1 | 5 mg | 6930 |
| Cayman2015 | 10006611 | GW 4064 | 1 mg | 350 |
| Cayman2015 | 10006611 | GW 4064 | 10 mg | 1512 |
| Cayman2015 | 10006611 | GW 4064 | 5 mg | 966 |
| Cayman2015 | 10006616 | S1P1 Blocking Peptide | 1 ea | 1498 |
| Cayman2015 | 10006617 | Goat Anti-Mouse (IgG+IgM) FITC | 1 ea | 910 |
| Cayman2015 | 10006618 | 5-OxoETE Receptor Blocking Peptide | 1 ea | 1498 |
| Cayman2015 | 10006620 | Serine Palmitoyltransferase Blocking Peptide | 1 ea | 1498 |
| Cayman2015 | 10006626 | Lauric Acid | 100 g | 336 |
| Cayman2015 | 10006626 | Lauric Acid | 25 g | 140 |
| Cayman2015 | 10006626 | Lauric Acid | 250 g | 700 |
| Cayman2015 | 10006626 | Lauric Acid | 50 g | 196 |
| Cayman2015 | 10006627 | Palmitic Acid | 10 g | 280 |
| Cayman2015 | 10006627 | Palmitic Acid | 100 g | 1680 |
| Cayman2015 | 10006627 | Palmitic Acid | 25 g | 490 |
| Cayman2015 | 10006627 | Palmitic Acid | 50 g | 910 |
| Cayman2015 | 10006654 | 5-iPF2α-VI-d11 | 10 μg | 2184 |
| Cayman2015 | 10006654 | 5-iPF2α-VI-d11 | 100 μg | 17472 |
| Cayman2015 | 10006654 | 5-iPF2α-VI-d11 | 25 μg | 5194 |
| Cayman2015 | 10006654 | 5-iPF2α-VI-d11 | 50 μg | 9828 |
| Cayman2015 | 10006661 | Ketoprofen | 1000 mg | 112 |
| Cayman2015 | 10006661 | Ketoprofen | 10000 mg | 896 |
| Cayman2015 | 10006661 | Ketoprofen | 25000 mg | 1960 |
| Cayman2015 | 10006661 | Ketoprofen | 5000 mg | 504 |
| Cayman2015 | 10006692 | (+)-15-epi Cloprostenol | 1 mg | 546 |
| Cayman2015 | 10006692 | (+)-15-epi Cloprostenol | 10 mg | 4368 |
| Cayman2015 | 10006692 | (+)-15-epi Cloprostenol | 5 mg | 2464 |
| Cayman2015 | 10006692 | (+)-15-epi Cloprostenol | 50 mg | 19110 |
| Cayman2015 | 10006695 | HEPC | 10 mg | 3402 |
| Cayman2015 | 10006695 | HEPC | 25 mg | 8064 |
| Cayman2015 | 10006695 | HEPC | 5 mg | 1792 |
| Cayman2015 | 10006695 | HEPC | 50 mg | 14336 |
| Cayman2015 | 10006697 | Prostaglandin D2-biotin | 1 mg | 9422 |
| Cayman2015 | 10006697 | Prostaglandin D2-biotin | 100 μg | 1540 |
| Cayman2015 | 10006697 | Prostaglandin D2-biotin | 50 μg | 812 |
| Cayman2015 | 10006697 | Prostaglandin D2-biotin | 500 μg | 5362 |
| Cayman2015 | 10006726 | PD 98059 | 1 mg | 168 |
| Cayman2015 | 10006726 | PD 98059 | 10 mg | 910 |
| Cayman2015 | 10006726 | PD 98059 | 5 mg | 630 |
| Cayman2015 | 10006726 | PD 98059 | 50 mg | 3640 |
| Cayman2015 | 10006727 | PD 169316 | 1 mg | 686 |
| Cayman2015 | 10006727 | PD 169316 | 10 mg | 1918 |
| Cayman2015 | 10006727 | PD 169316 | 25 mg | 4116 |
| Cayman2015 | 10006727 | PD 169316 | 5 mg | 1092 |
| Cayman2015 | 10006731 | VDM11 | 10 mg | 882 |
| Cayman2015 | 10006731 | VDM11 | 25 mg | 2086 |
| Cayman2015 | 10006731 | VDM11 | 5 mg | 462 |
| Cayman2015 | 10006731 | VDM11 | 50 mg | 3696 |
| Cayman2015 | 10006734 | QNZ | 1 mg | 406 |
| Cayman2015 | 10006734 | QNZ | 10 mg | 2940 |
| Cayman2015 | 10006734 | QNZ | 5 mg | 1680 |
| Cayman2015 | 10006734 | QNZ | 500 μg | 210 |
| Cayman2015 | 10006735 | CAY10471 | 1 mg | 756 |
| Cayman2015 | 10006735 | CAY10471 | 10 mg | 6048 |
| Cayman2015 | 10006735 | CAY10471 | 5 mg | 3402 |
| Cayman2015 | 10006735 | CAY10471 | 50 mg | 26460 |
| Cayman2015 | 10006758 | Arachidonic Acid-d11 | 1 mg | 2072 |
| Cayman2015 | 10006758 | Arachidonic Acid-d11 | 100 μg | 350 |
| Cayman2015 | 10006758 | Arachidonic Acid-d11 | 500 μg | 1316 |
| Cayman2015 | 10006778 | Nitrotyrosine (Peptide) Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 10006782 | Oleic Acid-2,6-diisopropylanilide | 10 mg | 714 |
| Cayman2015 | 10006782 | Oleic Acid-2,6-diisopropylanilide | 5 mg | 378 |
| Cayman2015 | 10006782 | Oleic Acid-2,6-diisopropylanilide | 50 mg | 3024 |
| Cayman2015 | 10006788 | Prostaglandin D Synthase (lipocalin-type; human recombinant) | 100 μg | 1568 |
| Cayman2015 | 10006788 | Prostaglandin D Synthase (lipocalin-type; human recombinant) | 250 μg | 3724 |
| Cayman2015 | 10006788 | Prostaglandin D Synthase (lipocalin-type; human recombinant) | 50 μg | 826 |
| Cayman2015 | 10006790 | ChREBP Blocking Peptide | 1 ea | 1498 |
| Cayman2015 | 10006794 | (+)-Xestospongin A | 100 μg | 4396 |
| Cayman2015 | 10006794 | (+)-Xestospongin A | 250 μg | 10402 |
| Cayman2015 | 10006794 | (+)-Xestospongin A | 50 μg | 2310 |
| Cayman2015 | 10006797 | Araguspongin B | 100 μg | 4578 |
| Cayman2015 | 10006797 | Araguspongin B | 250 μg | 10878 |
| Cayman2015 | 10006798 | GW 0742 | 10 mg | 2100 |
| Cayman2015 | 10006798 | GW 0742 | 25 mg | 4984 |
| Cayman2015 | 10006798 | GW 0742 | 5 mg | 1106 |
| Cayman2015 | 10006798 | GW 0742 | 50 mg | 8848 |
| Cayman2015 | 10006800 | (R)-Bromoenol lactone | 1 mg | 630 |
| Cayman2015 | 10006800 | (R)-Bromoenol lactone | 10 mg | 4200 |
| Cayman2015 | 10006800 | (R)-Bromoenol lactone | 5 mg | 2632 |
| Cayman2015 | 10006800 | (R)-Bromoenol lactone | 500 μg | 350 |
| Cayman2015 | 10006801 | (S)-Bromoenol lactone | 1 mg | 630 |
| Cayman2015 | 10006801 | (S)-Bromoenol lactone | 10 mg | 4200 |
| Cayman2015 | 10006801 | (S)-Bromoenol lactone | 5 mg | 2632 |
| Cayman2015 | 10006801 | (S)-Bromoenol lactone | 500 μg | 350 |
| Cayman2015 | 10006803 | O-1602 | 1 mg | 308 |
| Cayman2015 | 10006803 | O-1602 | 10 mg | 1848 |
| Cayman2015 | 10006803 | O-1602 | 25 mg | 3472 |
| Cayman2015 | 10006803 | O-1602 | 5 mg | 1232 |
| Cayman2015 | 10006804 | O-1821 | 1 mg | 280 |
| Cayman2015 | 10006804 | O-1821 | 10 mg | 2240 |
| Cayman2015 | 10006804 | O-1821 | 5 mg | 1260 |
| Cayman2015 | 10006804 | O-1821 | 50 mg | 9800 |
| Cayman2015 | 10006809 | Heptanoyl thio-PC | 10 mg | 3276 |
| Cayman2015 | 10006809 | Heptanoyl thio-PC | 25 mg | 7756 |
| Cayman2015 | 10006809 | Heptanoyl thio-PC | 5 mg | 1722 |
| Cayman2015 | 10006809 | Heptanoyl thio-PC | 50 mg | 13776 |
| Cayman2015 | 10006822 | Sphingosine Kinase 1 Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 10006823 | Sphingosine Kinase 1 Blocking Peptide | 1 ea | 1498 |
| Cayman2015 | 10006829 | Docosahexaenoic Acid Quant-PAK | 1 ea | 966 |
| Cayman2015 | 10006830 | 6-keto Prostaglandin F1α Quant-PAK | 1 ea | 6244 |
| Cayman2015 | 10006831 | 11-dehydro Thromboxane B2 Quant-PAK | 1 ea | 14854 |
| Cayman2015 | 10006832 | Thromboxane B2 Quant-PAK | 1 ea | 7378 |
| Cayman2015 | 10006833 | ω-3 Arachidonic Acid Quant-PAK | 1 ea | 4438 |
| Cayman2015 | 10006834 | Linoleic Acid Quant-PAK | 1 ea | 462 |
| Cayman2015 | 10006835 | Arachidonic Acid Quant-PAK | 1 ea | 1386 |
| Cayman2015 | 10006840 | Prostaglandin A2 Quant-PAK | 1 ea | 2478 |
| Cayman2015 | 10006841 | Prostaglandin B2 Quant-PAK | 1 ea | 4046 |
| Cayman2015 | 10006842 | Prostaglandin D1 Quant-PAK | 1 ea | 5922 |
| Cayman2015 | 10006843 | Prostaglandin D2 Quant-PAK | 1 ea | 4410 |
| Cayman2015 | 10006844 | Prostaglandin E1 Quant-PAK | 1 ea | 2086 |
| Cayman2015 | 10006845 | 13,14-dihydro Prostaglandin E1 Quant-PAK | 1 ea | 7392 |
| Cayman2015 | 10006846 | Prostaglandin E2 Quant-PAK | 1 ea | 2142 |
| Cayman2015 | 10006848 | Prostaglandin F2α Quant-PAK | 1 ea | 2100 |
| Cayman2015 | 10006850 | 15-deoxy-Δ12,14-Prostaglandin J2 Quant-PAK | 1 ea | 6090 |
| Cayman2015 | 10006855 | PPARγ Transcription Factor Assay Kit | 96 Well | 5740 |
| Cayman2015 | 10006856 | Stearidonic Acid ethyl ester | 1 mg | 966 |
| Cayman2015 | 10006856 | Stearidonic Acid ethyl ester | 10 mg | 7728 |
| Cayman2015 | 10006856 | Stearidonic Acid ethyl ester | 5 mg | 4354 |
| Cayman2015 | 10006859 | N-HBG | 1 mg | 378 |
| Cayman2015 | 10006859 | N-HBG | 10 mg | 3024 |
| Cayman2015 | 10006859 | N-HBG | 25 mg | 6622 |
| Cayman2015 | 10006859 | N-HBG | 5 mg | 1708 |
| Cayman2015 | 10006860 | N-HFG | 1 mg | 378 |
| Cayman2015 | 10006860 | N-HFG | 10 mg | 3024 |
| Cayman2015 | 10006860 | N-HFG | 25 mg | 6622 |
| Cayman2015 | 10006860 | N-HFG | 5 mg | 1708 |
| Cayman2015 | 10006861 | nor-NOHA | 1 mg | 238 |
| Cayman2015 | 10006861 | nor-NOHA | 10 mg | 1904 |
| Cayman2015 | 10006861 | nor-NOHA | 5 mg | 1078 |
| Cayman2015 | 10006861 | nor-NOHA | 50 mg | 8330 |
| Cayman2015 | 10006862 | ABH | 1 mg | 406 |
| Cayman2015 | 10006862 | ABH | 10 mg | 3248 |
| Cayman2015 | 10006862 | ABH | 5 mg | 1834 |
| Cayman2015 | 10006864 | cis-7-Hexadecenoic Acid methyl ester | 10 mg | 1008 |
| Cayman2015 | 10006864 | cis-7-Hexadecenoic Acid methyl ester | 25 mg | 2394 |
| Cayman2015 | 10006864 | cis-7-Hexadecenoic Acid methyl ester | 5 mg | 532 |
| Cayman2015 | 10006864 | cis-7-Hexadecenoic Acid methyl ester | 50 mg | 4256 |
| Cayman2015 | 10006865 | Docosahexaenoic Acid methyl ester | 100 mg | 672 |
| Cayman2015 | 10006865 | Docosahexaenoic Acid methyl ester | 1000 mg | 4900 |
| Cayman2015 | 10006865 | Docosahexaenoic Acid methyl ester | 50 mg | 350 |
| Cayman2015 | 10006865 | Docosahexaenoic Acid methyl ester | 500 mg | 2632 |
| Cayman2015 | 10006866 | cis-4,10,13,16-Docosatetraenoic Acid methyl ester | 1 mg | 350 |
| Cayman2015 | 10006866 | cis-4,10,13,16-Docosatetraenoic Acid methyl ester | 10 mg | 2450 |
| Cayman2015 | 10006866 | cis-4,10,13,16-Docosatetraenoic Acid methyl ester | 5 mg | 1316 |
| Cayman2015 | 10006870 | Renin Assay Buffer (10X) | 1 ea | 308 |
| Cayman2015 | 10006872 | Renin Substrate | 1 ea | 2030 |
| Cayman2015 | 10006874 | Ethyl Tricosanoate | 10 mg | 294 |
| Cayman2015 | 10006874 | Ethyl Tricosanoate | 100 mg | 2156 |
| Cayman2015 | 10006874 | Ethyl Tricosanoate | 5 mg | 154 |
| Cayman2015 | 10006874 | Ethyl Tricosanoate | 50 mg | 1232 |
| Cayman2015 | 10006876 | Diethylstilbestrol | 1000 mg | 280 |
| Cayman2015 | 10006876 | Diethylstilbestrol | 10000 mg | 2240 |
| Cayman2015 | 10006876 | Diethylstilbestrol | 25000 mg | 4900 |
| Cayman2015 | 10006876 | Diethylstilbestrol | 5000 mg | 1260 |
| Cayman2015 | 10006878 | 8,12-iso-iPF2α-VI-d11 | 10 μg | 2184 |
| Cayman2015 | 10006878 | 8,12-iso-iPF2α-VI-d11 | 25 μg | 5194 |
| Cayman2015 | 10006878 | 8,12-iso-iPF2α-VI-d11 | 50 μg | 9828 |
| Cayman2015 | 10006880 | Transcription Factor Binding Assay Buffer (4X) | 1 ea | 462 |
| Cayman2015 | 10006881 | Transcription Factor PPARγ Positive Control | 1 ea | 910 |
| Cayman2015 | 10006882 | Transcription Factor Antibody Binding Buffer (10X) | 1 ea | 462 |
| Cayman2015 | 10006883 | Transcription Factor PPARγ Primary Antibody | 1 ea | 1428 |
| Cayman2015 | 10006884 | Transcription Factor Goat Anti-Rabbit HRP Conjugate | 1 ea | 574 |
| Cayman2015 | 10006885 | Transcription Factor PPAR Competitor dsDNA | 1 ea | 686 |
| Cayman2015 | 10006887 | Transcription Factor PPAR 96-Well Strip Plate | 1 ea | 896 |
| Cayman2015 | 10006888 | Transcription Factor Developing Solution | 1 ea | 462 |
| Cayman2015 | 10006889 | Transcription Factor Stop Solution | 1 ea | 462 |
| Cayman2015 | 10006906 | Renin Fluorogenic Substrate | 1 mg | 5000 |
| Cayman2015 | 10006908 | Adipogenesis Assay Kit | 1 ea | 3556 |
| Cayman2015 | 10006910 | HIF-1α Transcription Factor Assay Kit | 96 Well | 5740 |
| Cayman2015 | 10006912 | NF-κB (human p50) Transcription Factor Assay Kit | 96 Well | 5740 |
| Cayman2015 | 10006914 | PPARδ Transcription Factor Assay Kit | 96 Well | 5740 |
| Cayman2015 | 10006915 | PPARα Transcription Factor Assay Kit | 96 Well | 5740 |
| Cayman2015 | 10006943 | Vilogenin (fathead minnow) EIA Kit | 480 Well | 52960 |
| Cayman2015 | 10006943 | Vilogenin (fathead minnow) EIA Kit | 96 Well | 14120 |
| Cayman2015 | 10006966 | Nitrotyrosine Monoclonal Antibody - Biotinylated | 100 μg | 3346 |
| Cayman2015 | 10006967 | Zileuton | 10 mg | 420 |
| Cayman2015 | 10006967 | Zileuton | 25 mg | 1008 |
| Cayman2015 | 10006967 | Zileuton | 5 mg | 224 |
| Cayman2015 | 10006967 | Zileuton | 50 mg | 1792 |
| Cayman2015 | 10006972 | AM281 | 1 mg | 350 |
| Cayman2015 | 10006972 | AM281 | 10 mg | 1750 |
| Cayman2015 | 10006972 | AM281 | 5 mg | 966 |
| Cayman2015 | 10006973 | Pravadoline | 10 mg | 1470 |
| Cayman2015 | 10006973 | Pravadoline | 25 mg | 3472 |
| Cayman2015 | 10006973 | Pravadoline | 5 mg | 770 |
| Cayman2015 | 10006974 | AM630 | 10 mg | 1036 |
| Cayman2015 | 10006974 | AM630 | 100 mg | 7644 |
| Cayman2015 | 10006974 | AM630 | 5 mg | 546 |
| Cayman2015 | 10006974 | AM630 | 50 mg | 4102 |
| Cayman2015 | 10006976 | Thiocarlide | 100 mg | 588 |
| Cayman2015 | 10006976 | Thiocarlide | 1000 mg | 4312 |
| Cayman2015 | 10006976 | Thiocarlide | 50 mg | 308 |
| Cayman2015 | 10006976 | Thiocarlide | 500 mg | 2464 |
| Cayman2015 | 10006984 | LPA1 Blocking Peptide | 1 ea | 1498 |
| Cayman2015 | 10006987 | Prostaglandin E2-biotin | 1 mg | 10388 |
| Cayman2015 | 10006987 | Prostaglandin E2-biotin | 100 μg | 1414 |
| Cayman2015 | 10006987 | Prostaglandin E2-biotin | 50 μg | 742 |
| Cayman2015 | 10006987 | Prostaglandin E2-biotin | 500 μg | 5936 |
| Cayman2015 | 10006988 | Prostaglandin F2α-biotin | 100 μg | 1414 |
| Cayman2015 | 10006988 | Prostaglandin F2α-biotin | 50 μg | 742 |
| Cayman2015 | 10006988 | Prostaglandin F2α-biotin | 500 μg | 5936 |
| Cayman2015 | 10006995 | Piloty's Acid | 1000 mg | 210 |
| Cayman2015 | 10006995 | Piloty's Acid | 10000 mg | 1568 |
| Cayman2015 | 10006995 | Piloty's Acid | 500 mg | 112 |
| Cayman2015 | 10006995 | Piloty's Acid | 5000 mg | 896 |
| Cayman2015 | 10006998 | (±)14,15-DiHETE | 100 μg | 3836 |
| Cayman2015 | 10006998 | (±)14,15-DiHETE | 25 μg | 1064 |
| Cayman2015 | 10006998 | (±)14,15-DiHETE | 50 μg | 2016 |
| Cayman2015 | 10006999 | (±)17,18-DiHETE | 100 μg | 3836 |
| Cayman2015 | 10006999 | (±)17,18-DiHETE | 25 μg | 1064 |
| Cayman2015 | 10006999 | (±)17,18-DiHETE | 50 μg | 2016 |
| Cayman2015 | 10007001 | (±)19,20-DiHDPA | 1 mg | 13524 |
| Cayman2015 | 10007001 | (±)19,20-DiHDPA | 100 μg | 1834 |
| Cayman2015 | 10007001 | (±)19,20-DiHDPA | 50 μg | 966 |
| Cayman2015 | 10007001 | (±)19,20-DiHDPA | 500 μg | 7728 |
| Cayman2015 | 10007002 | CRTH2/DP2 Receptor (C-Term) Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 10007003 | CRTH2/DP2 Receptor (C-Term) Blocking Peptide | 1 ea | 1498 |
| Cayman2015 | 10007048 | Vilogenin (bird) Monoclonal Antibody (ND-3C3) | 100 μL | 5180 |
| Cayman2015 | 10007048 | Vilogenin (bird) Monoclonal Antibody (ND-3C3) | 500 μL | 23320 |
| Cayman2015 | 10007049 | Vilogenin (bird) Monoclonal Antibody (ND-3G6) | 100 μL | 5180 |
| Cayman2015 | 10007049 | Vilogenin (bird) Monoclonal Antibody (ND-3G6) | 500 μL | 23320 |
| Cayman2015 | 10007055 | 3-keto Petromyzonol | 1 mg | 880 |
| Cayman2015 | 10007055 | 3-keto Petromyzonol | 10 mg | 6160 |
| Cayman2015 | 10007055 | 3-keto Petromyzonol | 5 mg | 3300 |
| Cayman2015 | 10007061 | Calmodulin (1 μM) | 1 ea | 168 |
| Cayman2015 | 10007062 | Reaction Buffer (2X) | 1 ea | 168 |
| Cayman2015 | 10007063 | Homogenization Buffer (10X) | 1 ea | 168 |
| Cayman2015 | 10007064 | Stop Buffer | 1 ea | 168 |
| Cayman2015 | 10007065 | Equilibrated Resin | 1 ea | 308 |
| Cayman2015 | 10007066 | Calcium Chloride (6 mM) | 1 ea | 168 |
| Cayman2015 | 10007067 | L-NNA (10 mM) | 1 ea | 602 |
| Cayman2015 | 10007068 | iNOS Positive Control | 1 ea | 756 |
| Cayman2015 | 10007069 | Spin Cups and Cup Holders | 50 ea | 994 |
| Cayman2015 | 10007072 | 1-Palmitoyl-2-linoleoyl PE | 10 mg | 826 |
| Cayman2015 | 10007072 | 1-Palmitoyl-2-linoleoyl PE | 100 mg | 6076 |
| Cayman2015 | 10007072 | 1-Palmitoyl-2-linoleoyl PE | 5 mg | 434 |
| Cayman2015 | 10007072 | 1-Palmitoyl-2-linoleoyl PE | 50 mg | 3472 |
| Cayman2015 | 10007073 | PTEN Blocking Peptide | 1 ea | 1498 |
| Cayman2015 | 10007075 | 4-(1-piperazinyl)-1H-Indole (hydrochloride) | 1 g | 2720 |
| Cayman2015 | 10007075 | 4-(1-piperazinyl)-1H-Indole (hydrochloride) | 100 mg | 340 |
| Cayman2015 | 10007075 | 4-(1-piperazinyl)-1H-Indole (hydrochloride) | 250 mg | 800 |
| Cayman2015 | 10007075 | 4-(1-piperazinyl)-1H-Indole (hydrochloride) | 500 mg | 1440 |
| Cayman2015 | 10007076 | CAY10491 | 1 g | 7360 |
| Cayman2015 | 10007076 | CAY10491 | 100 mg | 920 |
| Cayman2015 | 10007076 | CAY10491 | 500 mg | 4060 |
| Cayman2015 | 10007077 | CAY10492 | 1 g | 4200 |
| Cayman2015 | 10007077 | CAY10492 | 100 mg | 500 |
| Cayman2015 | 10007077 | CAY10492 | 5 g | 17500 |
| Cayman2015 | 10007077 | CAY10492 | 500 mg | 2260 |
| Cayman2015 | 10007078 | CAY10493 | 1 g | 7200 |
| Cayman2015 | 10007078 | CAY10493 | 100 mg | 900 |
| Cayman2015 | 10007078 | CAY10493 | 500 mg | 4060 |
| Cayman2015 | 10007079 | 5-Bromoisoquinoline | 1 g | 1260 |
| Cayman2015 | 10007079 | 5-Bromoisoquinoline | 5 g | 3860 |
| Cayman2015 | 10007079 | 5-Bromoisoquinoline | 500 mg | 700 |
| Cayman2015 | 10007080 | 6-Bromoisoquinoline | 1 g | 1260 |
| Cayman2015 | 10007080 | 6-Bromoisoquinoline | 5 g | 3860 |
| Cayman2015 | 10007080 | 6-Bromoisoquinoline | 500 mg | 700 |
| Cayman2015 | 10007081 | 7-Bromoisoquinoline | 1 g | 1260 |
| Cayman2015 | 10007081 | 7-Bromoisoquinoline | 5 g | 3860 |
| Cayman2015 | 10007081 | 7-Bromoisoquinoline | 500 mg | 700 |
| Cayman2015 | 10007082 | 8-Bromoisoquinoline | 1 g | 1260 |
| Cayman2015 | 10007082 | 8-Bromoisoquinoline | 5 g | 3860 |
| Cayman2015 | 10007082 | 8-Bromoisoquinoline | 500 mg | 700 |
| Cayman2015 | 10007083 | 5,6,7,8-tetrahydro-2-Quinolone | 1 g | 15120 |
| Cayman2015 | 10007083 | 5,6,7,8-tetrahydro-2-Quinolone | 100 mg | 2060 |
| Cayman2015 | 10007083 | 5,6,7,8-tetrahydro-2-Quinolone | 50 mg | 1080 |
| Cayman2015 | 10007083 | 5,6,7,8-tetrahydro-2-Quinolone | 500 mg | 8480 |
| Cayman2015 | 10007084 | 4-Cyanoindole | 1 g | 1200 |
| Cayman2015 | 10007084 | 4-Cyanoindole | 10 g | 9600 |
| Cayman2015 | 10007084 | 4-Cyanoindole | 5 g | 5400 |
| Cayman2015 | 10007084 | 4-Cyanoindole | 500 mg | 620 |
| Cayman2015 | 10007085 | 4-Aminomethylindole | 1 g | 1780 |
| Cayman2015 | 10007085 | 4-Aminomethylindole | 5 g | 7680 |
| Cayman2015 | 10007085 | 4-Aminomethylindole | 500 mg | 1180 |
| Cayman2015 | 10007086 | 4-formyl Indole | 1 g | 1760 |
| Cayman2015 | 10007086 | 4-formyl Indole | 10 g | 14080 |
| Cayman2015 | 10007086 | 4-formyl Indole | 5 g | 7920 |
| Cayman2015 | 10007086 | 4-formyl Indole | 500 mg | 900 |
| Cayman2015 | 10007087 | (1H-Indol-4-yl)-Carbamic Acid tert-butyl ester | 1 g | 1360 |
| Cayman2015 | 10007087 | (1H-Indol-4-yl)-Carbamic Acid tert-butyl ester | 5 g | 5860 |
| Cayman2015 | 10007087 | (1H-Indol-4-yl)-Carbamic Acid tert-butyl ester | 500 mg | 900 |
| Cayman2015 | 10007089 | N-(diphenylmethylene) Glycine benzyl ester | 1 g | 620 |
| Cayman2015 | 10007089 | N-(diphenylmethylene) Glycine benzyl ester | 10 g | 4960 |
| Cayman2015 | 10007089 | N-(diphenylmethylene) Glycine benzyl ester | 5 g | 2800 |
| Cayman2015 | 10007089 | N-(diphenylmethylene) Glycine benzyl ester | 500 mg | 320 |
| Cayman2015 | 10007090 | (S)-(+)-2-hydroxy-3-Methylbutyric Acid | 1 g | 520 |
| Cayman2015 | 10007090 | (S)-(+)-2-hydroxy-3-Methylbutyric Acid | 10 g | 4160 |
| Cayman2015 | 10007090 | (S)-(+)-2-hydroxy-3-Methylbutyric Acid | 5 g | 2340 |
| Cayman2015 | 10007090 | (S)-(+)-2-hydroxy-3-Methylbutyric Acid | 500 mg | 260 |
| Cayman2015 | 10007091 | N,N-dimethyl-L-Valine | 1 g | 1120 |
| Cayman2015 | 10007091 | N,N-dimethyl-L-Valine | 100 mg | 140 |
| Cayman2015 | 10007091 | N,N-dimethyl-L-Valine | 5 g | 4900 |
| Cayman2015 | 10007091 | N,N-dimethyl-L-Valine | 500 mg | 540 |
| Cayman2015 | 10007092 | N-Pivaloylaniline | 1 g | 480 |
| Cayman2015 | 10007092 | N-Pivaloylaniline | 10 g | 3840 |
| Cayman2015 | 10007092 | N-Pivaloylaniline | 5 g | 2160 |
| Cayman2015 | 10007092 | N-Pivaloylaniline | 500 mg | 240 |
| Cayman2015 | 10007093 | 2-Aminopyrazine | 10 g | 540 |
| Cayman2015 | 10007093 | 2-Aminopyrazine | 25 g | 1260 |
| Cayman2015 | 10007093 | 2-Aminopyrazine | 5 g | 280 |
| Cayman2015 | 10007093 | 2-Aminopyrazine | 50 g | 2240 |
| Cayman2015 | 10007094 | 7-chlorothieno[2,3-c]Pyridine | 1 g | 3520 |
| Cayman2015 | 10007094 | 7-chlorothieno[2,3-c]Pyridine | 100 mg | 440 |
| Cayman2015 | 10007094 | 7-chlorothieno[2,3-c]Pyridine | 5 g | 15400 |
| Cayman2015 | 10007094 | 7-chlorothieno[2,3-c]Pyridine | 500 mg | 1900 |
| Cayman2015 | 10007102 | 3-thio-Pheneacrylic Acid methyl ester | 1 g | 280 |
| Cayman2015 | 10007102 | 3-thio-Pheneacrylic Acid methyl ester | 10 g | 2240 |
| Cayman2015 | 10007102 | 3-thio-Pheneacrylic Acid methyl ester | 25 g | 4900 |
| Cayman2015 | 10007102 | 3-thio-Pheneacrylic Acid methyl ester | 5 g | 1260 |
| Cayman2015 | 10007103 | 3-thio-Pheneacrylic Acid | 1 g | 280 |
| Cayman2015 | 10007103 | 3-thio-Pheneacrylic Acid | 10 g | 2240 |
| Cayman2015 | 10007103 | 3-thio-Pheneacrylic Acid | 25 g | 4900 |
| Cayman2015 | 10007103 | 3-thio-Pheneacrylic Acid | 5 g | 1260 |
| Cayman2015 | 10007106 | 2-Aminomethylpyrimidine (hydrochloride) | 1 g | 15120 |
| Cayman2015 | 10007106 | 2-Aminomethylpyrimidine (hydrochloride) | 100 mg | 2060 |
| Cayman2015 | 10007106 | 2-Aminomethylpyrimidine (hydrochloride) | 50 mg | 1080 |
| Cayman2015 | 10007106 | 2-Aminomethylpyrimidine (hydrochloride) | 500 mg | 8480 |
| Cayman2015 | 10007108 | 2-Pyrimidin-2-yl-Propionic Acid | 1 g | 8640 |
| Cayman2015 | 10007108 | 2-Pyrimidin-2-yl-Propionic Acid | 100 mg | 1080 |
| Cayman2015 | 10007108 | 2-Pyrimidin-2-yl-Propionic Acid | 500 mg | 4780 |
| Cayman2015 | 10007109 | 3-Pyrimidin-2-yl-Propionic Acid | 1 g | 15120 |
| Cayman2015 | 10007109 | 3-Pyrimidin-2-yl-Propionic Acid | 100 mg | 2060 |
| Cayman2015 | 10007109 | 3-Pyrimidin-2-yl-Propionic Acid | 50 mg | 1080 |
| Cayman2015 | 10007109 | 3-Pyrimidin-2-yl-Propionic Acid | 500 mg | 8480 |
| Cayman2015 | 10007110 | 3-Pyrimidin-2-yl-2-pyrimidin-2-ylmethyl-Propionic Acid | 1 g | 8640 |
| Cayman2015 | 10007110 | 3-Pyrimidin-2-yl-2-pyrimidin-2-ylmethyl-Propionic Acid | 100 mg | 1080 |
| Cayman2015 | 10007110 | 3-Pyrimidin-2-yl-2-pyrimidin-2-ylmethyl-Propionic Acid | 500 mg | 4780 |
| Cayman2015 | 10007111 | Pyrimidin-4-yl-Methanol | 1 g | 15120 |
| Cayman2015 | 10007111 | Pyrimidin-4-yl-Methanol | 100 mg | 2060 |
| Cayman2015 | 10007111 | Pyrimidin-4-yl-Methanol | 50 mg | 1080 |
| Cayman2015 | 10007111 | Pyrimidin-4-yl-Methanol | 500 mg | 8480 |
| Cayman2015 | 10007112 | 2-(hydroxymethyl)-Pyrimidine | 1 g | 15120 |
| Cayman2015 | 10007112 | 2-(hydroxymethyl)-Pyrimidine | 100 mg | 2060 |
| Cayman2015 | 10007112 | 2-(hydroxymethyl)-Pyrimidine | 50 mg | 1080 |
| Cayman2015 | 10007112 | 2-(hydroxymethyl)-Pyrimidine | 500 mg | 8480 |
| Cayman2015 | 10007113 | Pyrimidine-4-Carboxylic Acid (sodium salt) | 1 g | 8640 |
| Cayman2015 | 10007113 | Pyrimidine-4-Carboxylic Acid (sodium salt) | 100 mg | 1080 |
| Cayman2015 | 10007113 | Pyrimidine-4-Carboxylic Acid (sodium salt) | 500 mg | 4780 |
| Cayman2015 | 10007114 | methyl 4-Pyrimidine Carboxylate | 1 g | 8640 |
| Cayman2015 | 10007114 | methyl 4-Pyrimidine Carboxylate | 100 mg | 1080 |
| Cayman2015 | 10007114 | methyl 4-Pyrimidine Carboxylate | 500 mg | 4780 |
| Cayman2015 | 10007116 | 2-Pyrimidine Acetic Acid | 1 g | 8640 |
| Cayman2015 | 10007116 | 2-Pyrimidine Acetic Acid | 100 mg | 1080 |
| Cayman2015 | 10007116 | 2-Pyrimidine Acetic Acid | 500 mg | 4780 |
| Cayman2015 | 10007117 | 2-methyl-3-Pyrimidin-4-yl-Propionic Acid | 1 g | 15120 |
| Cayman2015 | 10007117 | 2-methyl-3-Pyrimidin-4-yl-Propionic Acid | 100 mg | 2060 |
| Cayman2015 | 10007117 | 2-methyl-3-Pyrimidin-4-yl-Propionic Acid | 50 mg | 1080 |
| Cayman2015 | 10007117 | 2-methyl-3-Pyrimidin-4-yl-Propionic Acid | 500 mg | 8480 |
| Cayman2015 | 10007118 | 2-methyl-3-Pyrimidin-2-yl-Propionic Acid | 1 g | 12880 |
| Cayman2015 | 10007118 | 2-methyl-3-Pyrimidin-2-yl-Propionic Acid | 100 mg | 1740 |
| Cayman2015 | 10007118 | 2-methyl-3-Pyrimidin-2-yl-Propionic Acid | 50 mg | 920 |
| Cayman2015 | 10007118 | 2-methyl-3-Pyrimidin-2-yl-Propionic Acid | 500 mg | 7200 |
| Cayman2015 | 10007119 | methyl 2-Pyrimidine Carboxylate | 1 g | 2800 |
| Cayman2015 | 10007119 | methyl 2-Pyrimidine Carboxylate | 100 mg | 380 |
| Cayman2015 | 10007119 | methyl 2-Pyrimidine Carboxylate | 50 mg | 200 |
| Cayman2015 | 10007119 | methyl 2-Pyrimidine Carboxylate | 500 mg | 1440 |
| Cayman2015 | 10007120 | 4-Pyrimidinecarboxaldehyde, dimethyl acetal | 1 g | 5920 |
| Cayman2015 | 10007120 | 4-Pyrimidinecarboxaldehyde, dimethyl acetal | 100 mg | 740 |
| Cayman2015 | 10007120 | 4-Pyrimidinecarboxaldehyde, dimethyl acetal | 5 g | 25900 |
| Cayman2015 | 10007120 | 4-Pyrimidinecarboxaldehyde, dimethyl acetal | 500 mg | 3240 |
| Cayman2015 | 10007121 | 2-cyano-Pyrimidine | 1 g | 196 |
| Cayman2015 | 10007121 | 2-cyano-Pyrimidine | 10 g | 1568 |
| Cayman2015 | 10007121 | 2-cyano-Pyrimidine | 5 g | 882 |
| Cayman2015 | 10007121 | 2-cyano-Pyrimidine | 500 mg | 98 |
| Cayman2015 | 10007122 | 2-(chloromethyl)-Pyrimidine (hydrochloride) | 1 g | 8960 |
| Cayman2015 | 10007122 | 2-(chloromethyl)-Pyrimidine (hydrochloride) | 100 mg | 1220 |
| Cayman2015 | 10007122 | 2-(chloromethyl)-Pyrimidine (hydrochloride) | 50 mg | 640 |
| Cayman2015 | 10007122 | 2-(chloromethyl)-Pyrimidine (hydrochloride) | 500 mg | 5120 |
| Cayman2015 | 10007123 | 2-carboxy-Pyrimidine | 1 g | 4640 |
| Cayman2015 | 10007123 | 2-carboxy-Pyrimidine | 100 mg | 580 |
| Cayman2015 | 10007123 | 2-carboxy-Pyrimidine | 5 g | 20300 |
| Cayman2015 | 10007123 | 2-carboxy-Pyrimidine | 500 mg | 2620 |
| Cayman2015 | 10007124 | 4-Pyrimidine Methanamine (hydrochloride) | 1 g | 15120 |
| Cayman2015 | 10007124 | 4-Pyrimidine Methanamine (hydrochloride) | 100 mg | 2060 |
| Cayman2015 | 10007124 | 4-Pyrimidine Methanamine (hydrochloride) | 50 mg | 1080 |
| Cayman2015 | 10007124 | 4-Pyrimidine Methanamine (hydrochloride) | 500 mg | 8480 |
| Cayman2015 | 10007125 | 8-Isoquinoline methanamine (hydrochloride) | 100 mg | 4380 |
| Cayman2015 | 10007125 | 8-Isoquinoline methanamine (hydrochloride) | 50 mg | 2300 |
| Cayman2015 | 10007125 | 8-Isoquinoline methanamine (hydrochloride) | 500 mg | 18400 |
| Cayman2015 | 10007126 | CAY10494 | 1 g | 7360 |
| Cayman2015 | 10007126 | CAY10494 | 100 mg | 920 |
| Cayman2015 | 10007126 | CAY10494 | 500 mg | 4060 |
| Cayman2015 | 10007127 | 5-Chlororesorcinol dimethyl ether | 10 g | 380 |
| Cayman2015 | 10007127 | 5-Chlororesorcinol dimethyl ether | 25 g | 900 |
| Cayman2015 | 10007127 | 5-Chlororesorcinol dimethyl ether | 5 g | 200 |
| Cayman2015 | 10007127 | 5-Chlororesorcinol dimethyl ether | 50 g | 1600 |
| Cayman2015 | 10007128 | R-(-)-Mandelic Acid | 100 g | 3460 |
| Cayman2015 | 10007128 | R-(-)-Mandelic Acid | 25 g | 960 |
| Cayman2015 | 10007128 | R-(-)-Mandelic Acid | 250 g | 7680 |
| Cayman2015 | 10007128 | R-(-)-Mandelic Acid | 50 g | 1820 |
| Cayman2015 | 10007129 | tert-butyl p-(bromomethyl) Benzoate | 1 g | 1040 |
| Cayman2015 | 10007129 | tert-butyl p-(bromomethyl) Benzoate | 5 g | 4680 |
| Cayman2015 | 10007130 | tert-butyl p-Toluate | 1 g | 140 |
| Cayman2015 | 10007130 | tert-butyl p-Toluate | 10 g | 1120 |
| Cayman2015 | 10007130 | tert-butyl p-Toluate | 5 g | 640 |
| Cayman2015 | 10007130 | tert-butyl p-Toluate | 50 g | 4900 |
| Cayman2015 | 10007131 | 5,6,7,8-tetrahydro-2-Naphthoic Acid | 1 g | 4000 |
| Cayman2015 | 10007131 | 5,6,7,8-tetrahydro-2-Naphthoic Acid | 5 g | 16800 |
| Cayman2015 | 10007131 | 5,6,7,8-tetrahydro-2-Naphthoic Acid | 500 mg | 2100 |
| Cayman2015 | 10007132 | (R)-(-)-2-Phenylglycinol | 1 g | 180 |
| Cayman2015 | 10007132 | (R)-(-)-2-Phenylglycinol | 10 g | 1440 |
| Cayman2015 | 10007132 | (R)-(-)-2-Phenylglycinol | 25 g | 3160 |
| Cayman2015 | 10007132 | (R)-(-)-2-Phenylglycinol | 5 g | 820 |
| Cayman2015 | 10007133 | CMPF | 1 mg | 910 |
| Cayman2015 | 10007133 | CMPF | 10 mg | 6664 |
| Cayman2015 | 10007133 | CMPF | 5 mg | 3808 |
| Cayman2015 | 10007133 | CMPF | 500 μg | 476 |
| Cayman2015 | 10007134 | 5-Bromotetralone | 100 mg | 380 |
| Cayman2015 | 10007134 | 5-Bromotetralone | 250 mg | 900 |
| Cayman2015 | 10007134 | 5-Bromotetralone | 50 mg | 200 |
| Cayman2015 | 10007134 | 5-Bromotetralone | 500 mg | 1600 |
| Cayman2015 | 10007135 | 7-Bromotetralone | 100 mg | 380 |
| Cayman2015 | 10007135 | 7-Bromotetralone | 250 mg | 900 |
| Cayman2015 | 10007135 | 7-Bromotetralone | 50 mg | 200 |
| Cayman2015 | 10007135 | 7-Bromotetralone | 500 mg | 1600 |
| Cayman2015 | 10007136 | 7-Piperazin-1-yl-thieno[2,3-c] Pyridine (hydrochloride) | 100 mg | 760 |
| Cayman2015 | 10007136 | 7-Piperazin-1-yl-thieno[2,3-c] Pyridine (hydrochloride) | 250 mg | 1800 |
| Cayman2015 | 10007136 | 7-Piperazin-1-yl-thieno[2,3-c] Pyridine (hydrochloride) | 50 mg | 400 |
| Cayman2015 | 10007136 | 7-Piperazin-1-yl-thieno[2,3-c] Pyridine (hydrochloride) | 500 mg | 3200 |
| Cayman2015 | 10007138 | 2-methyl-1,3-Cyclohexanedione | 1 g | 140 |
| Cayman2015 | 10007138 | 2-methyl-1,3-Cyclohexanedione | 10 g | 1120 |
| Cayman2015 | 10007138 | 2-methyl-1,3-Cyclohexanedione | 5 g | 640 |
| Cayman2015 | 10007138 | 2-methyl-1,3-Cyclohexanedione | 50 g | 4900 |
| Cayman2015 | 10007142 | S-Nitrosylation Blocking Reagent | 1 ea | 350 |
| Cayman2015 | 10007143 | Vilogenin (alligator) Monoclonal Antibody (ND-1E8) | 100 μL | 5180 |
| Cayman2015 | 10007143 | Vilogenin (alligator) Monoclonal Antibody (ND-1E8) | 500 μL | 23320 |
| Cayman2015 | 10007145 | (R)-benzyl Mandelate | 1 g | 140 |
| Cayman2015 | 10007145 | (R)-benzyl Mandelate | 10 g | 1120 |
| Cayman2015 | 10007145 | (R)-benzyl Mandelate | 5 g | 640 |
| Cayman2015 | 10007145 | (R)-benzyl Mandelate | 50 g | 4900 |
| Cayman2015 | 10007146 | 8-piperazin-1-yl-Isoquinoline (hydrochloride) | 1 g | 23520 |
| Cayman2015 | 10007146 | 8-piperazin-1-yl-Isoquinoline (hydrochloride) | 100 mg | 3200 |
| Cayman2015 | 10007146 | 8-piperazin-1-yl-Isoquinoline (hydrochloride) | 50 mg | 1680 |
| Cayman2015 | 10007146 | 8-piperazin-1-yl-Isoquinoline (hydrochloride) | 500 mg | 13120 |
| Cayman2015 | 10007147 | 7-piperazin-1-yl-Isoquinoline (hydrochloride) | 1 g | 24080 |
| Cayman2015 | 10007147 | 7-piperazin-1-yl-Isoquinoline (hydrochloride) | 100 mg | 3260 |
| Cayman2015 | 10007147 | 7-piperazin-1-yl-Isoquinoline (hydrochloride) | 50 mg | 1720 |
| Cayman2015 | 10007147 | 7-piperazin-1-yl-Isoquinoline (hydrochloride) | 500 mg | 13760 |
| Cayman2015 | 10007148 | 6-piperazin-1-yl-Isoquinoline (hydrochloride) | 1 g | 23520 |
| Cayman2015 | 10007148 | 6-piperazin-1-yl-Isoquinoline (hydrochloride) | 100 mg | 3200 |
| Cayman2015 | 10007148 | 6-piperazin-1-yl-Isoquinoline (hydrochloride) | 50 mg | 1680 |
| Cayman2015 | 10007148 | 6-piperazin-1-yl-Isoquinoline (hydrochloride) | 500 mg | 13120 |
| Cayman2015 | 10007164 | Leukotriene C4 methyl ester | 100 μg | 5950 |
| Cayman2015 | 10007164 | Leukotriene C4 methyl ester | 25 μg | 1652 |
| Cayman2015 | 10007164 | Leukotriene C4 methyl ester | 50 μg | 3136 |
| Cayman2015 | 10007165 | Leukotriene D4 methyl ester | 100 μg | 5950 |
| Cayman2015 | 10007165 | Leukotriene D4 methyl ester | 25 μg | 1652 |
| Cayman2015 | 10007165 | Leukotriene D4 methyl ester | 50 μg | 3136 |
| Cayman2015 | 10007166 | Leukotriene E4 methyl ester | 100 μg | 3976 |
| Cayman2015 | 10007166 | Leukotriene E4 methyl ester | 25 μg | 1106 |
| Cayman2015 | 10007166 | Leukotriene E4 methyl ester | 50 μg | 2100 |
| Cayman2015 | 10007171 | Cetaben | 10 mg | 742 |
| Cayman2015 | 10007171 | Cetaben | 100 mg | 5488 |
| Cayman2015 | 10007171 | Cetaben | 5 mg | 392 |
| Cayman2015 | 10007171 | Cetaben | 50 mg | 3136 |
| Cayman2015 | 10007185 | PCSK9 (human) Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 10007186 | PCSK9 (human) Blocking Peptide | 1 ea | 1498 |
| Cayman2015 | 10007187 | Microcystin-LA | 100 μg | 3360 |
| Cayman2015 | 10007187 | Microcystin-LA | 25 μg | 2100 |
| Cayman2015 | 10007187 | Microcystin-LA | 500 μg | 14700 |
| Cayman2015 | 10007188 | Microcystin-LR | 1 mg | 4550 |
| Cayman2015 | 10007188 | Microcystin-LR | 100 μg | 630 |
| Cayman2015 | 10007188 | Microcystin-LR | 50 μg | 350 |
| Cayman2015 | 10007188 | Microcystin-LR | 500 μg | 2632 |
| Cayman2015 | 10007190 | Nodularin | 1 mg | 6860 |
| Cayman2015 | 10007190 | Nodularin | 100 μg | 938 |
| Cayman2015 | 10007190 | Nodularin | 50 μg | 490 |
| Cayman2015 | 10007190 | Nodularin | 500 μg | 3920 |
| Cayman2015 | 10007191 | PH Domain Leucine-rich Repeat Protein Phosphatase 1 Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 10007192 | PH Domain Leucine-rich Repeat Protein Phosphatase Blocking Peptide | 1 ea | 1498 |
| Cayman2015 | 10007193 | Lysophospholipase D Blocking Peptide | 1 ea | 1498 |
| Cayman2015 | 10007199 | Prostaglandin A2 Lipid Maps MS Standard | 1 mg | 420 |
| Cayman2015 | 10007199 | Prostaglandin A2 Lipid Maps MS Standard | 5 mg | 1792 |
| Cayman2015 | 10007200 | 13,14-dihydro-15-keto Prostaglandin A2 Lipid Maps MS Standard | 1 mg | 1148 |
| Cayman2015 | 10007200 | 13,14-dihydro-15-keto Prostaglandin A2 Lipid Maps MS Standard | 5 mg | 5166 |
| Cayman2015 | 10007200 | 13,14-dihydro-15-keto Prostaglandin A2 Lipid Maps MS Standard | 500 μg | 728 |
| Cayman2015 | 10007201 | Prostaglandin B2 Lipid Maps MS Standard | 1 mg | 588 |
| Cayman2015 | 10007201 | Prostaglandin B2 Lipid Maps MS Standard | 10 mg | 3822 |
| Cayman2015 | 10007201 | Prostaglandin B2 Lipid Maps MS Standard | 25 mg | 7350 |
| Cayman2015 | 10007201 | Prostaglandin B2 Lipid Maps MS Standard | 5 mg | 2506 |
| Cayman2015 | 10007202 | Prostaglandin D2 Lipid Maps MS Standard | 1 mg | 602 |
| Cayman2015 | 10007202 | Prostaglandin D2 Lipid Maps MS Standard | 10 mg | 4816 |
| Cayman2015 | 10007202 | Prostaglandin D2 Lipid Maps MS Standard | 5 mg | 2716 |
| Cayman2015 | 10007202 | Prostaglandin D2 Lipid Maps MS Standard | 50 mg | 21070 |
| Cayman2015 | 10007203 | Prostaglandin D2 Ethanolamide Lipid Maps MS Standard | 1 mg | 1120 |
| Cayman2015 | 10007203 | Prostaglandin D2 Ethanolamide Lipid Maps MS Standard | 5 mg | 5040 |
| Cayman2015 | 10007203 | Prostaglandin D2 Ethanolamide Lipid Maps MS Standard | 500 μg | 700 |
| Cayman2015 | 10007205 | GPR40 Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 10007206 | GPR40 Blocking Peptide | 1 ea | 1498 |
| Cayman2015 | 10007207 | tetranor-12(S)-HETE | 100 μg | 5138 |
| Cayman2015 | 10007207 | tetranor-12(S)-HETE | 25 μg | 1428 |
| Cayman2015 | 10007207 | tetranor-12(S)-HETE | 50 μg | 2716 |
| Cayman2015 | 10007208 | 13,14-dihydro-15-keto Prostaglandin D2 Lipid Maps MS Standard | 1 mg | 1764 |
| Cayman2015 | 10007208 | 13,14-dihydro-15-keto Prostaglandin D2 Lipid Maps MS Standard | 5 mg | 7966 |
| Cayman2015 | 10007208 | 13,14-dihydro-15-keto Prostaglandin D2 Lipid Maps MS Standard | 500 μg | 1092 |
| Cayman2015 | 10007210 | 6-keto Prostaglandin E1 Lipid Maps MS Standard | 1 mg | 1176 |
| Cayman2015 | 10007210 | 6-keto Prostaglandin E1 Lipid Maps MS Standard | 10 mg | 9408 |
| Cayman2015 | 10007210 | 6-keto Prostaglandin E1 Lipid Maps MS Standard | 5 mg | 5292 |
| Cayman2015 | 10007211 | Prostaglandin E2 Lipid Maps MS Standard | 1 mg | 322 |
| Cayman2015 | 10007211 | Prostaglandin E2 Lipid Maps MS Standard | 10 mg | 2576 |
| Cayman2015 | 10007211 | Prostaglandin E2 Lipid Maps MS Standard | 5 mg | 1456 |
| Cayman2015 | 10007212 | Prostaglandin E2 Ethanolamide Lipid Maps MS Standard | 1 mg | 826 |
| Cayman2015 | 10007212 | Prostaglandin E2 Ethanolamide Lipid Maps MS Standard | 10 mg | 6608 |
| Cayman2015 | 10007212 | Prostaglandin E2 Ethanolamide Lipid Maps MS Standard | 5 mg | 3724 |
| Cayman2015 | 10007213 | Bicyclo Prostaglandin E2 Lipid Maps MS Standard | 1 mg | 994 |
| Cayman2015 | 10007213 | Bicyclo Prostaglandin E2 Lipid Maps MS Standard | 10 mg | 7952 |
| Cayman2015 | 10007213 | Bicyclo Prostaglandin E2 Lipid Maps MS Standard | 5 mg | 4480 |
| Cayman2015 | 10007214 | 13,14-dihydro-15-keto Prostaglandin E2 Lipid Maps MS Standard | 1 mg | 994 |
| Cayman2015 | 10007214 | 13,14-dihydro-15-keto Prostaglandin E2 Lipid Maps MS Standard | 10 mg | 7952 |
| Cayman2015 | 10007214 | 13,14-dihydro-15-keto Prostaglandin E2 Lipid Maps MS Standard | 5 mg | 4480 |
| Cayman2015 | 10007215 | 15-keto Prostaglandin E2 Lipid Maps MS Standard | 1 mg | 1666 |
| Cayman2015 | 10007215 | 15-keto Prostaglandin E2 Lipid Maps MS Standard | 10 mg | 13328 |
| Cayman2015 | 10007215 | 15-keto Prostaglandin E2 Lipid Maps MS Standard | 5 mg | 7504 |
| Cayman2015 | 10007216 | tetranor-PGEM Lipid Maps MS Standard | 100 μg | 6552 |
| Cayman2015 | 10007216 | tetranor-PGEM Lipid Maps MS Standard | 25 μg | 1820 |
| Cayman2015 | 10007216 | tetranor-PGEM Lipid Maps MS Standard | 50 μg | 3458 |
| Cayman2015 | 10007217 | 19(R)-hydroxy Prostaglandin E2 Lipid Maps MS Standard | 100 μg | 1414 |
| Cayman2015 | 10007217 | 19(R)-hydroxy Prostaglandin E2 Lipid Maps MS Standard | 50 μg | 742 |
| Cayman2015 | 10007217 | 19(R)-hydroxy Prostaglandin E2 Lipid Maps MS Standard | 500 μg | 5936 |
| Cayman2015 | 10007218 | 20-hydroxy Prostaglandin E2 Lipid Maps MS Standard | 1 mg | 11760 |
| Cayman2015 | 10007218 | 20-hydroxy Prostaglandin E2 Lipid Maps MS Standard | 100 μg | 1596 |
| Cayman2015 | 10007218 | 20-hydroxy Prostaglandin E2 Lipid Maps MS Standard | 50 μg | 840 |
| Cayman2015 | 10007218 | 20-hydroxy Prostaglandin E2 Lipid Maps MS Standard | 500 μg | 6720 |
| Cayman2015 | 10007219 | 6-keto Prostaglandin F1α Lipid Maps MS Standard | 1 mg | 1484 |
| Cayman2015 | 10007219 | 6-keto Prostaglandin F1α Lipid Maps MS Standard | 10 mg | 11872 |
| Cayman2015 | 10007219 | 6-keto Prostaglandin F1α Lipid Maps MS Standard | 5 mg | 6678 |
| Cayman2015 | 10007220 | 6,15-diketo-13,14-dihydro Prostaglandin F1α Lipid Maps MS Standard | 1 mg | 3360 |
| Cayman2015 | 10007220 | 6,15-diketo-13,14-dihydro Prostaglandin F1α Lipid Maps MS Standard | 100 μg | 420 |
| Cayman2015 | 10007220 | 6,15-diketo-13,14-dihydro Prostaglandin F1α Lipid Maps MS Standard | 500 μg | 1890 |
| Cayman2015 | 10007221 | Prostaglandin F2α Lipid Maps MS Standard | 1 mg | 490 |
| Cayman2015 | 10007221 | Prostaglandin F2α Lipid Maps MS Standard | 10 mg | 3920 |
| Cayman2015 | 10007221 | Prostaglandin F2α Lipid Maps MS Standard | 5 mg | 2198 |
| Cayman2015 | 10007222 | Prostaglandin F2α Ethanolamide Lipid Maps MS Standard | 1 mg | 952 |
| Cayman2015 | 10007222 | Prostaglandin F2α Ethanolamide Lipid Maps MS Standard | 10 mg | 7616 |
| Cayman2015 | 10007222 | Prostaglandin F2α Ethanolamide Lipid Maps MS Standard | 5 mg | 4284 |
| Cayman2015 | 10007224 | 11β-Prostaglandin F2α Lipid Maps MS Standard | 1 mg | 1918 |
| Cayman2015 | 10007224 | 11β-Prostaglandin F2α Lipid Maps MS Standard | 10 mg | 15344 |
| Cayman2015 | 10007224 | 11β-Prostaglandin F2α Lipid Maps MS Standard | 5 mg | 8638 |
| Cayman2015 | 10007225 | 2,3-dinor-11β-Prostaglandin F2α Lipid Maps MS Standard | 100 μg | 5740 |
| Cayman2015 | 10007225 | 2,3-dinor-11β-Prostaglandin F2α Lipid Maps MS Standard | 25 μg | 1596 |
| Cayman2015 | 10007225 | 2,3-dinor-11β-Prostaglandin F2α Lipid Maps MS Standard | 50 μg | 3038 |
| Cayman2015 | 10007226 | 13,14-dihydro-15-keto Prostaglandin F2α Lipid Maps MS Standard | 1 mg | 1064 |
| Cayman2015 | 10007226 | 13,14-dihydro-15-keto Prostaglandin F2α Lipid Maps MS Standard | 10 mg | 8512 |
| Cayman2015 | 10007226 | 13,14-dihydro-15-keto Prostaglandin F2α Lipid Maps MS Standard | 5 mg | 4788 |
| Cayman2015 | 10007227 | 15-keto Prostaglandin F2α Lipid Maps MS Standard | 1 mg | 896 |
| Cayman2015 | 10007227 | 15-keto Prostaglandin F2α Lipid Maps MS Standard | 10 mg | 7168 |
| Cayman2015 | 10007227 | 15-keto Prostaglandin F2α Lipid Maps MS Standard | 5 mg | 4032 |
| Cayman2015 | 10007228 | tetranor-PGFM Lipid Maps MS Standard | 100 μg | 6552 |
| Cayman2015 | 10007228 | tetranor-PGFM Lipid Maps MS Standard | 25 μg | 1820 |
| Cayman2015 | 10007228 | tetranor-PGFM Lipid Maps MS Standard | 50 μg | 3458 |
| Cayman2015 | 10007229 | 20-hydroxy Prostaglandin F2α Lipid Maps MS Standard | 100 μg | 1624 |
| Cayman2015 | 10007229 | 20-hydroxy Prostaglandin F2α Lipid Maps MS Standard | 50 μg | 854 |
| Cayman2015 | 10007229 | 20-hydroxy Prostaglandin F2α Lipid Maps MS Standard | 500 μg | 6832 |
| Cayman2015 | 10007230 | Prostaglandin G2 Lipid Maps MS Standard | 100 μg | 4340 |
| Cayman2015 | 10007230 | Prostaglandin G2 Lipid Maps MS Standard | 25 μg | 1204 |
| Cayman2015 | 10007230 | Prostaglandin G2 Lipid Maps MS Standard | 50 μg | 2282 |
| Cayman2015 | 10007230 | Prostaglandin G2 Lipid Maps MS Standard | 500 μg | 19264 |
| Cayman2015 | 10007231 | Prostaglandin H2 Lipid Maps MS Standard | 100 μg | 1568 |
| Cayman2015 | 10007231 | Prostaglandin H2 Lipid Maps MS Standard | 25 μg | 490 |
| Cayman2015 | 10007231 | Prostaglandin H2 Lipid Maps MS Standard | 50 μg | 882 |
| Cayman2015 | 10007231 | Prostaglandin H2 Lipid Maps MS Standard | 500 μg | 6860 |
| Cayman2015 | 10007232 | Prostaglandin F2β Lipid Maps MS Standard | 1 mg | 1120 |
| Cayman2015 | 10007232 | Prostaglandin F2β Lipid Maps MS Standard | 10 mg | 8960 |
| Cayman2015 | 10007232 | Prostaglandin F2β Lipid Maps MS Standard | 5 mg | 5040 |
| Cayman2015 | 10007233 | Prostaglandin J2 Lipid Maps MS Standard | 1 mg | 2072 |
| Cayman2015 | 10007233 | Prostaglandin J2 Lipid Maps MS Standard | 5 mg | 8736 |
| Cayman2015 | 10007233 | Prostaglandin J2 Lipid Maps MS Standard | 500 μg | 1092 |
| Cayman2015 | 10007234 | Δ12-Prostaglandin J2 Lipid Maps MS Standard | 1 mg | 4368 |
| Cayman2015 | 10007234 | Δ12-Prostaglandin J2 Lipid Maps MS Standard | 100 μg | 546 |
| Cayman2015 | 10007234 | Δ12-Prostaglandin J2 Lipid Maps MS Standard | 500 μg | 2464 |
| Cayman2015 | 10007235 | 15-deoxy-Δ12,14-Prostaglandin J2 Lipid Maps MS Standard | 1 mg | 3360 |
| Cayman2015 | 10007235 | 15-deoxy-Δ12,14-Prostaglandin J2 Lipid Maps MS Standard | 100 μg | 420 |
| Cayman2015 | 10007235 | 15-deoxy-Δ12,14-Prostaglandin J2 Lipid Maps MS Standard | 500 μg | 1890 |
| Cayman2015 | 10007236 | Prostaglandin K2 Lipid Maps MS Standard | 1 mg | 4704 |
| Cayman2015 | 10007236 | Prostaglandin K2 Lipid Maps MS Standard | 100 μg | 588 |
| Cayman2015 | 10007236 | Prostaglandin K2 Lipid Maps MS Standard | 5 mg | 20580 |
| Cayman2015 | 10007236 | Prostaglandin K2 Lipid Maps MS Standard | 500 μg | 2646 |
| Cayman2015 | 10007237 | Thromboxane B2 Lipid Maps MS Standard | 1 mg | 770 |
| Cayman2015 | 10007237 | Thromboxane B2 Lipid Maps MS Standard | 10 mg | 6160 |
| Cayman2015 | 10007237 | Thromboxane B2 Lipid Maps MS Standard | 5 mg | 3472 |
| Cayman2015 | 10007239 | 11-dehydro Thromboxane B2 Lipid Maps MS Standard | 100 μg | 1946 |
| Cayman2015 | 10007239 | 11-dehydro Thromboxane B2 Lipid Maps MS Standard | 1000 μg | 15568 |
| Cayman2015 | 10007239 | 11-dehydro Thromboxane B2 Lipid Maps MS Standard | 250 μg | 4620 |
| Cayman2015 | 10007239 | 11-dehydro Thromboxane B2 Lipid Maps MS Standard | 500 μg | 8764 |
| Cayman2015 | 10007240 | Leukotriene B4 Lipid Maps MS Standard | 100 μg | 6188 |
| Cayman2015 | 10007240 | Leukotriene B4 Lipid Maps MS Standard | 25 μg | 1722 |
| Cayman2015 | 10007240 | Leukotriene B4 Lipid Maps MS Standard | 50 μg | 3276 |
| Cayman2015 | 10007241 | Leukotriene C4 Lipid Maps MS Standard | 100 μg | 5740 |
| Cayman2015 | 10007241 | Leukotriene C4 Lipid Maps MS Standard | 25 μg | 1596 |
| Cayman2015 | 10007241 | Leukotriene C4 Lipid Maps MS Standard | 50 μg | 3038 |
| Cayman2015 | 10007241 | Leukotriene C4 Lipid Maps MS Standard | 500 μg | 25536 |
| Cayman2015 | 10007242 | Leukotriene E4 Lipid Maps MS Standard | 100 μg | 3976 |
| Cayman2015 | 10007242 | Leukotriene E4 Lipid Maps MS Standard | 25 μg | 1106 |
| Cayman2015 | 10007242 | Leukotriene E4 Lipid Maps MS Standard | 50 μg | 2100 |
| Cayman2015 | 10007243 | 5(S)-HETE Lipid Maps MS Standard | 100 μg | 4606 |
| Cayman2015 | 10007243 | 5(S)-HETE Lipid Maps MS Standard | 25 μg | 1372 |
| Cayman2015 | 10007243 | 5(S)-HETE Lipid Maps MS Standard | 250 μg | 10318 |
| Cayman2015 | 10007243 | 5(S)-HETE Lipid Maps MS Standard | 50 μg | 2464 |
| Cayman2015 | 10007244 | 5-OxoETE Lipid Maps MS Standard | 100 μg | 3836 |
| Cayman2015 | 10007244 | 5-OxoETE Lipid Maps MS Standard | 25 μg | 1064 |
| Cayman2015 | 10007244 | 5-OxoETE Lipid Maps MS Standard | 250 μg | 8512 |
| Cayman2015 | 10007244 | 5-OxoETE Lipid Maps MS Standard | 50 μg | 2016 |
| Cayman2015 | 10007245 | 8(S)-HETE Lipid Maps MS Standard | 100 μg | 5852 |
| Cayman2015 | 10007245 | 8(S)-HETE Lipid Maps MS Standard | 25 μg | 1848 |
| Cayman2015 | 10007245 | 8(S)-HETE Lipid Maps MS Standard | 50 μg | 3080 |
| Cayman2015 | 10007246 | 11(S)-HETE Lipid Maps MS Standard | 100 μg | 6650 |
| Cayman2015 | 10007246 | 11(S)-HETE Lipid Maps MS Standard | 25 μg | 1848 |
| Cayman2015 | 10007246 | 11(S)-HETE Lipid Maps MS Standard | 50 μg | 3514 |
| Cayman2015 | 10007247 | 12(R)-HETE Lipid Maps MS Standard | 100 μg | 6650 |
| Cayman2015 | 10007247 | 12(R)-HETE Lipid Maps MS Standard | 25 μg | 1848 |
| Cayman2015 | 10007247 | 12(R)-HETE Lipid Maps MS Standard | 50 μg | 3514 |
| Cayman2015 | 10007248 | 12(S)-HETE Lipid Maps MS Standard | 100 μg | 5852 |
| Cayman2015 | 10007248 | 12(S)-HETE Lipid Maps MS Standard | 25 μg | 1848 |
| Cayman2015 | 10007248 | 12(S)-HETE Lipid Maps MS Standard | 50 μg | 3080 |
| Cayman2015 | 10007249 | 12-OxoETE Lipid Maps MS Standard | 100 μg | 5852 |
| Cayman2015 | 10007249 | 12-OxoETE Lipid Maps MS Standard | 25 μg | 1624 |
| Cayman2015 | 10007249 | 12-OxoETE Lipid Maps MS Standard | 250 μg | 12992 |
| Cayman2015 | 10007249 | 12-OxoETE Lipid Maps MS Standard | 50 μg | 3080 |
| Cayman2015 | 10007250 | 12(S)-HHTrE Lipid Maps MS Standard | 100 μg | 5488 |
| Cayman2015 | 10007250 | 12(S)-HHTrE Lipid Maps MS Standard | 25 μg | 1526 |
| Cayman2015 | 10007250 | 12(S)-HHTrE Lipid Maps MS Standard | 250 μg | 12208 |
| Cayman2015 | 10007250 | 12(S)-HHTrE Lipid Maps MS Standard | 50 μg | 2898 |
| Cayman2015 | 10007251 | 15(S)-HETE Lipid Maps MS Standard | 100 μg | 1932 |
| Cayman2015 | 10007251 | 15(S)-HETE Lipid Maps MS Standard | 25 μg | 602 |
| Cayman2015 | 10007251 | 15(S)-HETE Lipid Maps MS Standard | 50 μg | 1078 |
| Cayman2015 | 10007251 | 15(S)-HETE Lipid Maps MS Standard | 500 μg | 8414 |
| Cayman2015 | 10007252 | 5(S),6(R)-DiHETE Lipid Maps MS Standard | 100 μg | 4732 |
| Cayman2015 | 10007252 | 5(S),6(R)-DiHETE Lipid Maps MS Standard | 25 μg | 1316 |
| Cayman2015 | 10007252 | 5(S),6(R)-DiHETE Lipid Maps MS Standard | 250 μg | 10528 |
| Cayman2015 | 10007252 | 5(S),6(R)-DiHETE Lipid Maps MS Standard | 50 μg | 2506 |
| Cayman2015 | 10007253 | 5(S),6(S)-DiHETE Lipid Maps MS Standard | 100 μg | 7910 |
| Cayman2015 | 10007253 | 5(S),6(S)-DiHETE Lipid Maps MS Standard | 25 μg | 2198 |
| Cayman2015 | 10007253 | 5(S),6(S)-DiHETE Lipid Maps MS Standard | 250 μg | 17584 |
| Cayman2015 | 10007253 | 5(S),6(S)-DiHETE Lipid Maps MS Standard | 50 μg | 4172 |
| Cayman2015 | 10007254 | 6-trans Leukotriene B4 Lipid Maps MS Standard | 100 μg | 5446 |
| Cayman2015 | 10007254 | 6-trans Leukotriene B4 Lipid Maps MS Standard | 25 μg | 1512 |
| Cayman2015 | 10007254 | 6-trans Leukotriene B4 Lipid Maps MS Standard | 50 μg | 2870 |
| Cayman2015 | 10007255 | 5(S),15(S)-DiHETE Lipid Maps MS Standard | 100 μg | 3836 |
| Cayman2015 | 10007255 | 5(S),15(S)-DiHETE Lipid Maps MS Standard | 25 μg | 1064 |
| Cayman2015 | 10007255 | 5(S),15(S)-DiHETE Lipid Maps MS Standard | 250 μg | 8512 |
| Cayman2015 | 10007255 | 5(S),15(S)-DiHETE Lipid Maps MS Standard | 50 μg | 2016 |
| Cayman2015 | 10007256 | 6-trans-12-epi Leukotriene B4 Lipid Maps MS Standard | 100 μg | 5446 |
| Cayman2015 | 10007256 | 6-trans-12-epi Leukotriene B4 Lipid Maps MS Standard | 25 μg | 1512 |
| Cayman2015 | 10007256 | 6-trans-12-epi Leukotriene B4 Lipid Maps MS Standard | 50 μg | 2870 |
| Cayman2015 | 10007257 | 5(S)-HpETE Lipid Maps MS Standard | 100 μg | 4186 |
| Cayman2015 | 10007257 | 5(S)-HpETE Lipid Maps MS Standard | 25 μg | 1162 |
| Cayman2015 | 10007257 | 5(S)-HpETE Lipid Maps MS Standard | 250 μg | 9296 |
| Cayman2015 | 10007257 | 5(S)-HpETE Lipid Maps MS Standard | 50 μg | 2212 |
| Cayman2015 | 10007258 | 12(S)-HpETE Lipid Maps MS Standard | 100 μg | 5894 |
| Cayman2015 | 10007258 | 12(S)-HpETE Lipid Maps MS Standard | 25 μg | 1638 |
| Cayman2015 | 10007258 | 12(S)-HpETE Lipid Maps MS Standard | 250 μg | 13104 |
| Cayman2015 | 10007258 | 12(S)-HpETE Lipid Maps MS Standard | 50 μg | 3108 |
| Cayman2015 | 10007259 | 15(S)-HpETE Lipid Maps MS Standard | 100 μg | 1610 |
| Cayman2015 | 10007259 | 15(S)-HpETE Lipid Maps MS Standard | 25 μg | 448 |
| Cayman2015 | 10007259 | 15(S)-HpETE Lipid Maps MS Standard | 50 μg | 854 |
| Cayman2015 | 10007259 | 15(S)-HpETE Lipid Maps MS Standard | 500 μg | 7168 |
| Cayman2015 | 10007260 | 5(6)-EET Lipid Maps MS Standard | 100 μg | 2016 |
| Cayman2015 | 10007260 | 5(6)-EET Lipid Maps MS Standard | 25 μg | 560 |
| Cayman2015 | 10007260 | 5(6)-EET Lipid Maps MS Standard | 50 μg | 1064 |
| Cayman2015 | 10007260 | 5(6)-EET Lipid Maps MS Standard | 500 μg | 8960 |
| Cayman2015 | 10007261 | 8(9)-EET Lipid Maps MS Standard | 100 μg | 2016 |
| Cayman2015 | 10007261 | 8(9)-EET Lipid Maps MS Standard | 25 μg | 560 |
| Cayman2015 | 10007261 | 8(9)-EET Lipid Maps MS Standard | 50 μg | 1064 |
| Cayman2015 | 10007261 | 8(9)-EET Lipid Maps MS Standard | 500 μg | 8960 |
| Cayman2015 | 10007262 | 11(12)-EET Lipid Maps MS Standard | 100 μg | 2016 |
| Cayman2015 | 10007262 | 11(12)-EET Lipid Maps MS Standard | 25 μg | 560 |
| Cayman2015 | 10007262 | 11(12)-EET Lipid Maps MS Standard | 50 μg | 1064 |
| Cayman2015 | 10007262 | 11(12)-EET Lipid Maps MS Standard | 500 μg | 8960 |
| Cayman2015 | 10007263 | 14(15)-EET Lipid Maps MS Standard | 100 μg | 2016 |
| Cayman2015 | 10007263 | 14(15)-EET Lipid Maps MS Standard | 25 μg | 560 |
| Cayman2015 | 10007263 | 14(15)-EET Lipid Maps MS Standard | 50 μg | 1064 |
| Cayman2015 | 10007263 | 14(15)-EET Lipid Maps MS Standard | 500 μg | 8960 |
| Cayman2015 | 10007264 | (±)5,6-DHET Lipid Maps MS Standard | 100 μg | 4088 |
| Cayman2015 | 10007264 | (±)5,6-DHET Lipid Maps MS Standard | 25 μg | 1134 |
| Cayman2015 | 10007264 | (±)5,6-DHET Lipid Maps MS Standard | 250 μg | 9072 |
| Cayman2015 | 10007264 | (±)5,6-DHET Lipid Maps MS Standard | 50 μg | 2156 |
| Cayman2015 | 10007265 | (±)8,9-DHET Lipid Maps MS Standard | 100 μg | 4088 |
| Cayman2015 | 10007265 | (±)8,9-DHET Lipid Maps MS Standard | 25 μg | 1134 |
| Cayman2015 | 10007265 | (±)8,9-DHET Lipid Maps MS Standard | 250 μg | 9072 |
| Cayman2015 | 10007265 | (±)8,9-DHET Lipid Maps MS Standard | 50 μg | 2156 |
| Cayman2015 | 10007266 | (±)11,12-DHET Lipid Maps MS Standard | 100 μg | 4088 |
| Cayman2015 | 10007266 | (±)11,12-DHET Lipid Maps MS Standard | 25 μg | 1134 |
| Cayman2015 | 10007266 | (±)11,12-DHET Lipid Maps MS Standard | 250 μg | 9072 |
| Cayman2015 | 10007266 | (±)11,12-DHET Lipid Maps MS Standard | 50 μg | 2156 |
| Cayman2015 | 10007267 | (±)14,15-DHET Lipid Maps MS Standard | 100 μg | 4088 |
| Cayman2015 | 10007267 | (±)14,15-DHET Lipid Maps MS Standard | 25 μg | 1134 |
| Cayman2015 | 10007267 | (±)14,15-DHET Lipid Maps MS Standard | 50 μg | 2156 |
| Cayman2015 | 10007268 | Arachidonic Acid Lipid Maps MS Standard | 100 mg | 686 |
| Cayman2015 | 10007268 | Arachidonic Acid Lipid Maps MS Standard | 250 mg | 1638 |
| Cayman2015 | 10007268 | Arachidonic Acid Lipid Maps MS Standard | 50 mg | 364 |
| Cayman2015 | 10007268 | Arachidonic Acid Lipid Maps MS Standard | 500 mg | 2912 |
| Cayman2015 | 10007269 | 20-HETE Lipid Maps MS Standard | 100 μg | 6650 |
| Cayman2015 | 10007269 | 20-HETE Lipid Maps MS Standard | 25 μg | 1848 |
| Cayman2015 | 10007269 | 20-HETE Lipid Maps MS Standard | 50 μg | 3514 |
| Cayman2015 | 10007270 | Arachidonoyl Ethanolamide Lipid Maps MS Standard | 10 mg | 1064 |
| Cayman2015 | 10007270 | Arachidonoyl Ethanolamide Lipid Maps MS Standard | 100 mg | 7840 |
| Cayman2015 | 10007270 | Arachidonoyl Ethanolamide Lipid Maps MS Standard | 5 mg | 560 |
| Cayman2015 | 10007270 | Arachidonoyl Ethanolamide Lipid Maps MS Standard | 50 mg | 4480 |
| Cayman2015 | 10007271 | 5(S),6(R)-Lipoxin A4 Lipid Maps MS Standard | 100 μg | 9072 |
| Cayman2015 | 10007271 | 5(S),6(R)-Lipoxin A4 Lipid Maps MS Standard | 25 μg | 2520 |
| Cayman2015 | 10007271 | 5(S),6(R)-Lipoxin A4 Lipid Maps MS Standard | 50 μg | 4788 |
| Cayman2015 | 10007272 | Prostaglandin D2-d4 Lipid Maps MS Standard | 100 μg | 4536 |
| Cayman2015 | 10007272 | Prostaglandin D2-d4 Lipid Maps MS Standard | 25 μg | 1260 |
| Cayman2015 | 10007272 | Prostaglandin D2-d4 Lipid Maps MS Standard | 50 μg | 2394 |
| Cayman2015 | 10007273 | Prostaglandin E2-d4 Lipid Maps MS Standard | 100 μg | 1624 |
| Cayman2015 | 10007273 | Prostaglandin E2-d4 Lipid Maps MS Standard | 50 μg | 854 |
| Cayman2015 | 10007273 | Prostaglandin E2-d4 Lipid Maps MS Standard | 500 μg | 6832 |
| Cayman2015 | 10007274 | 6-keto Prostaglandin F1α-d4 Lipid Maps MS Standard | 100 μg | 3122 |
| Cayman2015 | 10007274 | 6-keto Prostaglandin F1α-d4 Lipid Maps MS Standard | 25 μg | 868 |
| Cayman2015 | 10007274 | 6-keto Prostaglandin F1α-d4 Lipid Maps MS Standard | 50 μg | 1652 |
| Cayman2015 | 10007275 | Prostaglandin F2α-d4 Lipid Maps MS Standard | 100 μg | 1148 |
| Cayman2015 | 10007275 | Prostaglandin F2α-d4 Lipid Maps MS Standard | 50 μg | 602 |
| Cayman2015 | 10007275 | Prostaglandin F2α-d4 Lipid Maps MS Standard | 500 μg | 4816 |
| Cayman2015 | 10007276 | 5(S)-HETE-d8 Lipid Maps MS Standard | 100 μg | 6958 |
| Cayman2015 | 10007276 | 5(S)-HETE-d8 Lipid Maps MS Standard | 25 μg | 1932 |
| Cayman2015 | 10007276 | 5(S)-HETE-d8 Lipid Maps MS Standard | 50 μg | 3668 |
| Cayman2015 | 10007277 | Arachidonic Acid-d8 Lipid Maps MS Standard | 1 mg | 1456 |
| Cayman2015 | 10007277 | Arachidonic Acid-d8 Lipid Maps MS Standard | 5 mg | 6650 |
| Cayman2015 | 10007277 | Arachidonic Acid-d8 Lipid Maps MS Standard | 500 μg | 910 |
| Cayman2015 | 10007279 | Resolvin D2 | 10 μg | 1750 |
| Cayman2015 | 10007279 | Resolvin D2 | 100 μg | 13832 |
| Cayman2015 | 10007279 | Resolvin D2 | 25 μg | 4158 |
| Cayman2015 | 10007279 | Resolvin D2 | 50 μg | 7882 |
| Cayman2015 | 10007286 | N-Lignoceroyl Taurine | 1 mg | 896 |
| Cayman2015 | 10007286 | N-Lignoceroyl Taurine | 10 mg | 7168 |
| Cayman2015 | 10007286 | N-Lignoceroyl Taurine | 5 mg | 4032 |
| Cayman2015 | 10007287 | N-Nervonoyl Taurine | 1 mg | 938 |
| Cayman2015 | 10007287 | N-Nervonoyl Taurine | 10 mg | 7504 |
| Cayman2015 | 10007287 | N-Nervonoyl Taurine | 5 mg | 4228 |
| Cayman2015 | 10007288 | N-Docosanoyl Taurine | 1 mg | 938 |
| Cayman2015 | 10007288 | N-Docosanoyl Taurine | 10 mg | 7504 |
| Cayman2015 | 10007288 | N-Docosanoyl Taurine | 5 mg | 4228 |
| Cayman2015 | 10007289 | cis-4,10,13,16-Docosatetraenoic Acid | 1 mg | 350 |
| Cayman2015 | 10007289 | cis-4,10,13,16-Docosatetraenoic Acid | 10 mg | 2450 |
| Cayman2015 | 10007289 | cis-4,10,13,16-Docosatetraenoic Acid | 5 mg | 1316 |
| Cayman2015 | 10007290 | cis-7-Hexadecenoic Acid | 10 mg | 1008 |
| Cayman2015 | 10007290 | cis-7-Hexadecenoic Acid | 100 mg | 7448 |
| Cayman2015 | 10007290 | cis-7-Hexadecenoic Acid | 5 mg | 532 |
| Cayman2015 | 10007290 | cis-7-Hexadecenoic Acid | 50 mg | 4256 |
| Cayman2015 | 10007293 | Arachidonoyl-N,N-dimethyl amide | 10 mg | 882 |
| Cayman2015 | 10007293 | Arachidonoyl-N,N-dimethyl amide | 100 mg | 6468 |
| Cayman2015 | 10007293 | Arachidonoyl-N,N-dimethyl amide | 5 mg | 462 |
| Cayman2015 | 10007293 | Arachidonoyl-N,N-dimethyl amide | 50 mg | 3696 |
| Cayman2015 | 10007294 | Arachidonoyl-N-methyl amide | 10 mg | 882 |
| Cayman2015 | 10007294 | Arachidonoyl-N-methyl amide | 100 mg | 6468 |
| Cayman2015 | 10007294 | Arachidonoyl-N-methyl amide | 5 mg | 462 |
| Cayman2015 | 10007294 | Arachidonoyl-N-methyl amide | 50 mg | 3696 |
| Cayman2015 | 10007295 | Arachidonoyl amide | 10 mg | 882 |
| Cayman2015 | 10007295 | Arachidonoyl amide | 25 mg | 2086 |
| Cayman2015 | 10007295 | Arachidonoyl amide | 5 mg | 462 |
| Cayman2015 | 10007295 | Arachidonoyl amide | 50 mg | 3696 |
| Cayman2015 | 10007349 | TGX-221 | 1 mg | 966 |
| Cayman2015 | 10007349 | TGX-221 | 10 mg | 2464 |
| Cayman2015 | 10007349 | TGX-221 | 5 mg | 1372 |
| Cayman2015 | 10007349 | TGX-221 | 500 μg | 686 |
| Cayman2015 | 10007358 | Palmitic Acid methyl ester | 1000 mg | 140 |
| Cayman2015 | 10007358 | Palmitic Acid methyl ester | 10000 mg | 980 |
| Cayman2015 | 10007358 | Palmitic Acid methyl ester | 25000 mg | 2282 |
| Cayman2015 | 10007358 | Palmitic Acid methyl ester | 5000 mg | 532 |
| Cayman2015 | 10007412 | Combrestatin A4 | 10 mg | 1330 |
| Cayman2015 | 10007412 | Combrestatin A4 | 25 mg | 3150 |
| Cayman2015 | 10007412 | Combrestatin A4 | 5 mg | 700 |
| Cayman2015 | 10007412 | Combrestatin A4 | 50 mg | 5600 |
| Cayman2015 | 10007417 | 10-Thiastearic Acid | 10 mg | 882 |
| Cayman2015 | 10007417 | 10-Thiastearic Acid | 100 mg | 6468 |
| Cayman2015 | 10007417 | 10-Thiastearic Acid | 5 mg | 462 |
| Cayman2015 | 10007417 | 10-Thiastearic Acid | 50 mg | 3696 |
| Cayman2015 | 10007431 | N-Arachidonoyl Dopamine-d8 | 1 mg | 5040 |
| Cayman2015 | 10007431 | N-Arachidonoyl Dopamine-d8 | 100 μg | 630 |
| Cayman2015 | 10007431 | N-Arachidonoyl Dopamine-d8 | 500 μg | 2842 |
| Cayman2015 | 10007432 | FABP3 (human recombinant) | 100 μg | 3976 |
| Cayman2015 | 10007432 | FABP3 (human recombinant) | 25 μg | 1106 |
| Cayman2015 | 10007432 | FABP3 (human recombinant) | 50 μg | 2100 |
| Cayman2015 | 10007433 | FABP5 (mouse recombinant) | 100 μg | 4984 |
| Cayman2015 | 10007433 | FABP5 (mouse recombinant) | 25 μg | 1386 |
| Cayman2015 | 10007433 | FABP5 (mouse recombinant) | 50 μg | 2632 |
| Cayman2015 | 10007441 | Transcription Factor PPARα Positive Control | 1 ea | 910 |
| Cayman2015 | 10007442 | Transcription Factor PPARα Primary Antibody | 1 ea | 1092 |
| Cayman2015 | 10007443 | Transcription Factor PPARδ Positive Control | 1 ea | 910 |
| Cayman2015 | 10007444 | Transcription Factor PPARδ Primary Antibody | 1 ea | 1092 |
| Cayman2015 | 10007448 | Triacsin C | 1 mg | 5586 |
| Cayman2015 | 10007448 | Triacsin C | 500 μg | 2940 |
| Cayman2015 | 10007451 | PPARδ (human recombinant) | 10 μg | 2156 |
| Cayman2015 | 10007451 | PPARδ (human recombinant) | 25 μg | 5124 |
| Cayman2015 | 10007451 | PPARδ (human recombinant) | 50 μg | 9702 |
| Cayman2015 | 10007452 | Vinclozolin M2 | 10 mg | 1008 |
| Cayman2015 | 10007452 | Vinclozolin M2 | 25 mg | 2394 |
| Cayman2015 | 10007452 | Vinclozolin M2 | 5 mg | 532 |
| Cayman2015 | 10007452 | Vinclozolin M2 | 50 mg | 4256 |
| Cayman2015 | 10007457 | URB602 | 10 mg | 742 |
| Cayman2015 | 10007457 | URB602 | 100 mg | 5488 |
| Cayman2015 | 10007457 | URB602 | 5 mg | 392 |
| Cayman2015 | 10007457 | URB602 | 50 mg | 3136 |
| Cayman2015 | 10007461 | L-Glutathione, reduced | 1 g | 196 |
| Cayman2015 | 10007461 | L-Glutathione, reduced | 10 g | 1568 |
| Cayman2015 | 10007461 | L-Glutathione, reduced | 25 g | 3430 |
| Cayman2015 | 10007461 | L-Glutathione, reduced | 5 g | 882 |
| Cayman2015 | 10007464 | 10-methyl-9-(phenoxycarbonyl) Acridinium fluorosulfonate | 10 mg | 938 |
| Cayman2015 | 10007464 | 10-methyl-9-(phenoxycarbonyl) Acridinium fluorosulfonate | 100 mg | 6566 |
| Cayman2015 | 10007464 | 10-methyl-9-(phenoxycarbonyl) Acridinium fluorosulfonate | 5 mg | 490 |
| Cayman2015 | 10007464 | 10-methyl-9-(phenoxycarbonyl) Acridinium fluorosulfonate | 50 mg | 3878 |
| Cayman2015 | 10007466 | Arachidonic Acid-biotin | 1 mg | 5040 |
| Cayman2015 | 10007466 | Arachidonic Acid-biotin | 100 μg | 630 |
| Cayman2015 | 10007466 | Arachidonic Acid-biotin | 500 μg | 2842 |
| Cayman2015 | 10007472 | Transcription Factor Reagent A | 1 ea | 1092 |
| Cayman2015 | 10007475 | PEPCK Blocking Peptide | 1 ea | 1498 |
| Cayman2015 | 10007517 | N-Arachidonyl Maleimide | 10 mg | 1148 |
| Cayman2015 | 10007517 | N-Arachidonyl Maleimide | 100 mg | 8428 |
| Cayman2015 | 10007517 | N-Arachidonyl Maleimide | 5 mg | 602 |
| Cayman2015 | 10007517 | N-Arachidonyl Maleimide | 50 mg | 4816 |
| Cayman2015 | 10007518 | Capsazepine | 1 mg | 350 |
| Cayman2015 | 10007518 | Capsazepine | 10 mg | 1344 |
| Cayman2015 | 10007518 | Capsazepine | 5 mg | 952 |
| Cayman2015 | 10007518 | Capsazepine | 50 mg | 5460 |
| Cayman2015 | 10007527 | 14(15)-EpEDE | 100 μg | 1918 |
| Cayman2015 | 10007527 | 14(15)-EpEDE | 25 μg | 532 |
| Cayman2015 | 10007527 | 14(15)-EpEDE | 50 μg | 1008 |
| Cayman2015 | 10007527 | 14(15)-EpEDE | 500 μg | 8512 |
| Cayman2015 | 10007528 | 14(15)-EpEDE methyl ester | 100 μg | 1918 |
| Cayman2015 | 10007528 | 14(15)-EpEDE methyl ester | 25 μg | 532 |
| Cayman2015 | 10007528 | 14(15)-EpEDE methyl ester | 50 μg | 1008 |
| Cayman2015 | 10007528 | 14(15)-EpEDE methyl ester | 500 μg | 8512 |
| Cayman2015 | 10007531 | Arachidonoyl Glycine-d8 | 1 mg | 3024 |
| Cayman2015 | 10007531 | Arachidonoyl Glycine-d8 | 100 μg | 378 |
| Cayman2015 | 10007531 | Arachidonoyl Glycine-d8 | 5 mg | 13230 |
| Cayman2015 | 10007531 | Arachidonoyl Glycine-d8 | 500 μg | 1708 |
| Cayman2015 | 10007534 | Docosahexaenoyl Ethanolamide | 10 mg | 882 |
| Cayman2015 | 10007534 | Docosahexaenoyl Ethanolamide | 25 mg | 2086 |
| Cayman2015 | 10007534 | Docosahexaenoyl Ethanolamide | 5 mg | 462 |
| Cayman2015 | 10007534 | Docosahexaenoyl Ethanolamide | 50 mg | 3696 |
| Cayman2015 | 10007542 | KAPA (hydrochloride) | 1 mg | 154 |
| Cayman2015 | 10007542 | KAPA (hydrochloride) | 10 mg | 1232 |
| Cayman2015 | 10007542 | KAPA (hydrochloride) | 5 mg | 700 |
| Cayman2015 | 10007542 | KAPA (hydrochloride) | 50 mg | 5390 |
| Cayman2015 | 10007556 | PGDS Screening Assay Prostaglandin D Synthase (hematopoietic-type) | 1 ea | 896 |
| Cayman2015 | 10007557 | PGDS Screening Assay Prostaglandin D Synthase (lipocalin-type) | 1 ea | 896 |
| Cayman2015 | 10007558 | PGDS Screening Assay Glutathione | 1 ea | 84 |
| Cayman2015 | 10007559 | PGDS Screening Assay Dithiothreitol | 1 ea | 84 |
| Cayman2015 | 10007561 | PGDS Screening Assay Hydrochloric Acid | 1 ea | 84 |
| Cayman2015 | 10007562 | PGDS Screening Assay Iron (II) Chloride | 1 ea | 84 |
| Cayman2015 | 10007565 | Tetradecyl Phosphonate | 100 mg | 210 |
| Cayman2015 | 10007565 | Tetradecyl Phosphonate | 1000 mg | 826 |
| Cayman2015 | 10007565 | Tetradecyl Phosphonate | 500 mg | 490 |
| Cayman2015 | 10007572 | PGDS Screening Assay Reaction Buffer | 1 ea | 112 |
| Cayman2015 | 10007599 | Prorenin (human recombinant) | 100 μg | 3024 |
| Cayman2015 | 10007599 | Prorenin (human recombinant) | 25 μg | 1372 |
| Cayman2015 | 10007599 | Prorenin (human recombinant) | 50 μg | 2464 |
| Cayman2015 | 10007601 | 5α-hydroxy-6-keto Cholesterol | 1 mg | 350 |
| Cayman2015 | 10007601 | 5α-hydroxy-6-keto Cholesterol | 10 mg | 3150 |
| Cayman2015 | 10007601 | 5α-hydroxy-6-keto Cholesterol | 5 mg | 1666 |
| Cayman2015 | 10007602 | Δ2-cis Eicosenoic Acid | 10 mg | 1148 |
| Cayman2015 | 10007602 | Δ2-cis Eicosenoic Acid | 100 mg | 8428 |
| Cayman2015 | 10007602 | Δ2-cis Eicosenoic Acid | 5 mg | 602 |
| Cayman2015 | 10007602 | Δ2-cis Eicosenoic Acid | 50 mg | 4816 |
| Cayman2015 | 10007608 | Leptin Receptor (human) EIA Kit | 1 ea | 10500 |
| Cayman2015 | 10007609 | Leptin (mouse/rat) EIA Kit | 1 ea | 9140 |
| Cayman2015 | 10007610 | Resistin (human) EIA Kit | 1 ea | 9000 |
| Cayman2015 | 10007612 | Resistin (rat) EIA Kit | 1 ea | 11500 |
| Cayman2015 | 10007614 | FABP4 (human) EIA Kit | 1 ea | 13000 |
| Cayman2015 | 10007619 | Adiponectin (human) EIA Kit (HS) | 96 Well | 9500 |
| Cayman2015 | 10007620 | Adiponectin (mouse) EIA Kit | 1 ea | 8900 |
| Cayman2015 | 10007621 | GFAP (human) EIA Kit | 1 ea | 13500 |
| Cayman2015 | 10007622 | Δ2-trans Eicosenoic Acid | 10 mg | 1148 |
| Cayman2015 | 10007622 | Δ2-trans Eicosenoic Acid | 100 mg | 8428 |
| Cayman2015 | 10007622 | Δ2-trans Eicosenoic Acid | 5 mg | 602 |
| Cayman2015 | 10007622 | Δ2-trans Eicosenoic Acid | 50 mg | 4816 |
| Cayman2015 | 10007640 | Cholesterol Fluorometric Assay Kit | 1 ea | 2072 |
| Cayman2015 | 10007640 | Cholesterol Fluorometric Assay Kit | 5 ea | 5880 |
| Cayman2015 | 10007652 | 8-iso Prostaglandin F2α Quant-PAK | 1 ea | 9394 |
| Cayman2015 | 10007653 | (S)-H-1152 (hydrochloride) | 1 mg | 742 |
| Cayman2015 | 10007653 | (S)-H-1152 (hydrochloride) | 10 mg | 5488 |
| Cayman2015 | 10007653 | (S)-H-1152 (hydrochloride) | 5 mg | 3136 |
| Cayman2015 | 10007653 | (S)-H-1152 (hydrochloride) | 500 μg | 392 |
| Cayman2015 | 10007660 | GPR35 Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 10007661 | GPR35 Blocking Peptide | 1 ea | 1498 |
| Cayman2015 | 10007662 | L-Biopterin | 10 mg | 826 |
| Cayman2015 | 10007662 | L-Biopterin | 25 mg | 1960 |
| Cayman2015 | 10007662 | L-Biopterin | 5 mg | 434 |
| Cayman2015 | 10007662 | L-Biopterin | 50 mg | 3472 |
| Cayman2015 | 10007663 | SREBP-2 Polyclonal Antibody | 1 ea | 3668 |
| Cayman2015 | 10007665 | LDL Receptor Polyclonal Antibody | 1 ea | 3374 |
| Cayman2015 | 10007672 | LDL Receptor Blocking Peptide | 1 ea | 1498 |
| Cayman2015 | 10007680 | Semi-Quantitative Biomarker EIA Component Kit (anti-mouse) | 1 ea | 2600 |
| Cayman2015 | 10007680 | Semi-Quantitative Biomarker EIA Component Kit (anti-mouse) | 5 ea | 9760 |
| Cayman2015 | 10007681 | Serum Retinol Binding Protein 4 Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 10007682 | Serum Retinol Binding Protein 4 Blocking Peptide | 1 ea | 1498 |
| Cayman2015 | 10007685 | PPARγ Ligand Screening Assay Kit | 1920 Well | 23366 |
| Cayman2015 | 10007685 | PPARγ Ligand Screening Assay Kit | 384 Well | 6230 |
| Cayman2015 | 10007686 | Acetyl Podocarpic Acid Anhydride | 1 mg | 252 |
| Cayman2015 | 10007686 | Acetyl Podocarpic Acid Anhydride | 10 mg | 2016 |
| Cayman2015 | 10007686 | Acetyl Podocarpic Acid Anhydride | 5 mg | 1134 |
| Cayman2015 | 10007686 | Acetyl Podocarpic Acid Anhydride | 50 mg | 8820 |
| Cayman2015 | 10007691 | URB754 | 10 mg | 742 |
| Cayman2015 | 10007691 | URB754 | 100 mg | 5488 |
| Cayman2015 | 10007691 | URB754 | 5 mg | 392 |
| Cayman2015 | 10007691 | URB754 | 50 mg | 3136 |
| Cayman2015 | 10007692 | Licofelone | 1 mg | 602 |
| Cayman2015 | 10007692 | Licofelone | 10 mg | 3318 |
| Cayman2015 | 10007692 | Licofelone | 5 mg | 1806 |
| Cayman2015 | 10007692 | Licofelone | 50 mg | 15050 |
| Cayman2015 | 10007697 | N-Palmitoyl Dopamine | 10 mg | 1008 |
| Cayman2015 | 10007697 | N-Palmitoyl Dopamine | 100 mg | 7448 |
| Cayman2015 | 10007697 | N-Palmitoyl Dopamine | 5 mg | 532 |
| Cayman2015 | 10007697 | N-Palmitoyl Dopamine | 50 mg | 4256 |
| Cayman2015 | 10007704 | N-(3-hydroxyphenyl)-Arachidonoyl amide | 10 mg | 826 |
| Cayman2015 | 10007704 | N-(3-hydroxyphenyl)-Arachidonoyl amide | 100 mg | 6076 |
| Cayman2015 | 10007704 | N-(3-hydroxyphenyl)-Arachidonoyl amide | 5 mg | 434 |
| Cayman2015 | 10007704 | N-(3-hydroxyphenyl)-Arachidonoyl amide | 50 mg | 3472 |
| Cayman2015 | 10007705 | α-CEHC | 1 mg | 294 |
| Cayman2015 | 10007705 | α-CEHC | 10 mg | 2352 |
| Cayman2015 | 10007705 | α-CEHC | 25 mg | 5152 |
| Cayman2015 | 10007705 | α-CEHC | 5 mg | 1330 |
| Cayman2015 | 10007706 | δ-CEHC | 1 mg | 406 |
| Cayman2015 | 10007706 | δ-CEHC | 10 mg | 3248 |
| Cayman2015 | 10007706 | δ-CEHC | 25 mg | 7112 |
| Cayman2015 | 10007706 | δ-CEHC | 5 mg | 1834 |
| Cayman2015 | 10007707 | AS-605240 | 1 mg | 350 |
| Cayman2015 | 10007707 | AS-605240 | 10 mg | 1232 |
| Cayman2015 | 10007707 | AS-605240 | 25 mg | 2716 |
| Cayman2015 | 10007707 | AS-605240 | 5 mg | 700 |
| Cayman2015 | 10007710 | PtdIns-(1,2-dipalmitoyl) (ammonium salt) | 1 mg | 5600 |
| Cayman2015 | 10007710 | PtdIns-(1,2-dipalmitoyl) (ammonium salt) | 100 μg | 700 |
| Cayman2015 | 10007710 | PtdIns-(1,2-dipalmitoyl) (ammonium salt) | 500 μg | 3150 |
| Cayman2015 | 10007711 | PtdIns-(4)-P1 (1,2-dioctanoyl) (ammonium salt) | 1 mg | 5600 |
| Cayman2015 | 10007711 | PtdIns-(4)-P1 (1,2-dioctanoyl) (ammonium salt) | 100 μg | 700 |
| Cayman2015 | 10007711 | PtdIns-(4)-P1 (1,2-dioctanoyl) (ammonium salt) | 500 μg | 3150 |
| Cayman2015 | 10007712 | L-902,688 | 1 mg | 2184 |
| Cayman2015 | 10007712 | L-902,688 | 10 mg | 16072 |
| Cayman2015 | 10007712 | L-902,688 | 5 mg | 9184 |
| Cayman2015 | 10007712 | L-902,688 | 500 μg | 1148 |
| Cayman2015 | 10007713 | HMB-Val-Ser-Leu-VE | 1 mg | 798 |
| Cayman2015 | 10007713 | HMB-Val-Ser-Leu-VE | 10 mg | 6384 |
| Cayman2015 | 10007713 | HMB-Val-Ser-Leu-VE | 25 mg | 13972 |
| Cayman2015 | 10007713 | HMB-Val-Ser-Leu-VE | 5 mg | 3598 |
| Cayman2015 | 10007737 | 5(S),6(R)-Lipoxin A4-d5 | 10 μg | 2198 |
| Cayman2015 | 10007737 | 5(S),6(R)-Lipoxin A4-d5 | 100 μg | 17584 |
| Cayman2015 | 10007737 | 5(S),6(R)-Lipoxin A4-d5 | 25 μg | 5222 |
| Cayman2015 | 10007737 | 5(S),6(R)-Lipoxin A4-d5 | 50 μg | 9898 |
| Cayman2015 | 10007739 | N-Cyclohexanecarbonylpentadecylamine | 10 mg | 714 |
| Cayman2015 | 10007739 | N-Cyclohexanecarbonylpentadecylamine | 100 mg | 5292 |
| Cayman2015 | 10007739 | N-Cyclohexanecarbonylpentadecylamine | 5 mg | 378 |
| Cayman2015 | 10007739 | N-Cyclohexanecarbonylpentadecylamine | 50 mg | 3024 |
| Cayman2015 | 10007757 | PtdIns-(4)-P1 (1,2-dihexanoyl) (sodium salt) | 1 mg | 5600 |
| Cayman2015 | 10007757 | PtdIns-(4)-P1 (1,2-dihexanoyl) (sodium salt) | 100 μg | 700 |
| Cayman2015 | 10007757 | PtdIns-(4)-P1 (1,2-dihexanoyl) (sodium salt) | 500 μg | 3150 |
| Cayman2015 | 10007758 | PtdIns-(5)-P1 (1,2-dioctanoyl) (ammonium salt) | 1 mg | 5600 |
| Cayman2015 | 10007758 | PtdIns-(5)-P1 (1,2-dioctanoyl) (ammonium salt) | 100 μg | 700 |
| Cayman2015 | 10007758 | PtdIns-(5)-P1 (1,2-dioctanoyl) (ammonium salt) | 500 μg | 3150 |
| Cayman2015 | 10007759 | PtdIns-(3,4)-P2 (1,2-dihexanoyl) (sodium salt) | 1 mg | 5600 |
| Cayman2015 | 10007759 | PtdIns-(3,4)-P2 (1,2-dihexanoyl) (sodium salt) | 100 μg | 700 |
| Cayman2015 | 10007759 | PtdIns-(3,4)-P2 (1,2-dihexanoyl) (sodium salt) | 500 μg | 3150 |
| Cayman2015 | 10007762 | PtdIns-(4,5)-P2 (1,2-dihexanoyl) (sodium salt) | 1 mg | 5600 |
| Cayman2015 | 10007762 | PtdIns-(4,5)-P2 (1,2-dihexanoyl) (sodium salt) | 100 μg | 700 |
| Cayman2015 | 10007762 | PtdIns-(4,5)-P2 (1,2-dihexanoyl) (sodium salt) | 500 μg | 3150 |
| Cayman2015 | 10007763 | PtdIns-(3,5)-P2 (1,2-dioctanoyl) (sodium salt) | 1 mg | 4480 |
| Cayman2015 | 10007763 | PtdIns-(3,5)-P2 (1,2-dioctanoyl) (sodium salt) | 100 μg | 560 |
| Cayman2015 | 10007763 | PtdIns-(3,5)-P2 (1,2-dioctanoyl) (sodium salt) | 500 μg | 2520 |
| Cayman2015 | 10007764 | PtdIns-(3,4,5)-P3 (1,2-dioctanoyl) (sodium salt) | 1 mg | 5264 |
| Cayman2015 | 10007764 | PtdIns-(3,4,5)-P3 (1,2-dioctanoyl) (sodium salt) | 100 μg | 658 |
| Cayman2015 | 10007764 | PtdIns-(3,4,5)-P3 (1,2-dioctanoyl) (sodium salt) | 500 μg | 2968 |
| Cayman2015 | 10007766 | 19(S)-HETE | 100 μg | 6048 |
| Cayman2015 | 10007766 | 19(S)-HETE | 25 μg | 1680 |
| Cayman2015 | 10007766 | 19(S)-HETE | 50 μg | 3192 |
| Cayman2015 | 10007767 | 19(R)-HETE | 100 μg | 6048 |
| Cayman2015 | 10007767 | 19(R)-HETE | 25 μg | 1680 |
| Cayman2015 | 10007767 | 19(R)-HETE | 50 μg | 3192 |
| Cayman2015 | 10007777 | D-myo-Inositol-1-phosphate (sodium salt) | 1 mg | 798 |
| Cayman2015 | 10007777 | D-myo-Inositol-1-phosphate (sodium salt) | 10 mg | 5880 |
| Cayman2015 | 10007777 | D-myo-Inositol-1-phosphate (sodium salt) | 5 mg | 3360 |
| Cayman2015 | 10007777 | D-myo-Inositol-1-phosphate (sodium salt) | 500 μg | 420 |
| Cayman2015 | 10007778 | D-myo-Inositol-3-phosphate (sodium salt) | 1 mg | 2282 |
| Cayman2015 | 10007778 | D-myo-Inositol-3-phosphate (sodium salt) | 100 μg | 350 |
| Cayman2015 | 10007778 | D-myo-Inositol-3-phosphate (sodium salt) | 5 mg | 7000 |
| Cayman2015 | 10007778 | D-myo-Inositol-3-phosphate (sodium salt) | 500 μg | 1232 |
| Cayman2015 | 10007779 | D-myo-Inositol-2,4,5-triphosphate (sodium salt) | 1 mg | 5488 |
| Cayman2015 | 10007779 | D-myo-Inositol-2,4,5-triphosphate (sodium salt) | 100 μg | 686 |
| Cayman2015 | 10007779 | D-myo-Inositol-2,4,5-triphosphate (sodium salt) | 500 μg | 3094 |
| Cayman2015 | 10007780 | D-myo-Inositol-1,2,6-triphosphate (sodium salt) | 1 mg | 5040 |
| Cayman2015 | 10007780 | D-myo-Inositol-1,2,6-triphosphate (sodium salt) | 100 μg | 630 |
| Cayman2015 | 10007780 | D-myo-Inositol-1,2,6-triphosphate (sodium salt) | 500 μg | 2842 |
| Cayman2015 | 10007781 | D-myo-Inositol-1,3,5-triphosphate (sodium salt) | 1 mg | 3920 |
| Cayman2015 | 10007781 | D-myo-Inositol-1,3,5-triphosphate (sodium salt) | 100 μg | 490 |
| Cayman2015 | 10007781 | D-myo-Inositol-1,3,5-triphosphate (sodium salt) | 500 μg | 2212 |
| Cayman2015 | 10007782 | D-myo-Inositol-3,4,5,6-tetraphosphate (sodium salt) | 1 mg | 12320 |
| Cayman2015 | 10007782 | D-myo-Inositol-3,4,5,6-tetraphosphate (sodium salt) | 100 μg | 1540 |
| Cayman2015 | 10007782 | D-myo-Inositol-3,4,5,6-tetraphosphate (sodium salt) | 500 μg | 6930 |
| Cayman2015 | 10007783 | D-myo-Inositol-1,4,5,6-tetraphosphate (sodium salt) | 1 mg | 12320 |
| Cayman2015 | 10007783 | D-myo-Inositol-1,4,5,6-tetraphosphate (sodium salt) | 100 μg | 1540 |
| Cayman2015 | 10007783 | D-myo-Inositol-1,4,5,6-tetraphosphate (sodium salt) | 500 μg | 6930 |
| Cayman2015 | 10007784 | D-myo-Inositol-1,3,4,5,6-pentaphosphate (sodium salt) | 1 mg | 5488 |
| Cayman2015 | 10007784 | D-myo-Inositol-1,3,4,5,6-pentaphosphate (sodium salt) | 100 μg | 686 |
| Cayman2015 | 10007784 | D-myo-Inositol-1,3,4,5,6-pentaphosphate (sodium salt) | 500 μg | 3094 |
| Cayman2015 | 10007793 | 13,14-dihydro-15-keto Prostaglandin F2α-d4 | 100 μg | 1652 |
| Cayman2015 | 10007793 | 13,14-dihydro-15-keto Prostaglandin F2α-d4 | 50 μg | 868 |
| Cayman2015 | 10007793 | 13,14-dihydro-15-keto Prostaglandin F2α-d4 | 500 μg | 6944 |
| Cayman2015 | 10007806 | Epoxomicin | 100 μg | 2520 |
| Cayman2015 | 10007806 | Epoxomicin | 25 μg | 700 |
| Cayman2015 | 10007806 | Epoxomicin | 250 μg | 5600 |
| Cayman2015 | 10007806 | Epoxomicin | 50 μg | 1330 |
| Cayman2015 | 10007812 | Monoacylglycerol Lipase (human recombinant) | 10 μg | 980 |
| Cayman2015 | 10007812 | Monoacylglycerol Lipase (human recombinant) | 25 μg | 2324 |
| Cayman2015 | 10007812 | Monoacylglycerol Lipase (human recombinant) | 50 μg | 4410 |
| Cayman2015 | 10007815 | 11β-Hydroxysteroid Dehydrogenase | 100 μg | 4984 |
| Cayman2015 | 10007815 | 11β-Hydroxysteroid Dehydrogenase | 25 μg | 1386 |
| Cayman2015 | 10007815 | 11β-Hydroxysteroid Dehydrogenase | 50 μg | 2632 |
| Cayman2015 | 10007817 | Leukotriene A4 Hydrolase (human recombinant) | 100 μg | 5796 |
| Cayman2015 | 10007817 | Leukotriene A4 Hydrolase (human recombinant) | 25 μg | 1610 |
| Cayman2015 | 10007817 | Leukotriene A4 Hydrolase (human recombinant) | 50 μg | 3066 |
| Cayman2015 | 10007818 | Serum Retinol Binding Protein 4 (human recombinant) | 100 μg | 6146 |
| Cayman2015 | 10007818 | Serum Retinol Binding Protein 4 (human recombinant) | 25 μg | 1708 |
| Cayman2015 | 10007818 | Serum Retinol Binding Protein 4 (human recombinant) | 50 μg | 3248 |
| Cayman2015 | 10007819 | SREBP-2 Transcription Factor Assay Kit | 96 Well | 5740 |
| Cayman2015 | 10007820 | 5-Lipoxygenase (Phospho-Ser523) Polyclonal Antibody | 1 ea | 6300 |
| Cayman2015 | 10007823 | Oleoyl Ethanolamide-d2 | 1 mg | 3136 |
| Cayman2015 | 10007823 | Oleoyl Ethanolamide-d2 | 100 μg | 392 |
| Cayman2015 | 10007823 | Oleoyl Ethanolamide-d2 | 5 mg | 13720 |
| Cayman2015 | 10007823 | Oleoyl Ethanolamide-d2 | 500 μg | 1764 |
| Cayman2015 | 10007824 | Palmitoyl Ethanolamide-d4 | 1 mg | 3136 |
| Cayman2015 | 10007824 | Palmitoyl Ethanolamide-d4 | 100 μg | 392 |
| Cayman2015 | 10007824 | Palmitoyl Ethanolamide-d4 | 5 mg | 13720 |
| Cayman2015 | 10007824 | Palmitoyl Ethanolamide-d4 | 500 μg | 1764 |
| Cayman2015 | 10007839 | PLC thio-PIP2 (sodium salt) | 1 mg | 10304 |
| Cayman2015 | 10007839 | PLC thio-PIP2 (sodium salt) | 100 μg | 1288 |
| Cayman2015 | 10007839 | PLC thio-PIP2 (sodium salt) | 500 μg | 5796 |
| Cayman2015 | 10007850 | 9,11-methane-epoxy Prostaglandin F1α | 1 mg | 4032 |
| Cayman2015 | 10007850 | 9,11-methane-epoxy Prostaglandin F1α | 100 μg | 504 |
| Cayman2015 | 10007850 | 9,11-methane-epoxy Prostaglandin F1α | 500 μg | 2268 |
| Cayman2015 | 10007852 | Pargyline (hydrochloride) | 100 mg | 84 |
| Cayman2015 | 10007852 | Pargyline (hydrochloride) | 1000 mg | 672 |
| Cayman2015 | 10007852 | Pargyline (hydrochloride) | 500 mg | 378 |
| Cayman2015 | 10007852 | Pargyline (hydrochloride) | 5000 mg | 2940 |
| Cayman2015 | 10007858 | Leukotriene E4-d5 | 100 μg | 11536 |
| Cayman2015 | 10007858 | Leukotriene E4-d5 | 25 μg | 3206 |
| Cayman2015 | 10007858 | Leukotriene E4-d5 | 50 μg | 6090 |
| Cayman2015 | 10007863 | 1,2-Dioleoyl-rac-glycerol | 10 mg | 1078 |
| Cayman2015 | 10007863 | 1,2-Dioleoyl-rac-glycerol | 100 mg | 8624 |
| Cayman2015 | 10007863 | 1,2-Dioleoyl-rac-glycerol | 25 mg | 2562 |
| Cayman2015 | 10007863 | 1,2-Dioleoyl-rac-glycerol | 50 mg | 4858 |
| Cayman2015 | 10007867 | Cylindrospermopsin | 25 μg | 1890 |
| Cayman2015 | 10007867 | Cylindrospermopsin | 50 μg | 2716 |
| Cayman2015 | 10007868 | Microcystin-RR | 100 μg | 1988 |
| Cayman2015 | 10007868 | Microcystin-RR | 50 μg | 1106 |
| Cayman2015 | 10007868 | Microcystin-RR | 500 μg | 7742 |
| Cayman2015 | 10007875 | CAY10499 | 1 mg | 154 |
| Cayman2015 | 10007875 | CAY10499 | 10 mg | 1232 |
| Cayman2015 | 10007875 | CAY10499 | 25 mg | 2702 |
| Cayman2015 | 10007875 | CAY10499 | 5 mg | 700 |
| Cayman2015 | 10007881 | Transcription Factor NF-κB (human p50) Positive Control | 1 ea | 910 |
| Cayman2015 | 10007882 | Transcription Factor NF-κB 96-Well Strip Plate | 1 ea | 896 |
| Cayman2015 | 10007883 | Transcription Factor NF-κB (p50) Primary Antibody | 1 ea | 1092 |
| Cayman2015 | 10007884 | Transcription Factor NF-κB Competitor dsDNA | 1 ea | 896 |
| Cayman2015 | 10007889 | NF-κB (p65) Transcription Factor Assay Kit | 96 Well | 5740 |
| Cayman2015 | 10007892 | Thioredoxin Reductase Colorimetric Assay Kit | 96 Well | 2492 |
| Cayman2015 | 10007895 | N-3-oxo-dodecanoyl-L-Homoserine lactone | 1 mg | 322 |
| Cayman2015 | 10007895 | N-3-oxo-dodecanoyl-L-Homoserine lactone | 10 mg | 2576 |
| Cayman2015 | 10007895 | N-3-oxo-dodecanoyl-L-Homoserine lactone | 5 mg | 1456 |
| Cayman2015 | 10007895 | N-3-oxo-dodecanoyl-L-Homoserine lactone | 50 mg | 11270 |
| Cayman2015 | 10007896 | N-hexanoyl-L-Homoserine lactone | 10 mg | 378 |
| Cayman2015 | 10007896 | N-hexanoyl-L-Homoserine lactone | 25 mg | 882 |
| Cayman2015 | 10007896 | N-hexanoyl-L-Homoserine lactone | 5 mg | 196 |
| Cayman2015 | 10007896 | N-hexanoyl-L-Homoserine lactone | 50 mg | 1568 |
| Cayman2015 | 10007897 | N-hexanoyl-L-Homoserine lactone-d3 | 1 mg | 588 |
| Cayman2015 | 10007897 | N-hexanoyl-L-Homoserine lactone-d3 | 10 mg | 4312 |
| Cayman2015 | 10007897 | N-hexanoyl-L-Homoserine lactone-d3 | 5 mg | 2464 |
| Cayman2015 | 10007897 | N-hexanoyl-L-Homoserine lactone-d3 | 500 μg | 308 |
| Cayman2015 | 10007898 | N-butyryl-L-Homoserine lactone | 10 mg | 378 |
| Cayman2015 | 10007898 | N-butyryl-L-Homoserine lactone | 25 mg | 882 |
| Cayman2015 | 10007898 | N-butyryl-L-Homoserine lactone | 5 mg | 196 |
| Cayman2015 | 10007898 | N-butyryl-L-Homoserine lactone | 50 mg | 1568 |
| Cayman2015 | 10007899 | N-butyryl-L-Homoserine lactone-d5 | 1 mg | 588 |
| Cayman2015 | 10007899 | N-butyryl-L-Homoserine lactone-d5 | 10 mg | 4312 |
| Cayman2015 | 10007899 | N-butyryl-L-Homoserine lactone-d5 | 5 mg | 2464 |
| Cayman2015 | 10007899 | N-butyryl-L-Homoserine lactone-d5 | 500 μg | 308 |
| Cayman2015 | 10007900 | 8,11,14-Eicosatriynoic Acid | 1 mg | 924 |
| Cayman2015 | 10007900 | 8,11,14-Eicosatriynoic Acid | 10 mg | 7392 |
| Cayman2015 | 10007900 | 8,11,14-Eicosatriynoic Acid | 5 mg | 4158 |
| Cayman2015 | 10007901 | D-erythro-Sphingosine C-15 | 1 mg | 700 |
| Cayman2015 | 10007901 | D-erythro-Sphingosine C-15 | 10 mg | 5600 |
| Cayman2015 | 10007901 | D-erythro-Sphingosine C-15 | 25 mg | 12250 |
| Cayman2015 | 10007901 | D-erythro-Sphingosine C-15 | 5 mg | 3150 |
| Cayman2015 | 10007902 | D-erythro-Sphingosine C-17 | 1 mg | 280 |
| Cayman2015 | 10007902 | D-erythro-Sphingosine C-17 | 10 mg | 2240 |
| Cayman2015 | 10007902 | D-erythro-Sphingosine C-17 | 25 mg | 4900 |
| Cayman2015 | 10007902 | D-erythro-Sphingosine C-17 | 5 mg | 1260 |
| Cayman2015 | 10007903 | D-erythro-Sphingosine C-20 | 1 mg | 630 |
| Cayman2015 | 10007903 | D-erythro-Sphingosine C-20 | 10 mg | 3500 |
| Cayman2015 | 10007903 | D-erythro-Sphingosine C-20 | 5 mg | 2100 |
| Cayman2015 | 10007903 | D-erythro-Sphingosine C-20 | 500 μg | 350 |
| Cayman2015 | 10007904 | Arachidonoyl-1-thio-Glycerol | 1 mg | 308 |
| Cayman2015 | 10007904 | Arachidonoyl-1-thio-Glycerol | 10 mg | 2464 |
| Cayman2015 | 10007904 | Arachidonoyl-1-thio-Glycerol | 25 mg | 5390 |
| Cayman2015 | 10007904 | Arachidonoyl-1-thio-Glycerol | 5 mg | 1386 |
| Cayman2015 | 10007907 | D-erythro-Sphingosine C-18 | 10 mg | 490 |
| Cayman2015 | 10007907 | D-erythro-Sphingosine C-18 | 100 mg | 2940 |
| Cayman2015 | 10007907 | D-erythro-Sphingosine C-18 | 25 mg | 1106 |
| Cayman2015 | 10007907 | D-erythro-Sphingosine C-18 | 50 mg | 1960 |
| Cayman2015 | 10007912 | 20-carboxy Arachidonic Acid | 100 μg | 9226 |
| Cayman2015 | 10007912 | 20-carboxy Arachidonic Acid | 25 μg | 2562 |
| Cayman2015 | 10007912 | 20-carboxy Arachidonic Acid | 50 μg | 4872 |
| Cayman2015 | 10007923 | CUDA | 10 mg | 742 |
| Cayman2015 | 10007923 | CUDA | 25 mg | 1764 |
| Cayman2015 | 10007923 | CUDA | 5 mg | 392 |
| Cayman2015 | 10007923 | CUDA | 50 mg | 3136 |
| Cayman2015 | 10007924 | Transcription Factor NF-κB (human p65) Positive Control | 1 ea | 910 |
| Cayman2015 | 10007925 | Transcription Factor NF-κB (p65) Primary Antibody | 1 ea | 1092 |
| Cayman2015 | 10007927 | AUDA | 10 mg | 826 |
| Cayman2015 | 10007927 | AUDA | 100 mg | 6076 |
| Cayman2015 | 10007927 | AUDA | 5 mg | 434 |
| Cayman2015 | 10007927 | AUDA | 50 mg | 3472 |
| Cayman2015 | 10007931 | 17-phenyl trinor 8-iso Prostaglandin E2 | 1 mg | 2058 |
| Cayman2015 | 10007931 | 17-phenyl trinor 8-iso Prostaglandin E2 | 5 mg | 9296 |
| Cayman2015 | 10007931 | 17-phenyl trinor 8-iso Prostaglandin E2 | 500 μg | 1120 |
| Cayman2015 | 10007938 | FABP2 (rat recombinant) | 100 μg | 4984 |
| Cayman2015 | 10007938 | FABP2 (rat recombinant) | 25 μg | 1386 |
| Cayman2015 | 10007938 | FABP2 (rat recombinant) | 50 μg | 2632 |
| Cayman2015 | 10007940 | Prostaglandin F Synthase (human recombinant) | 100 μg | 5292 |
| Cayman2015 | 10007940 | Prostaglandin F Synthase (human recombinant) | 25 μg | 1470 |
| Cayman2015 | 10007940 | Prostaglandin F Synthase (human recombinant) | 250 μg | 11760 |
| Cayman2015 | 10007940 | Prostaglandin F Synthase (human recombinant) | 50 μg | 2800 |
| Cayman2015 | 10007941 | PPARγ LBD (human recombinant) | 100 μg | 5950 |
| Cayman2015 | 10007941 | PPARγ LBD (human recombinant) | 25 μg | 1652 |
| Cayman2015 | 10007941 | PPARγ LBD (human recombinant) | 50 μg | 3136 |
| Cayman2015 | 10007945 | D-erythro-Sphinganine | 10 mg | 742 |
| Cayman2015 | 10007945 | D-erythro-Sphinganine | 25 mg | 1764 |
| Cayman2015 | 10007945 | D-erythro-Sphinganine | 5 mg | 392 |
| Cayman2015 | 10007945 | D-erythro-Sphinganine | 50 mg | 3136 |
| Cayman2015 | 10007946 | Palmitoyl Sphingomyelin | 1 mg | 784 |
| Cayman2015 | 10007946 | Palmitoyl Sphingomyelin | 10 mg | 6272 |
| Cayman2015 | 10007946 | Palmitoyl Sphingomyelin | 5 mg | 3528 |
| Cayman2015 | 10007947 | Lyso-Sphingomyelin | 1 mg | 364 |
| Cayman2015 | 10007947 | Lyso-Sphingomyelin | 10 mg | 2912 |
| Cayman2015 | 10007947 | Lyso-Sphingomyelin | 25 mg | 6370 |
| Cayman2015 | 10007947 | Lyso-Sphingomyelin | 5 mg | 1638 |
| Cayman2015 | 10007950 | 15-hydroxy Prostaglandin Dehydrogenase (human recombinant) | 100 μg | 5292 |
| Cayman2015 | 10007950 | 15-hydroxy Prostaglandin Dehydrogenase (human recombinant) | 25 μg | 1470 |
| Cayman2015 | 10007950 | 15-hydroxy Prostaglandin Dehydrogenase (human recombinant) | 50 μg | 2800 |
| Cayman2015 | 10007955 | CAY10498 | 1 mg | 2576 |
| Cayman2015 | 10007955 | CAY10498 | 100 μg | 322 |
| Cayman2015 | 10007955 | CAY10498 | 5 mg | 11270 |
| Cayman2015 | 10007955 | CAY10498 | 500 μg | 1456 |
| Cayman2015 | 10007957 | C-6 NBD-dihydro-Ceramide | 1 mg | 2030 |
| Cayman2015 | 10007957 | C-6 NBD-dihydro-Ceramide | 10 mg | 16240 |
| Cayman2015 | 10007957 | C-6 NBD-dihydro-Ceramide | 5 mg | 9142 |
| Cayman2015 | 10007958 | C-12 NBD Ceramide | 1 mg | 2030 |
| Cayman2015 | 10007958 | C-12 NBD Ceramide | 10 mg | 16240 |
| Cayman2015 | 10007958 | C-12 NBD Ceramide | 5 mg | 9142 |
| Cayman2015 | 10007963 | E-64 | 1 mg | 224 |
| Cayman2015 | 10007963 | E-64 | 10 mg | 1792 |
| Cayman2015 | 10007963 | E-64 | 25 mg | 3920 |
| Cayman2015 | 10007963 | E-64 | 5 mg | 1008 |
| Cayman2015 | 10007964 | E-64c | 1 mg | 686 |
| Cayman2015 | 10007964 | E-64c | 10 mg | 5488 |
| Cayman2015 | 10007964 | E-64c | 25 mg | 12012 |
| Cayman2015 | 10007964 | E-64c | 5 mg | 3094 |
| Cayman2015 | 10007965 | FK-506 | 10 mg | 742 |
| Cayman2015 | 10007965 | FK-506 | 100 mg | 5488 |
| Cayman2015 | 10007965 | FK-506 | 5 mg | 392 |
| Cayman2015 | 10007965 | FK-506 | 50 mg | 3136 |
| Cayman2015 | 10007974 | SLF | 10 mg | 1974 |
| Cayman2015 | 10007974 | SLF | 100 mg | 13888 |
| Cayman2015 | 10007974 | SLF | 5 mg | 1036 |
| Cayman2015 | 10007974 | SLF | 50 mg | 8288 |
| Cayman2015 | 10007975 | (±)11,12-DHET-d11 | 100 μg | 7462 |
| Cayman2015 | 10007975 | (±)11,12-DHET-d11 | 25 μg | 2072 |
| Cayman2015 | 10007975 | (±)11,12-DHET-d11 | 250 μg | 16576 |
| Cayman2015 | 10007975 | (±)11,12-DHET-d11 | 50 μg | 3934 |
| Cayman2015 | 10007978 | 13,14-dihydro-15-keto Prostaglandin D2-d4 | 100 μg | 5796 |
| Cayman2015 | 10007978 | 13,14-dihydro-15-keto Prostaglandin D2-d4 | 25 μg | 1610 |
| Cayman2015 | 10007978 | 13,14-dihydro-15-keto Prostaglandin D2-d4 | 50 μg | 3066 |
| Cayman2015 | 10007980 | 3,4-DAA | 1 mg | 182 |
| Cayman2015 | 10007980 | 3,4-DAA | 10 mg | 1456 |
| Cayman2015 | 10007980 | 3,4-DAA | 5 mg | 826 |
| Cayman2015 | 10007980 | 3,4-DAA | 50 mg | 6370 |
| Cayman2015 | 10008012 | SPD-304 | 1 mg | 616 |
| Cayman2015 | 10008012 | SPD-304 | 10 mg | 4508 |
| Cayman2015 | 10008012 | SPD-304 | 5 mg | 2576 |
| Cayman2015 | 10008012 | SPD-304 | 500 μg | 322 |
| Cayman2015 | 10008014 | Phorbol 12-myristate 13-acetate | 1 mg | 375 |
| Cayman2015 | 10008014 | Phorbol 12-myristate 13-acetate | 10 mg | 2070 |
| Cayman2015 | 10008014 | Phorbol 12-myristate 13-acetate | 25 mg | 4695 |
| Cayman2015 | 10008014 | Phorbol 12-myristate 13-acetate | 5 mg | 1125 |
| Cayman2015 | 10008040 | (±)14,15-DHET-d11 | 100 μg | 7462 |
| Cayman2015 | 10008040 | (±)14,15-DHET-d11 | 25 μg | 2072 |
| Cayman2015 | 10008040 | (±)14,15-DHET-d11 | 250 μg | 16576 |
| Cayman2015 | 10008040 | (±)14,15-DHET-d11 | 50 μg | 3934 |
| Cayman2015 | 10008041 | 20S Proteasome Assay Kit | 1 ea | 3766 |
| Cayman2015 | 10008042 | 9-Nitrooleate | 1 mg | 4130 |
| Cayman2015 | 10008042 | 9-Nitrooleate | 100 μg | 560 |
| Cayman2015 | 10008042 | 9-Nitrooleate | 50 μg | 350 |
| Cayman2015 | 10008042 | 9-Nitrooleate | 500 μg | 2352 |
| Cayman2015 | 10008043 | 10-Nitrooleate | 1 mg | 4130 |
| Cayman2015 | 10008043 | 10-Nitrooleate | 100 μg | 560 |
| Cayman2015 | 10008043 | 10-Nitrooleate | 50 μg | 350 |
| Cayman2015 | 10008043 | 10-Nitrooleate | 500 μg | 2352 |
| Cayman2015 | 10008050 | PtdIns-(5)-P1 (1,2-dihexanoyl) (sodium salt) | 1 mg | 5600 |
| Cayman2015 | 10008050 | PtdIns-(5)-P1 (1,2-dihexanoyl) (sodium salt) | 100 μg | 700 |
| Cayman2015 | 10008050 | PtdIns-(5)-P1 (1,2-dihexanoyl) (sodium salt) | 500 μg | 3150 |
| Cayman2015 | 10008051 | Acid Phosphatase Colorimetric Assay Kit | 1 ea | 1848 |
| Cayman2015 | 10008052 | Cholesterol Assay Buffer (10X) | 1 ea | 196 |
| Cayman2015 | 10008052 | Cholesterol Assay Buffer (10X) | 5 ea | 742 |
| Cayman2015 | 10008053 | Cholesterol Assay Standard | 1 ea | 196 |
| Cayman2015 | 10008053 | Cholesterol Assay Standard | 5 ea | 742 |
| Cayman2015 | 10008054 | Cholesterol Assay Detector | 1 ea | 350 |
| Cayman2015 | 10008055 | Cholesterol Assay Horseradish Peroxidase | 1 ea | 196 |
| Cayman2015 | 10008055 | Cholesterol Assay Horseradish Peroxidase | 5 ea | 742 |
| Cayman2015 | 10008056 | Cholesterol Assay Oxidase | 1 ea | 350 |
| Cayman2015 | 10008056 | Cholesterol Assay Oxidase | 5 ea | 1316 |
| Cayman2015 | 10008057 | Cholesterol Assay Esterase | 1 ea | 350 |
| Cayman2015 | 10008057 | Cholesterol Assay Esterase | 5 ea | 1316 |
| Cayman2015 | 10008097 | C-12 NBD-dihydro-Ceramide | 1 mg | 2030 |
| Cayman2015 | 10008097 | C-12 NBD-dihydro-Ceramide | 10 mg | 16240 |
| Cayman2015 | 10008097 | C-12 NBD-dihydro-Ceramide | 5 mg | 9142 |
| Cayman2015 | 10008099 | PtdIns-(1,2-dioctanoyl) (sodium salt) | 1 mg | 5600 |
| Cayman2015 | 10008099 | PtdIns-(1,2-dioctanoyl) (sodium salt) | 100 μg | 700 |
| Cayman2015 | 10008099 | PtdIns-(1,2-dioctanoyl) (sodium salt) | 500 μg | 3150 |
| Cayman2015 | 10008112 | Perifosine | 1 mg | 406 |
| Cayman2015 | 10008112 | Perifosine | 10 mg | 2030 |
| Cayman2015 | 10008112 | Perifosine | 25 mg | 4564 |
| Cayman2015 | 10008112 | Perifosine | 5 mg | 1428 |
| Cayman2015 | 10008115 | PtdIns-(4,5)-P2 (1,2-dipalmitoyl) (sodium salt) | 1 mg | 6720 |
| Cayman2015 | 10008115 | PtdIns-(4,5)-P2 (1,2-dipalmitoyl) (sodium salt) | 100 μg | 840 |
| Cayman2015 | 10008115 | PtdIns-(4,5)-P2 (1,2-dipalmitoyl) (sodium salt) | 500 μg | 3780 |
| Cayman2015 | 10008122 | ent-Prostaglandin F2α | 1 mg | 798 |
| Cayman2015 | 10008122 | ent-Prostaglandin F2α | 10 mg | 6384 |
| Cayman2015 | 10008122 | ent-Prostaglandin F2α | 5 mg | 3598 |
| Cayman2015 | 10008123 | cis-Δ2-11-methyl-Dodecenoic Acid | 1 mg | 910 |
| Cayman2015 | 10008123 | cis-Δ2-11-methyl-Dodecenoic Acid | 10 mg | 7826 |
| Cayman2015 | 10008123 | cis-Δ2-11-methyl-Dodecenoic Acid | 5 mg | 4102 |
| Cayman2015 | 10008127 | 15(R)-17-phenyl trinor Prostaglandin F2α ethyl amide | 1 mg | 1708 |
| Cayman2015 | 10008127 | 15(R)-17-phenyl trinor Prostaglandin F2α ethyl amide | 10 mg | 12544 |
| Cayman2015 | 10008127 | 15(R)-17-phenyl trinor Prostaglandin F2α ethyl amide | 5 mg | 7168 |
| Cayman2015 | 10008127 | 15(R)-17-phenyl trinor Prostaglandin F2α ethyl amide | 500 μg | 896 |
| Cayman2015 | 10008128 | 10(S),17(S)-DiHDoHE | 100 μg | 5642 |
| Cayman2015 | 10008128 | 10(S),17(S)-DiHDoHE | 25 μg | 1568 |
| Cayman2015 | 10008128 | 10(S),17(S)-DiHDoHE | 50 μg | 2982 |
| Cayman2015 | 10008128 | 10(S),17(S)-DiHDoHE | 500 μg | 25088 |
| Cayman2015 | 10008131 | JNJ-10198409 | 1 mg | 294 |
| Cayman2015 | 10008131 | JNJ-10198409 | 10 mg | 2352 |
| Cayman2015 | 10008131 | JNJ-10198409 | 5 mg | 1330 |
| Cayman2015 | 10008131 | JNJ-10198409 | 50 mg | 10290 |
| Cayman2015 | 10008132 | 5-trans-17-phenyl trinor Prostaglandin F2α ethyl amide | 1 mg | 770 |
| Cayman2015 | 10008132 | 5-trans-17-phenyl trinor Prostaglandin F2α ethyl amide | 10 mg | 6160 |
| Cayman2015 | 10008132 | 5-trans-17-phenyl trinor Prostaglandin F2α ethyl amide | 25 mg | 13482 |
| Cayman2015 | 10008132 | 5-trans-17-phenyl trinor Prostaglandin F2α ethyl amide | 5 mg | 3472 |
| Cayman2015 | 10008159 | PtdIns-(4,5)-P2-biotin (sodium salt) | 10 μg | 1806 |
| Cayman2015 | 10008159 | PtdIns-(4,5)-P2-biotin (sodium salt) | 100 μg | 11746 |
| Cayman2015 | 10008159 | PtdIns-(4,5)-P2-biotin (sodium salt) | 25 μg | 4284 |
| Cayman2015 | 10008159 | PtdIns-(4,5)-P2-biotin (sodium salt) | 50 μg | 7406 |
| Cayman2015 | 10008188 | Fatty Acid ethyl ester Standard Pack | 100 mg | 2072 |
| Cayman2015 | 10008196 | Stearic Acid ethyl ester | 100 mg | 140 |
| Cayman2015 | 10008196 | Stearic Acid ethyl ester | 1000 mg | 420 |
| Cayman2015 | 10008196 | Stearic Acid ethyl ester | 500 mg | 350 |
| Cayman2015 | 10008197 | Myristic Acid ethyl ester | 100 mg | 210 |
| Cayman2015 | 10008197 | Myristic Acid ethyl ester | 1000 mg | 1470 |
| Cayman2015 | 10008197 | Myristic Acid ethyl ester | 500 mg | 952 |
| Cayman2015 | 10008198 | Linoleic Acid ethyl ester | 100 mg | 210 |
| Cayman2015 | 10008198 | Linoleic Acid ethyl ester | 1000 mg | 420 |
| Cayman2015 | 10008198 | Linoleic Acid ethyl ester | 50 mg | 140 |
| Cayman2015 | 10008198 | Linoleic Acid ethyl ester | 500 mg | 350 |
| Cayman2015 | 10008199 | Linolenic Acid ethyl ester | 100 mg | 308 |
| Cayman2015 | 10008199 | Linolenic Acid ethyl ester | 1000 mg | 1344 |
| Cayman2015 | 10008199 | Linolenic Acid ethyl ester | 50 mg | 168 |
| Cayman2015 | 10008199 | Linolenic Acid ethyl ester | 500 mg | 840 |
| Cayman2015 | 10008200 | Arachidonic Acid ethyl ester | 100 mg | 826 |
| Cayman2015 | 10008200 | Arachidonic Acid ethyl ester | 25 mg | 378 |
| Cayman2015 | 10008200 | Arachidonic Acid ethyl ester | 50 mg | 574 |
| Cayman2015 | 10008200 | Arachidonic Acid ethyl ester | 500 mg | 1890 |
| Cayman2015 | 10008201 | Oleic Acid ethyl ester | 1000 mg | 420 |
| Cayman2015 | 10008201 | Oleic Acid ethyl ester | 50 mg | 140 |
| Cayman2015 | 10008202 | Palmitic Acid ethyl ester | 10000 mg | 630 |
| Cayman2015 | 10008202 | Palmitic Acid ethyl ester | 25000 mg | 1050 |
| Cayman2015 | 10008202 | Palmitic Acid ethyl ester | 5000 mg | 350 |
| Cayman2015 | 10008203 | Lauric Acid ethyl ester | 100 mg | 140 |
| Cayman2015 | 10008203 | Lauric Acid ethyl ester | 1000 mg | 490 |
| Cayman2015 | 10008203 | Lauric Acid ethyl ester | 500 mg | 350 |
| Cayman2015 | 10008204 | Palmitoleic Acid ethyl ester | 10 mg | 154 |
| Cayman2015 | 10008204 | Palmitoleic Acid ethyl ester | 100 mg | 1232 |
| Cayman2015 | 10008204 | Palmitoleic Acid ethyl ester | 50 mg | 700 |
| Cayman2015 | 10008204 | Palmitoleic Acid ethyl ester | 500 mg | 5390 |
| Cayman2015 | 10008205 | D-myo-Inositol-1,4,5-triphosphate (sodium salt) | 1 mg | 840 |
| Cayman2015 | 10008205 | D-myo-Inositol-1,4,5-triphosphate (sodium salt) | 5 mg | 3920 |
| Cayman2015 | 10008205 | D-myo-Inositol-1,4,5-triphosphate (sodium salt) | 500 μg | 490 |
| Cayman2015 | 10008206 | IGFBP5 Blocking Peptide | 1 ea | 1498 |
| Cayman2015 | 10008207 | IGFBP5 Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 10008282 | Zafirlukast | 10 mg | 196 |
| Cayman2015 | 10008282 | Zafirlukast | 100 mg | 1568 |
| Cayman2015 | 10008282 | Zafirlukast | 1000 mg | 11760 |
| Cayman2015 | 10008282 | Zafirlukast | 500 mg | 6860 |
| Cayman2015 | 10008284 | N-acetyl-2-carboxy Benzenesulfonamide | 1 mg | 182 |
| Cayman2015 | 10008284 | N-acetyl-2-carboxy Benzenesulfonamide | 10 mg | 1456 |
| Cayman2015 | 10008284 | N-acetyl-2-carboxy Benzenesulfonamide | 5 mg | 826 |
| Cayman2015 | 10008284 | N-acetyl-2-carboxy Benzenesulfonamide | 50 mg | 6370 |
| Cayman2015 | 10008294 | ent-Prostaglandin E2 | 1 mg | 798 |
| Cayman2015 | 10008294 | ent-Prostaglandin E2 | 10 mg | 6384 |
| Cayman2015 | 10008294 | ent-Prostaglandin E2 | 5 mg | 3598 |
| Cayman2015 | 10008313 | GW 610 | 1 mg | 238 |
| Cayman2015 | 10008313 | GW 610 | 10 mg | 1904 |
| Cayman2015 | 10008313 | GW 610 | 5 mg | 1078 |
| Cayman2015 | 10008313 | GW 610 | 50 mg | 8330 |
| Cayman2015 | 10008317 | N-Cyclohexanecarbonyltetradecylamine | 10 mg | 714 |
| Cayman2015 | 10008317 | N-Cyclohexanecarbonyltetradecylamine | 100 mg | 5292 |
| Cayman2015 | 10008317 | N-Cyclohexanecarbonyltetradecylamine | 5 mg | 378 |
| Cayman2015 | 10008317 | N-Cyclohexanecarbonyltetradecylamine | 50 mg | 3024 |
| Cayman2015 | 10008318 | Monukast (sodium salt) | 10 mg | 196 |
| Cayman2015 | 10008318 | Monukast (sodium salt) | 100 mg | 1568 |
| Cayman2015 | 10008318 | Monukast (sodium salt) | 50 mg | 882 |
| Cayman2015 | 10008318 | Monukast (sodium salt) | 500 mg | 6860 |
| Cayman2015 | 10008319 | Pranlukast | 10 mg | 196 |
| Cayman2015 | 10008319 | Pranlukast | 100 mg | 1568 |
| Cayman2015 | 10008319 | Pranlukast | 1000 mg | 11760 |
| Cayman2015 | 10008319 | Pranlukast | 500 mg | 6860 |
| Cayman2015 | 10008321 | trans-Δ2-11-methyl-Dodecenoic Acid | 1 mg | 392 |
| Cayman2015 | 10008321 | trans-Δ2-11-methyl-Dodecenoic Acid | 10 mg | 3136 |
| Cayman2015 | 10008321 | trans-Δ2-11-methyl-Dodecenoic Acid | 5 mg | 1764 |
| Cayman2015 | 10008321 | trans-Δ2-11-methyl-Dodecenoic Acid | 50 mg | 13720 |
| Cayman2015 | 10008333 | 9(Z),11(E),13(E)-Octadecatrienoic Acid methyl ester | 1 mg | 630 |
| Cayman2015 | 10008333 | 9(Z),11(E),13(E)-Octadecatrienoic Acid methyl ester | 10 mg | 5040 |
| Cayman2015 | 10008333 | 9(Z),11(E),13(E)-Octadecatrienoic Acid methyl ester | 5 mg | 2842 |
| Cayman2015 | 10008335 | all-cis-4,7,10,13,16-Docosapentaenoic Acid | 1 mg | 490 |
| Cayman2015 | 10008335 | all-cis-4,7,10,13,16-Docosapentaenoic Acid | 10 mg | 3920 |
| Cayman2015 | 10008335 | all-cis-4,7,10,13,16-Docosapentaenoic Acid | 25 mg | 8582 |
| Cayman2015 | 10008335 | all-cis-4,7,10,13,16-Docosapentaenoic Acid | 5 mg | 2212 |
| Cayman2015 | 10008346 | Gabapentin | 10 mg | 420 |
| Cayman2015 | 10008346 | Gabapentin | 100 mg | 3360 |
| Cayman2015 | 10008346 | Gabapentin | 25 mg | 994 |
| Cayman2015 | 10008346 | Gabapentin | 50 mg | 1890 |
| Cayman2015 | 10008349 | 9(Z),11(E),13(E)-Octadecatrienoic Acid | 1 mg | 630 |
| Cayman2015 | 10008349 | 9(Z),11(E),13(E)-Octadecatrienoic Acid | 10 mg | 5040 |
| Cayman2015 | 10008349 | 9(Z),11(E),13(E)-Octadecatrienoic Acid | 5 mg | 2842 |
| Cayman2015 | 10008350 | 9(Z),11(E),13(E)-Octadecatrienoic Acid ethyl ester | 1 mg | 630 |
| Cayman2015 | 10008350 | 9(Z),11(E),13(E)-Octadecatrienoic Acid ethyl ester | 10 mg | 5040 |
| Cayman2015 | 10008350 | 9(Z),11(E),13(E)-Octadecatrienoic Acid ethyl ester | 5 mg | 2842 |
| Cayman2015 | 10008351 | Propidium Iodide Solution | 1 ea | 308 |
| Cayman2015 | 10008370 | AL 8810 methyl ester | 1 mg | 798 |
| Cayman2015 | 10008370 | AL 8810 methyl ester | 10 mg | 6384 |
| Cayman2015 | 10008370 | AL 8810 methyl ester | 5 mg | 3598 |
| Cayman2015 | 10008377 | α-Tocotrienol | 1 mg | 294 |
| Cayman2015 | 10008377 | α-Tocotrienol | 10 mg | 2352 |
| Cayman2015 | 10008377 | α-Tocotrienol | 25 mg | 5152 |
| Cayman2015 | 10008377 | α-Tocotrienol | 5 mg | 1330 |
| Cayman2015 | 10008385 | Prostaglandin D2 methyl ester | 1 mg | 910 |
| Cayman2015 | 10008385 | Prostaglandin D2 methyl ester | 5 mg | 3808 |
| Cayman2015 | 10008385 | Prostaglandin D2 methyl ester | 500 μg | 476 |
| Cayman2015 | 10008390 | PtdIns-(3,4,5)-P3 (1,2-dihexanoyl) (ammonium salt) | 1 mg | 4480 |
| Cayman2015 | 10008390 | PtdIns-(3,4,5)-P3 (1,2-dihexanoyl) (ammonium salt) | 100 μg | 560 |
| Cayman2015 | 10008390 | PtdIns-(3,4,5)-P3 (1,2-dihexanoyl) (ammonium salt) | 500 μg | 2520 |
| Cayman2015 | 10008394 | PtdIns-(3)-P1 (1,2-dioctanoyl) (sodium salt) | 1 mg | 5600 |
| Cayman2015 | 10008394 | PtdIns-(3)-P1 (1,2-dioctanoyl) (sodium salt) | 100 μg | 700 |
| Cayman2015 | 10008394 | PtdIns-(3)-P1 (1,2-dioctanoyl) (sodium salt) | 500 μg | 3150 |
| Cayman2015 | 10008396 | PtdIns-(3,5)-P2 (1,2-dihexanoyl) (sodium salt) | 1 mg | 4480 |
| Cayman2015 | 10008396 | PtdIns-(3,5)-P2 (1,2-dihexanoyl) (sodium salt) | 100 μg | 560 |
| Cayman2015 | 10008396 | PtdIns-(3,5)-P2 (1,2-dihexanoyl) (sodium salt) | 500 μg | 2520 |
| Cayman2015 | 10008398 | PtdIns-(3,5)-P2 (1,2-dipalmitoyl) (sodium salt) | 1 mg | 5600 |
| Cayman2015 | 10008398 | PtdIns-(3,5)-P2 (1,2-dipalmitoyl) (sodium salt) | 100 μg | 700 |
| Cayman2015 | 10008398 | PtdIns-(3,5)-P2 (1,2-dipalmitoyl) (sodium salt) | 500 μg | 3150 |
| Cayman2015 | 10008400 | PtdIns-(3,4)-P2 (1,2-dioctanoyl) (sodium salt) | 1 mg | 5600 |
| Cayman2015 | 10008400 | PtdIns-(3,4)-P2 (1,2-dioctanoyl) (sodium salt) | 100 μg | 700 |
| Cayman2015 | 10008400 | PtdIns-(3,4)-P2 (1,2-dioctanoyl) (sodium salt) | 500 μg | 3150 |
| Cayman2015 | 10008418 | D-myo-Inositol-4,5-diphosphate (sodium salt) | 1 mg | 5488 |
| Cayman2015 | 10008418 | D-myo-Inositol-4,5-diphosphate (sodium salt) | 100 μg | 686 |
| Cayman2015 | 10008418 | D-myo-Inositol-4,5-diphosphate (sodium salt) | 500 μg | 3094 |
| Cayman2015 | 10008419 | D-myo-Inositol-2,4-diphosphate (sodium salt) | 1 mg | 5488 |
| Cayman2015 | 10008419 | D-myo-Inositol-2,4-diphosphate (sodium salt) | 100 μg | 686 |
| Cayman2015 | 10008419 | D-myo-Inositol-2,4-diphosphate (sodium salt) | 500 μg | 3094 |
| Cayman2015 | 10008422 | D-myo-Inositol-1,5,6-triphosphate (sodium salt) | 1 mg | 5488 |
| Cayman2015 | 10008422 | D-myo-Inositol-1,5,6-triphosphate (sodium salt) | 100 μg | 686 |
| Cayman2015 | 10008422 | D-myo-Inositol-1,5,6-triphosphate (sodium salt) | 500 μg | 3094 |
| Cayman2015 | 10008423 | D-myo-Inositol-2,3,5-triphosphate (ammonium salt) | 1 mg | 5488 |
| Cayman2015 | 10008423 | D-myo-Inositol-2,3,5-triphosphate (ammonium salt) | 100 μg | 686 |
| Cayman2015 | 10008423 | D-myo-Inositol-2,3,5-triphosphate (ammonium salt) | 500 μg | 3094 |
| Cayman2015 | 10008424 | D-myo-Inositol-2,5,6-triphosphate (sodium salt) | 1 mg | 5488 |
| Cayman2015 | 10008424 | D-myo-Inositol-2,5,6-triphosphate (sodium salt) | 100 μg | 686 |
| Cayman2015 | 10008424 | D-myo-Inositol-2,5,6-triphosphate (sodium salt) | 500 μg | 3094 |
| Cayman2015 | 10008425 | D-myo-Inositol-3,4,5-triphosphate (sodium salt) | 1 mg | 5488 |
| Cayman2015 | 10008425 | D-myo-Inositol-3,4,5-triphosphate (sodium salt) | 100 μg | 686 |
| Cayman2015 | 10008425 | D-myo-Inositol-3,4,5-triphosphate (sodium salt) | 500 μg | 3094 |
| Cayman2015 | 10008426 | L-myo-Inositol-1,4,5-triphosphate (sodium salt) | 1 mg | 10192 |
| Cayman2015 | 10008426 | L-myo-Inositol-1,4,5-triphosphate (sodium salt) | 100 μg | 1274 |
| Cayman2015 | 10008426 | L-myo-Inositol-1,4,5-triphosphate (sodium salt) | 500 μg | 5740 |
| Cayman2015 | 10008427 | D-myo-Inositol-1,4,6-triphosphate (sodium salt) | 1 mg | 5488 |
| Cayman2015 | 10008427 | D-myo-Inositol-1,4,6-triphosphate (sodium salt) | 100 μg | 686 |
| Cayman2015 | 10008427 | D-myo-Inositol-1,4,6-triphosphate (sodium salt) | 500 μg | 3094 |
| Cayman2015 | 10008435 | 8-iso-17-phenyl trinor Prostaglandin F2α | 1 mg | 1932 |
| Cayman2015 | 10008435 | 8-iso-17-phenyl trinor Prostaglandin F2α | 10 mg | 15456 |
| Cayman2015 | 10008435 | 8-iso-17-phenyl trinor Prostaglandin F2α | 5 mg | 8694 |
| Cayman2015 | 10008436 | 8-iso-17-phenyl trinor Prostaglandin F2β | 1 mg | 4158 |
| Cayman2015 | 10008436 | 8-iso-17-phenyl trinor Prostaglandin F2β | 100 μg | 630 |
| Cayman2015 | 10008436 | 8-iso-17-phenyl trinor Prostaglandin F2β | 500 μg | 2366 |
| Cayman2015 | 10008437 | D-myo-Inositol-4-phosphate (ammonium salt) | 1 mg | 12320 |
| Cayman2015 | 10008437 | D-myo-Inositol-4-phosphate (ammonium salt) | 100 μg | 1540 |
| Cayman2015 | 10008437 | D-myo-Inositol-4-phosphate (ammonium salt) | 500 μg | 6930 |
| Cayman2015 | 10008438 | D-myo-Inositol-1,4-diphosphate (sodium salt) | 1 mg | 5488 |
| Cayman2015 | 10008438 | D-myo-Inositol-1,4-diphosphate (sodium salt) | 100 μg | 686 |
| Cayman2015 | 10008438 | D-myo-Inositol-1,4-diphosphate (sodium salt) | 500 μg | 3094 |
| Cayman2015 | 10008439 | D-myo-Inositol-1,2-diphosphate (sodium salt) | 1 mg | 5488 |
| Cayman2015 | 10008439 | D-myo-Inositol-1,2-diphosphate (sodium salt) | 100 μg | 686 |
| Cayman2015 | 10008439 | D-myo-Inositol-1,2-diphosphate (sodium salt) | 500 μg | 3094 |
| Cayman2015 | 10008441 | D-myo-Inositol-1,5-diphosphate (sodium salt) | 1 mg | 5488 |
| Cayman2015 | 10008441 | D-myo-Inositol-1,5-diphosphate (sodium salt) | 100 μg | 686 |
| Cayman2015 | 10008441 | D-myo-Inositol-1,5-diphosphate (sodium salt) | 500 μg | 3094 |
| Cayman2015 | 10008442 | D-myo-Inositol-1,3,4,6-tetraphosphate (ammonium salt) | 1 mg | 5040 |
| Cayman2015 | 10008442 | D-myo-Inositol-1,3,4,6-tetraphosphate (ammonium salt) | 100 μg | 630 |
| Cayman2015 | 10008442 | D-myo-Inositol-1,3,4,6-tetraphosphate (ammonium salt) | 500 μg | 2842 |
| Cayman2015 | 10008443 | D-myo-Inositol-1,3-diphosphate (sodium salt) | 1 mg | 5488 |
| Cayman2015 | 10008443 | D-myo-Inositol-1,3-diphosphate (sodium salt) | 100 μg | 686 |
| Cayman2015 | 10008443 | D-myo-Inositol-1,3-diphosphate (sodium salt) | 500 μg | 3094 |
| Cayman2015 | 10008444 | D-myo-Inositol-1,2,5,6-tetraphosphate (sodium salt) | 1 mg | 12320 |
| Cayman2015 | 10008444 | D-myo-Inositol-1,2,5,6-tetraphosphate (sodium salt) | 100 μg | 1540 |
| Cayman2015 | 10008444 | D-myo-Inositol-1,2,5,6-tetraphosphate (sodium salt) | 500 μg | 6930 |
| Cayman2015 | 10008445 | 3-methoxy Limaprost | 1 mg | 1148 |
| Cayman2015 | 10008445 | 3-methoxy Limaprost | 10 mg | 8428 |
| Cayman2015 | 10008445 | 3-methoxy Limaprost | 5 mg | 4816 |
| Cayman2015 | 10008445 | 3-methoxy Limaprost | 500 μg | 602 |
| Cayman2015 | 10008448 | D-myo-Inositol-1,2,3,4-tetraphosphate (sodium salt) | 1 mg | 12320 |
| Cayman2015 | 10008448 | D-myo-Inositol-1,2,3,4-tetraphosphate (sodium salt) | 100 μg | 1540 |
| Cayman2015 | 10008448 | D-myo-Inositol-1,2,3,4-tetraphosphate (sodium salt) | 500 μg | 6930 |
| Cayman2015 | 10008449 | D-myo-Inositol-1,2,3,5-tetraphosphate (sodium salt) | 1 mg | 12320 |
| Cayman2015 | 10008449 | D-myo-Inositol-1,2,3,5-tetraphosphate (sodium salt) | 100 μg | 1540 |
| Cayman2015 | 10008449 | D-myo-Inositol-1,2,3,5-tetraphosphate (sodium salt) | 500 μg | 6930 |
| Cayman2015 | 10008450 | D-myo-Inositol-1,2,3,6-tetraphosphate (sodium salt) | 1 mg | 12320 |
| Cayman2015 | 10008450 | D-myo-Inositol-1,2,3,6-tetraphosphate (sodium salt) | 100 μg | 1540 |
| Cayman2015 | 10008450 | D-myo-Inositol-1,2,3,6-tetraphosphate (sodium salt) | 500 μg | 6930 |
| Cayman2015 | 10008451 | D-myo-Inositol-1,2,4,5-tetraphosphate (sodium salt) | 1 mg | 12320 |
| Cayman2015 | 10008451 | D-myo-Inositol-1,2,4,5-tetraphosphate (sodium salt) | 100 μg | 1540 |
| Cayman2015 | 10008451 | D-myo-Inositol-1,2,4,5-tetraphosphate (sodium salt) | 500 μg | 6930 |
| Cayman2015 | 10008452 | D-myo-Inositol-1,2,4,5,6-pentaphosphate (sodium salt) | 1 mg | 12320 |
| Cayman2015 | 10008452 | D-myo-Inositol-1,2,4,5,6-pentaphosphate (sodium salt) | 100 μg | 1540 |
| Cayman2015 | 10008452 | D-myo-Inositol-1,2,4,5,6-pentaphosphate (sodium salt) | 500 μg | 6930 |
| Cayman2015 | 10008453 | D-myo-Inositol-1,2,3,5,6-pentaphosphate (sodium salt) | 1 mg | 8848 |
| Cayman2015 | 10008453 | D-myo-Inositol-1,2,3,5,6-pentaphosphate (sodium salt) | 100 μg | 1106 |
| Cayman2015 | 10008453 | D-myo-Inositol-1,2,3,5,6-pentaphosphate (sodium salt) | 500 μg | 4984 |
| Cayman2015 | 10008455 | D-myo-Inositol-2,3,5,6-tetraphosphate (sodium salt) | 1 mg | 5488 |
| Cayman2015 | 10008455 | D-myo-Inositol-2,3,5,6-tetraphosphate (sodium salt) | 100 μg | 686 |
| Cayman2015 | 10008455 | D-myo-Inositol-2,3,5,6-tetraphosphate (sodium salt) | 500 μg | 3094 |
| Cayman2015 | 10008456 | D-myo-Inositol-2,3,4,5-tetraphosphate (ammonium salt) | 1 mg | 12320 |
| Cayman2015 | 10008456 | D-myo-Inositol-2,3,4,5-tetraphosphate (ammonium salt) | 100 μg | 1540 |
| Cayman2015 | 10008456 | D-myo-Inositol-2,3,4,5-tetraphosphate (ammonium salt) | 500 μg | 6930 |
| Cayman2015 | 10008463 | ApoA1 Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 10008477 | Creatinine Sodium Borate | 1 ea | 98 |
| Cayman2015 | 10008477 | Creatinine Sodium Borate | 5 ea | 364 |
| Cayman2015 | 10008478 | Creatinine Surfactant | 1 ea | 98 |
| Cayman2015 | 10008478 | Creatinine Surfactant | 5 ea | 364 |
| Cayman2015 | 10008492 | Adipose Triglyceride Lipase Blocking Peptide | 1 ea | 1498 |
| Cayman2015 | 10008494 | γ-Tocotrienol | 1 mg | 294 |
| Cayman2015 | 10008494 | γ-Tocotrienol | 10 mg | 2352 |
| Cayman2015 | 10008494 | γ-Tocotrienol | 25 mg | 5152 |
| Cayman2015 | 10008494 | γ-Tocotrienol | 5 mg | 1330 |
| Cayman2015 | 10008510 | 15(R)-Pinane Thromboxane A2 | 1 mg | 1148 |
| Cayman2015 | 10008510 | 15(R)-Pinane Thromboxane A2 | 10 mg | 8428 |
| Cayman2015 | 10008510 | 15(R)-Pinane Thromboxane A2 | 5 mg | 4816 |
| Cayman2015 | 10008510 | 15(R)-Pinane Thromboxane A2 | 500 μg | 602 |
| Cayman2015 | 10008513 | δ-Tocotrienol | 1 mg | 294 |
| Cayman2015 | 10008513 | δ-Tocotrienol | 10 mg | 2352 |
| Cayman2015 | 10008513 | δ-Tocotrienol | 25 mg | 5152 |
| Cayman2015 | 10008513 | δ-Tocotrienol | 5 mg | 1330 |
| Cayman2015 | 10008517 | Tienilic Acid | 10 mg | 1372 |
| Cayman2015 | 10008517 | Tienilic Acid | 25 mg | 3654 |
| Cayman2015 | 10008517 | Tienilic Acid | 5 mg | 812 |
| Cayman2015 | 10008517 | Tienilic Acid | 50 mg | 6496 |
| Cayman2015 | 10008518 | 4-hydroxy Diclofenac | 1 mg | 1980 |
| Cayman2015 | 10008518 | 4-hydroxy Diclofenac | 10 mg | 14260 |
| Cayman2015 | 10008518 | 4-hydroxy Diclofenac | 5 mg | 7420 |
| Cayman2015 | 10008519 | 6β-hydroxy Testosterone | 5 mg | 1204 |
| Cayman2015 | 10008520 | 4-hydroxy Tolbutamide | 5 mg | 1960 |
| Cayman2015 | 10008539 | 8-iso-15-keto Prostaglandin F2β | 1 mg | 4158 |
| Cayman2015 | 10008539 | 8-iso-15-keto Prostaglandin F2β | 100 μg | 630 |
| Cayman2015 | 10008539 | 8-iso-15-keto Prostaglandin F2β | 500 μg | 2366 |
| Cayman2015 | 10008581 | Myristoleic Acid methyl ester | 100 mg | 672 |
| Cayman2015 | 10008581 | Myristoleic Acid methyl ester | 1000 mg | 3150 |
| Cayman2015 | 10008581 | Myristoleic Acid methyl ester | 50 mg | 350 |
| Cayman2015 | 10008581 | Myristoleic Acid methyl ester | 500 mg | 2282 |
| Cayman2015 | 10008585 | 5-cis Iloprost | 1 mg | 2842 |
| Cayman2015 | 10008585 | 5-cis Iloprost | 10 mg | 20972 |
| Cayman2015 | 10008585 | 5-cis Iloprost | 5 mg | 11984 |
| Cayman2015 | 10008585 | 5-cis Iloprost | 500 μg | 1498 |
| Cayman2015 | 10008588 | 5-cis-15(R)-Iloprost | 1 mg | 2842 |
| Cayman2015 | 10008588 | 5-cis-15(R)-Iloprost | 10 mg | 20972 |
| Cayman2015 | 10008588 | 5-cis-15(R)-Iloprost | 5 mg | 11984 |
| Cayman2015 | 10008588 | 5-cis-15(R)-Iloprost | 500 μg | 1498 |
| Cayman2015 | 10008593 | PSN375963 | 1 mg | 182 |
| Cayman2015 | 10008593 | PSN375963 | 10 mg | 1456 |
| Cayman2015 | 10008593 | PSN375963 | 25 mg | 3192 |
| Cayman2015 | 10008593 | PSN375963 | 5 mg | 826 |
| Cayman2015 | 10008594 | PSN632408 | 1 mg | 294 |
| Cayman2015 | 10008594 | PSN632408 | 10 mg | 2352 |
| Cayman2015 | 10008594 | PSN632408 | 25 mg | 5152 |
| Cayman2015 | 10008594 | PSN632408 | 5 mg | 1330 |
| Cayman2015 | 10008596 | 5(6)-EET Ethanolamide | 100 μg | 3626 |
| Cayman2015 | 10008596 | 5(6)-EET Ethanolamide | 25 μg | 1008 |
| Cayman2015 | 10008596 | 5(6)-EET Ethanolamide | 50 μg | 1848 |
| Cayman2015 | 10008597 | 8(9)-EET Ethanolamide | 100 μg | 3626 |
| Cayman2015 | 10008597 | 8(9)-EET Ethanolamide | 25 μg | 1008 |
| Cayman2015 | 10008597 | 8(9)-EET Ethanolamide | 50 μg | 1918 |
| Cayman2015 | 10008598 | 11(12)-EET Ethanolamide | 100 μg | 3626 |
| Cayman2015 | 10008598 | 11(12)-EET Ethanolamide | 25 μg | 1008 |
| Cayman2015 | 10008598 | 11(12)-EET Ethanolamide | 50 μg | 1918 |
| Cayman2015 | 10008599 | 14(15)-EET Ethanolamide | 100 μg | 3626 |
| Cayman2015 | 10008599 | 14(15)-EET Ethanolamide | 25 μg | 1008 |
| Cayman2015 | 10008599 | 14(15)-EET Ethanolamide | 50 μg | 1918 |
| Cayman2015 | 10008602 | 20-HETE Ethanolamide | 100 μg | 9520 |
| Cayman2015 | 10008602 | 20-HETE Ethanolamide | 25 μg | 2646 |
| Cayman2015 | 10008602 | 20-HETE Ethanolamide | 50 μg | 5026 |
| Cayman2015 | 10008609 | S-NEPC | 1 mg | 210 |
| Cayman2015 | 10008609 | S-NEPC | 10 mg | 1680 |
| Cayman2015 | 10008609 | S-NEPC | 25 mg | 3682 |
| Cayman2015 | 10008609 | S-NEPC | 5 mg | 952 |
| Cayman2015 | 10008610 | Epoxy Fluor 7 | 1 mg | 504 |
| Cayman2015 | 10008610 | Epoxy Fluor 7 | 10 mg | 4032 |
| Cayman2015 | 10008610 | Epoxy Fluor 7 | 5 mg | 2268 |
| Cayman2015 | 10008610 | Epoxy Fluor 7 | 50 mg | 17640 |
| Cayman2015 | 10008612 | azido-FTY720 | 1 mg | 2912 |
| Cayman2015 | 10008612 | azido-FTY720 | 100 μg | 364 |
| Cayman2015 | 10008612 | azido-FTY720 | 5 mg | 12740 |
| Cayman2015 | 10008612 | azido-FTY720 | 500 μg | 1638 |
| Cayman2015 | 10008613 | GW 7647 | 1 mg | 392 |
| Cayman2015 | 10008613 | GW 7647 | 10 mg | 2352 |
| Cayman2015 | 10008613 | GW 7647 | 25 mg | 4410 |
| Cayman2015 | 10008613 | GW 7647 | 5 mg | 1568 |
| Cayman2015 | 10008614 | Leelamine (hydrochloride) | 10 mg | 938 |
| Cayman2015 | 10008614 | Leelamine (hydrochloride) | 100 mg | 6860 |
| Cayman2015 | 10008614 | Leelamine (hydrochloride) | 5 mg | 490 |
| Cayman2015 | 10008614 | Leelamine (hydrochloride) | 50 mg | 3920 |
| Cayman2015 | 10008616 | 15-keto Iloprost | 1 mg | 2842 |
| Cayman2015 | 10008616 | 15-keto Iloprost | 10 mg | 20972 |
| Cayman2015 | 10008616 | 15-keto Iloprost | 5 mg | 11984 |
| Cayman2015 | 10008616 | 15-keto Iloprost | 500 μg | 1498 |
| Cayman2015 | 10008617 | Arachidonic Acid Leelamide | 10 mg | 1092 |
| Cayman2015 | 10008617 | Arachidonic Acid Leelamide | 25 mg | 2590 |
| Cayman2015 | 10008617 | Arachidonic Acid Leelamide | 5 mg | 574 |
| Cayman2015 | 10008618 | Lauric Acid Leelamide | 10 mg | 1274 |
| Cayman2015 | 10008618 | Lauric Acid Leelamide | 5 mg | 672 |
| Cayman2015 | 10008618 | Lauric Acid Leelamide | 50 mg | 5376 |
| Cayman2015 | 10008639 | FTY720 Phosphate | 1 mg | 1232 |
| Cayman2015 | 10008639 | FTY720 Phosphate | 10 mg | 9856 |
| Cayman2015 | 10008639 | FTY720 Phosphate | 25 mg | 21560 |
| Cayman2015 | 10008639 | FTY720 Phosphate | 5 mg | 5544 |
| Cayman2015 | 10008640 | Asthma Treatment Standard Set | 1 ea | 854 |
| Cayman2015 | 10008642 | oxy-Arachidonoyl Ethanolamide | 10 mg | 1302 |
| Cayman2015 | 10008642 | oxy-Arachidonoyl Ethanolamide | 25 mg | 5488 |
| Cayman2015 | 10008642 | oxy-Arachidonoyl Ethanolamide | 5 mg | 686 |
| Cayman2015 | 10008642 | oxy-Arachidonoyl Ethanolamide | 50 mg | 9604 |
| Cayman2015 | 10008643 | Prostaglandin F2α-d9 | 100 μg | 1918 |
| Cayman2015 | 10008643 | Prostaglandin F2α-d9 | 25 μg | 532 |
| Cayman2015 | 10008643 | Prostaglandin F2α-d9 | 50 μg | 1008 |
| Cayman2015 | 10008646 | 1,2-Dihexanoyl-sn-glycerol | 10 mg | 490 |
| Cayman2015 | 10008646 | 1,2-Dihexanoyl-sn-glycerol | 100 mg | 3920 |
| Cayman2015 | 10008646 | 1,2-Dihexanoyl-sn-glycerol | 25 mg | 1162 |
| Cayman2015 | 10008646 | 1,2-Dihexanoyl-sn-glycerol | 50 mg | 2212 |
| Cayman2015 | 10008647 | 11α-hydroxy Testosterone | 5 mg | 2440 |
| Cayman2015 | 10008648 | 1,2-Dipalmitoyl-sn-glycerol | 100 mg | 532 |
| Cayman2015 | 10008648 | 1,2-Dipalmitoyl-sn-glycerol | 25 mg | 210 |
| Cayman2015 | 10008648 | 1,2-Dipalmitoyl-sn-glycerol | 250 mg | 1008 |
| Cayman2015 | 10008648 | 1,2-Dipalmitoyl-sn-glycerol | 50 mg | 350 |
| Cayman2015 | 10008650 | 1-Stearoyl-2-Arachidonoyl-sn-Glycerol | 1 mg | 154 |
| Cayman2015 | 10008650 | 1-Stearoyl-2-Arachidonoyl-sn-Glycerol | 10 mg | 1232 |
| Cayman2015 | 10008650 | 1-Stearoyl-2-Arachidonoyl-sn-Glycerol | 25 mg | 2702 |
| Cayman2015 | 10008650 | 1-Stearoyl-2-Arachidonoyl-sn-Glycerol | 5 mg | 700 |
| Cayman2015 | 10008652 | (±)-α-CMBHC | 1 mg | 434 |
| Cayman2015 | 10008652 | (±)-α-CMBHC | 10 mg | 3472 |
| Cayman2015 | 10008652 | (±)-α-CMBHC | 25 mg | 7602 |
| Cayman2015 | 10008652 | (±)-α-CMBHC | 5 mg | 1960 |
| Cayman2015 | 10008654 | Pinolenic Acid | 10 mg | 266 |
| Cayman2015 | 10008654 | Pinolenic Acid | 100 mg | 2128 |
| Cayman2015 | 10008654 | Pinolenic Acid | 25 mg | 630 |
| Cayman2015 | 10008654 | Pinolenic Acid | 50 mg | 1204 |
| Cayman2015 | 10008656 | Pinolenic Acid methyl ester | 1 mg | 140 |
| Cayman2015 | 10008656 | Pinolenic Acid methyl ester | 10 mg | 980 |
| Cayman2015 | 10008656 | Pinolenic Acid methyl ester | 5 mg | 546 |
| Cayman2015 | 10008656 | Pinolenic Acid methyl ester | 50 mg | 3500 |
| Cayman2015 | 10008657 | CAY10502 | 1 mg | 714 |
| Cayman2015 | 10008657 | CAY10502 | 10 mg | 5292 |
| Cayman2015 | 10008657 | CAY10502 | 5 mg | 3024 |
| Cayman2015 | 10008657 | CAY10502 | 500 μg | 378 |
| Cayman2015 | 10008658 | Pinolenic Acid ethyl ester | 10 mg | 700 |
| Cayman2015 | 10008658 | Pinolenic Acid ethyl ester | 5 mg | 378 |
| Cayman2015 | 10008658 | Pinolenic Acid ethyl ester | 50 mg | 3318 |
| Cayman2015 | 10008659 | Semi-Quantitative Biomarker EIA Component Kit (anti-rabbit) | 1 ea | 2600 |
| Cayman2015 | 10008659 | Semi-Quantitative Biomarker EIA Component Kit (anti-rabbit) | 5 ea | 9760 |
| Cayman2015 | 10008660 | JP83 | 10 mg | 798 |
| Cayman2015 | 10008660 | JP83 | 5 mg | 420 |
| Cayman2015 | 10008660 | JP83 | 50 mg | 3360 |
| Cayman2015 | 10008661 | JP104 | 10 mg | 952 |
| Cayman2015 | 10008661 | JP104 | 100 mg | 7056 |
| Cayman2015 | 10008661 | JP104 | 5 mg | 504 |
| Cayman2015 | 10008661 | JP104 | 50 mg | 4032 |
| Cayman2015 | 10008663 | LY2183240 | 1 mg | 1050 |
| Cayman2015 | 10008663 | LY2183240 | 5 mg | 2884 |
| Cayman2015 | 10008665 | Prostaglandin F1α-d9 | 100 μg | 2716 |
| Cayman2015 | 10008665 | Prostaglandin F1α-d9 | 25 μg | 756 |
| Cayman2015 | 10008665 | Prostaglandin F1α-d9 | 50 μg | 1442 |
| Cayman2015 | 10008665 | Prostaglandin F1α-d9 | 500 μg | 12096 |
| Cayman2015 | 10008669 | CAY10508 | 10 mg | 560 |
| Cayman2015 | 10008669 | CAY10508 | 25 mg | 1330 |
| Cayman2015 | 10008669 | CAY10508 | 5 mg | 294 |
| Cayman2015 | 10008669 | CAY10508 | 50 mg | 2352 |
| Cayman2015 | 10008671 | Sildenafil | 10 mg | 560 |
| Cayman2015 | 10008671 | Sildenafil | 25 mg | 980 |
| Cayman2015 | 10008671 | Sildenafil | 50 mg | 1512 |
| Cayman2015 | 10008672 | Celecoxib | 100 mg | 938 |
| Cayman2015 | 10008672 | Celecoxib | 250 mg | 2212 |
| Cayman2015 | 10008672 | Celecoxib | 50 mg | 490 |
| Cayman2015 | 10008673 | ASP EIA Kit | 1 ea | 12160 |
| Cayman2015 | 10008811 | PCSK9 (mouse) Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 10008840 | 13,14-dihydro-15-keto Prostaglandin J2 | 1 mg | 2632 |
| Cayman2015 | 10008840 | 13,14-dihydro-15-keto Prostaglandin J2 | 5 mg | 11088 |
| Cayman2015 | 10008840 | 13,14-dihydro-15-keto Prostaglandin J2 | 500 μg | 1386 |
| Cayman2015 | 10008841 | Propylpyrazole Triol | 1 mg | 224 |
| Cayman2015 | 10008841 | Propylpyrazole Triol | 10 mg | 1792 |
| Cayman2015 | 10008841 | Propylpyrazole Triol | 25 mg | 3920 |
| Cayman2015 | 10008841 | Propylpyrazole Triol | 5 mg | 1008 |
| Cayman2015 | 10008842 | 2,3-bis (4-Hydroxyphenyl) Propionitrile | 10 mg | 826 |
| Cayman2015 | 10008842 | 2,3-bis (4-Hydroxyphenyl) Propionitrile | 100 mg | 6076 |
| Cayman2015 | 10008842 | 2,3-bis (4-Hydroxyphenyl) Propionitrile | 5 mg | 434 |
| Cayman2015 | 10008842 | 2,3-bis (4-Hydroxyphenyl) Propionitrile | 50 mg | 3472 |
| Cayman2015 | 10008846 | CAY10573 | 1 mg | 938 |
| Cayman2015 | 10008846 | CAY10573 | 10 mg | 6860 |
| Cayman2015 | 10008846 | CAY10573 | 5 mg | 3920 |
| Cayman2015 | 10008846 | CAY10573 | 500 μg | 490 |
| Cayman2015 | 10008856 | GnRHa Polyclonal Antibody | 200 μL | 8940 |
| Cayman2015 | 10008857 | Transcription Factor SREBP-2 Positive Control | 1 ea | 910 |
| Cayman2015 | 10008858 | Transcription Factor SREBP 96-Well Strip Plate | 1 ea | 896 |
| Cayman2015 | 10008859 | Transcription Factor SREBP-2 Primary Antibody | 1 ea | 1092 |
| Cayman2015 | 10008860 | Transcription Factor SREBP Competitor dsDNA | 1 ea | 686 |
| Cayman2015 | 10008869 | 1-Linoleoyl Glycerol | 1 mg | 224 |
| Cayman2015 | 10008869 | 1-Linoleoyl Glycerol | 10 mg | 1792 |
| Cayman2015 | 10008869 | 1-Linoleoyl Glycerol | 25 mg | 3920 |
| Cayman2015 | 10008869 | 1-Linoleoyl Glycerol | 5 mg | 1008 |
| Cayman2015 | 10008872 | CAY10503 | 1 mg | 294 |
| Cayman2015 | 10008872 | CAY10503 | 10 mg | 2352 |
| Cayman2015 | 10008872 | CAY10503 | 5 mg | 1330 |
| Cayman2015 | 10008872 | CAY10503 | 50 mg | 10290 |
| Cayman2015 | 10008875 | 13(S)-HODE methyl ester | 1 mg | 7840 |
| Cayman2015 | 10008875 | 13(S)-HODE methyl ester | 100 μg | 980 |
| Cayman2015 | 10008875 | 13(S)-HODE methyl ester | 500 μg | 2324 |
| Cayman2015 | 10008878 | PPARα, δ, γ Complete Transcription Factor Assay Kit | 96 Well | 5740 |
| Cayman2015 | 10008879 | 3-(N-Maleimidopropionyl)-biocytin | 1 mg | 154 |
| Cayman2015 | 10008879 | 3-(N-Maleimidopropionyl)-biocytin | 10 mg | 518 |
| Cayman2015 | 10008879 | 3-(N-Maleimidopropionyl)-biocytin | 5 mg | 294 |
| Cayman2015 | 10008879 | 3-(N-Maleimidopropionyl)-biocytin | 50 mg | 1708 |
| Cayman2015 | 10008882 | LDH Cytotoxicity Assay Kit | 480 Well | 3472 |
| Cayman2015 | 10008882 | LDH Cytotoxicity Assay Kit | 96 Well | 924 |
| Cayman2015 | 10008883 | WST-1 Cell Proliferation Assay Kit | 1 ea | 700 |
| Cayman2015 | 10008883 | WST-1 Cell Proliferation Assay Kit | 5 ea | 1372 |
| Cayman2015 | 10008883 | WST-1 Cell Proliferation Assay Kit | 50 ea | 8400 |
| Cayman2015 | 10008884 | Eicosapentaenoic Acid ethyl ester | 10 mg | 350 |
| Cayman2015 | 10008884 | Eicosapentaenoic Acid ethyl ester | 100 mg | 1932 |
| Cayman2015 | 10008884 | Eicosapentaenoic Acid ethyl ester | 50 mg | 1134 |
| Cayman2015 | 10008884 | Eicosapentaenoic Acid ethyl ester | 500 mg | 7882 |
| Cayman2015 | 10008886 | (+)-Goniothalesdiol | 1 mg | 1092 |
| Cayman2015 | 10008886 | (+)-Goniothalesdiol | 10 mg | 8736 |
| Cayman2015 | 10008886 | (+)-Goniothalesdiol | 5 mg | 4914 |
| Cayman2015 | 10008887 | (+)-2,5-epi Goniothalesdiol | 1 mg | 490 |
| Cayman2015 | 10008887 | (+)-2,5-epi Goniothalesdiol | 10 mg | 3920 |
| Cayman2015 | 10008887 | (+)-2,5-epi Goniothalesdiol | 5 mg | 2212 |
| Cayman2015 | 10008892 | Transcription Factor Complete PPARα Positive Control | 1 ea | 714 |
| Cayman2015 | 10008893 | Transcription Factor Complete PPARδ Positive Control | 1 ea | 714 |
| Cayman2015 | 10008894 | Transcription Factor Complete PPARγ Positive Control | 1 ea | 714 |
| Cayman2015 | 10008895 | Transcription Factor Complete PPARα Primary Antibody | 1 ea | 1078 |
| Cayman2015 | 10008896 | Transcription Factor Complete PPARδ Primary Antibody | 1 ea | 1078 |
| Cayman2015 | 10008897 | Transcription Factor Complete PPARγ Primary Antibody | 1 ea | 1078 |
| Cayman2015 | 10008907 | GW 9508 | 10 mg | 798 |
| Cayman2015 | 10008907 | GW 9508 | 100 mg | 5880 |
| Cayman2015 | 10008907 | GW 9508 | 5 mg | 420 |
| Cayman2015 | 10008907 | GW 9508 | 50 mg | 3360 |
| Cayman2015 | 10008908 | GW 1100 | 10 mg | 1736 |
| Cayman2015 | 10008908 | GW 1100 | 25 mg | 4102 |
| Cayman2015 | 10008908 | GW 1100 | 5 mg | 910 |
| Cayman2015 | 10008908 | GW 1100 | 50 mg | 7280 |
| Cayman2015 | 10008933 | G-1 | 1 mg | 350 |
| Cayman2015 | 10008933 | G-1 | 10 mg | 2100 |
| Cayman2015 | 10008933 | G-1 | 25 mg | 4816 |
| Cayman2015 | 10008933 | G-1 | 5 mg | 1316 |
| Cayman2015 | 10008935 | 8-iso Prostaglandin F1α-d9 | 100 μg | 5894 |
| Cayman2015 | 10008935 | 8-iso Prostaglandin F1α-d9 | 25 μg | 1638 |
| Cayman2015 | 10008935 | 8-iso Prostaglandin F1α-d9 | 50 μg | 3108 |
| Cayman2015 | 10008952 | Ghrelin (human unacylated) EIA Kit | 96 Well | 9400 |
| Cayman2015 | 10008953 | Ghrelin (rat unacylated) EIA Kit | 96 Well | 9400 |
| Cayman2015 | 10008956 | α,β-methylene Adenosine 5'-triphosphate (sodium salt?) | 1 mg | 630 |
| Cayman2015 | 10008956 | α,β-methylene Adenosine 5'-triphosphate (sodium salt?) | 10 mg | 2212 |
| Cayman2015 | 10008956 | α,β-methylene Adenosine 5'-triphosphate (sodium salt?) | 5 mg | 1386 |
| Cayman2015 | 10008976 | WST-1 Reagent (powder) | 1 ea | 574 |
| Cayman2015 | 10008976 | WST-1 Reagent (powder) | 5 ea | 2156 |
| Cayman2015 | 10008977 | Electron Mediator Solution | 1 ea | 224 |
| Cayman2015 | 10008977 | Electron Mediator Solution | 5 ea | 840 |
| Cayman2015 | 10008977 | Electron Mediator Solution | 50 ea | 6720 |
| Cayman2015 | 10008978 | Cell-Based Assay IBMX Solution (1,000X) | 1 ea | 602 |
| Cayman2015 | 10008979 | Adipogenesis Assay Insulin Solution (1,000X) | 1 ea | 602 |
| Cayman2015 | 10008980 | Adipogenesis Assay Dexamethasone Solution (1,000X) | 1 ea | 602 |
| Cayman2015 | 10008981 | Lipid Droplets Assay Fixative (10X) | 1 ea | 602 |
| Cayman2015 | 10008989 | 11β-Prostaglandin F2α-d4 | 100 μg | 1806 |
| Cayman2015 | 10008989 | 11β-Prostaglandin F2α-d4 | 50 μg | 952 |
| Cayman2015 | 10008989 | 11β-Prostaglandin F2α-d4 | 500 μg | 4284 |
| Cayman2015 | 10009017 | CAY10514 | 1 mg | 266 |
| Cayman2015 | 10009017 | CAY10514 | 10 mg | 2128 |
| Cayman2015 | 10009017 | CAY10514 | 5 mg | 1204 |
| Cayman2015 | 10009017 | CAY10514 | 50 mg | 9310 |
| Cayman2015 | 10009018 | JWH 015 | 10 mg | 1960 |
| Cayman2015 | 10009018 | JWH 015 | 25 mg | 4172 |
| Cayman2015 | 10009018 | JWH 015 | 50 mg | 7350 |
| Cayman2015 | 10009019 | (+)-MK 801 (hydrogen maleate) | 10 mg | 812 |
| Cayman2015 | 10009019 | (+)-MK 801 (hydrogen maleate) | 50 mg | 3052 |
| Cayman2015 | 10009020 | N-Palmitoyl Glycine | 10 mg | 350 |
| Cayman2015 | 10009020 | N-Palmitoyl Glycine | 100 mg | 2282 |
| Cayman2015 | 10009020 | N-Palmitoyl Glycine | 50 mg | 1316 |
| Cayman2015 | 10009020 | N-Palmitoyl Glycine | 500 mg | 7882 |
| Cayman2015 | 10009021 | AVE-1625 | 1 mg | 686 |
| Cayman2015 | 10009021 | AVE-1625 | 10 mg | 5488 |
| Cayman2015 | 10009021 | AVE-1625 | 5 mg | 3094 |
| Cayman2015 | 10009022 | (S)-SLV 319 | 1 mg | 644 |
| Cayman2015 | 10009022 | (S)-SLV 319 | 10 mg | 5152 |
| Cayman2015 | 10009022 | (S)-SLV 319 | 5 mg | 2898 |
| Cayman2015 | 10009023 | (+)-WIN 55,212-2 (mesylate) | 10 mg | 882 |
| Cayman2015 | 10009023 | (+)-WIN 55,212-2 (mesylate) | 25 mg | 2086 |
| Cayman2015 | 10009023 | (+)-WIN 55,212-2 (mesylate) | 5 mg | 462 |
| Cayman2015 | 10009023 | (+)-WIN 55,212-2 (mesylate) | 50 mg | 3696 |
| Cayman2015 | 10009025 | Prion Protein Monoclonal Antibody (Clone 2G11) | 1 ea | 5900 |
| Cayman2015 | 10009026 | homo-Tienilic Alcohol | 5 mg | 3860 |
| Cayman2015 | 10009027 | 6α-hydroxy Paclitaxel | 1 mg | 3626 |
| Cayman2015 | 10009027 | 6α-hydroxy Paclitaxel | 5 mg | 16716 |
| Cayman2015 | 10009027 | 6α-hydroxy Paclitaxel | 500 μg | 2786 |
| Cayman2015 | 10009029 | 6-hydroxy Chlorzoxazone | 10 mg | 5880 |
| Cayman2015 | 10009029 | 6-hydroxy Chlorzoxazone | 5 mg | 3360 |
| Cayman2015 | 10009029 | 6-hydroxy Chlorzoxazone | 50 mg | 17940 |
| Cayman2015 | 10009030 | Prion Protein Monoclonal Antibody (Clone 11C6) | 1 ea | 5900 |
| Cayman2015 | 10009034 | Prion Protein Monoclonal Antibody (BAR 221) | 1 ea | 5900 |
| Cayman2015 | 10009035 | Prion Protein Monoclonal Antibody (Clone BAR 224) | 1 ea | 5900 |
| Cayman2015 | 10009036 | Prion Protein Monoclonal Antibody (Clone BAR 233) | 1 ea | 5900 |
| Cayman2015 | 10009037 | Prion Protein Monoclonal Antibody (Clone BAR 236) | 1 ea | 5900 |
| Cayman2015 | 10009039 | tetranor-PGDM-d6 | 100 μg | 11032 |
| Cayman2015 | 10009039 | tetranor-PGDM-d6 | 25 μg | 3066 |
| Cayman2015 | 10009039 | tetranor-PGDM-d6 | 50 μg | 5824 |
| Cayman2015 | 10009040 | Cytochrome b5 (human) | 1 ea | 2700 |
| Cayman2015 | 10009041 | Cytochrome P450 2B6 (human) Human Reductase with Cytochrome b5 | 1 ea | 6700 |
| Cayman2015 | 10009042 | Cytochrome P450 3A4 (human) Human Reductase with Cytochrome b5 | 1 ea | 6700 |
| Cayman2015 | 10009043 | Cytochrome P450 3A5 (human) Human Reductase with Cytochrome b5 | 1 ea | 6700 |
| Cayman2015 | 10009044 | Cytochrome P450 2B6 (human) Yeast Reductase | 1 ea | 4700 |
| Cayman2015 | 10009052 | AS-252424 | 1 mg | 434 |
| Cayman2015 | 10009052 | AS-252424 | 10 mg | 2170 |
| Cayman2015 | 10009052 | AS-252424 | 25 mg | 4886 |
| Cayman2015 | 10009052 | AS-252424 | 5 mg | 1190 |
| Cayman2015 | 10009055 | TBARS Assay Kit | 96 Well | 2590 |
| Cayman2015 | 10009078 | CAY10505 | 10 mg | 770 |
| Cayman2015 | 10009078 | CAY10505 | 25 mg | 1834 |
| Cayman2015 | 10009078 | CAY10505 | 5 mg | 406 |
| Cayman2015 | 10009078 | CAY10505 | 50 mg | 3248 |
| Cayman2015 | 10009079 | CAY10506 | 1 mg | 490 |
| Cayman2015 | 10009079 | CAY10506 | 10 mg | 3920 |
| Cayman2015 | 10009079 | CAY10506 | 5 mg | 2212 |
| Cayman2015 | 10009079 | CAY10506 | 50 mg | 17150 |
| Cayman2015 | 10009081 | Didox | 1 mg | 182 |
| Cayman2015 | 10009081 | Didox | 10 mg | 1456 |
| Cayman2015 | 10009081 | Didox | 5 mg | 826 |
| Cayman2015 | 10009081 | Didox | 50 mg | 6370 |
| Cayman2015 | 10009083 | Trimidox | 10 mg | 1302 |
| Cayman2015 | 10009083 | Trimidox | 100 mg | 9604 |
| Cayman2015 | 10009083 | Trimidox | 5 mg | 686 |
| Cayman2015 | 10009083 | Trimidox | 50 mg | 5488 |
| Cayman2015 | 10009085 | U-18666A | 10 mg | 1008 |
| Cayman2015 | 10009085 | U-18666A | 25 mg | 2394 |
| Cayman2015 | 10009085 | U-18666A | 5 mg | 532 |
| Cayman2015 | 10009085 | U-18666A | 50 mg | 4256 |
| Cayman2015 | 10009088 | PPARα LBD (human recombinant) | 100 μg | 5950 |
| Cayman2015 | 10009088 | PPARα LBD (human recombinant) | 25 μg | 1652 |
| Cayman2015 | 10009088 | PPARα LBD (human recombinant) | 50 μg | 3136 |
| Cayman2015 | 10009092 | TrxR Assay Buffer (10X) | 1 ea | 294 |
| Cayman2015 | 10009093 | Thioredoxin Reductase Control | 1 ea | 714 |
| Cayman2015 | 10009094 | TrxR Inhibitor | 1 ea | 154 |
| Cayman2015 | 10009095 | TrxR NADPH | 1 ea | 574 |
| Cayman2015 | 10009096 | TrxR DTNB | 1 ea | 154 |
| Cayman2015 | 10009097 | TrxR DMSO | 1 ea | 154 |
| Cayman2015 | 10009109 | W146 (trifluoroacetate salt) | 1 mg | 1680 |
| Cayman2015 | 10009109 | W146 (trifluoroacetate salt) | 10 mg | 12348 |
| Cayman2015 | 10009109 | W146 (trifluoroacetate salt) | 5 mg | 7056 |
| Cayman2015 | 10009109 | W146 (trifluoroacetate salt) | 500 μg | 882 |
| Cayman2015 | 10009110 | W140 (trifluoroacetate salt) | 1 mg | 1680 |
| Cayman2015 | 10009110 | W140 (trifluoroacetate salt) | 10 mg | 12348 |
| Cayman2015 | 10009110 | W140 (trifluoroacetate salt) | 5 mg | 7056 |
| Cayman2015 | 10009110 | W140 (trifluoroacetate salt) | 500 μg | 882 |
| Cayman2015 | 10009115 | pCAF Histone Acetyltransferase | 100 μg | 5642 |
| Cayman2015 | 10009115 | pCAF Histone Acetyltransferase | 25 μg | 1568 |
| Cayman2015 | 10009115 | pCAF Histone Acetyltransferase | 50 μg | 2982 |
| Cayman2015 | 10009134 | PHOME | 1 mg | 294 |
| Cayman2015 | 10009134 | PHOME | 10 mg | 2352 |
| Cayman2015 | 10009134 | PHOME | 5 mg | 1330 |
| Cayman2015 | 10009134 | PHOME | 50 mg | 10290 |
| Cayman2015 | 10009135 | Caspase-3 Fluorescence Assay Kit | 1 ea | 2772 |
| Cayman2015 | 10009137 | β-Gal-NONOate | 1 mg | 406 |
| Cayman2015 | 10009137 | β-Gal-NONOate | 10 mg | 3248 |
| Cayman2015 | 10009137 | β-Gal-NONOate | 5 mg | 1722 |
| Cayman2015 | 10009145 | Bezafibrate | 1000 mg | 238 |
| Cayman2015 | 10009145 | Bezafibrate | 10000 mg | 1764 |
| Cayman2015 | 10009145 | Bezafibrate | 500 mg | 126 |
| Cayman2015 | 10009145 | Bezafibrate | 5000 mg | 1008 |
| Cayman2015 | 10009146 | Acid Phosphatase Assay Buffer (10X) | 1 ea | 196 |
| Cayman2015 | 10009147 | Acid Phosphatase Substrate | 1 ea | 854 |
| Cayman2015 | 10009148 | Acid Phosphatase Stop Solution | 1 ea | 210 |
| Cayman2015 | 10009149 | Acid Phosphatase (control) | 1 ea | 98 |
| Cayman2015 | 10009150 | Acid Phosphatase Sodium Tartrate | 1 ea | 280 |
| Cayman2015 | 10009152 | Valinomycin | 10 mg | 406 |
| Cayman2015 | 10009152 | Valinomycin | 25 mg | 952 |
| Cayman2015 | 10009152 | Valinomycin | 5 mg | 210 |
| Cayman2015 | 10009152 | Valinomycin | 50 mg | 1680 |
| Cayman2015 | 10009162 | GW 627368X | 1 mg | 644 |
| Cayman2015 | 10009162 | GW 627368X | 10 mg | 5152 |
| Cayman2015 | 10009162 | GW 627368X | 25 mg | 11270 |
| Cayman2015 | 10009162 | GW 627368X | 5 mg | 2898 |
| Cayman2015 | 10009167 | CAY10509 | 1 mg | 1596 |
| Cayman2015 | 10009167 | CAY10509 | 100 μg | 266 |
| Cayman2015 | 10009167 | CAY10509 | 5 mg | 6650 |
| Cayman2015 | 10009167 | CAY10509 | 500 μg | 868 |
| Cayman2015 | 10009168 | CAY10510 | 1 mg | 1596 |
| Cayman2015 | 10009168 | CAY10510 | 100 μg | 266 |
| Cayman2015 | 10009168 | CAY10510 | 5 mg | 6650 |
| Cayman2015 | 10009168 | CAY10510 | 500 μg | 868 |
| Cayman2015 | 10009172 | JC-1 Mitochondrial Membrane Potential Assay Kit | 1 ea | 2772 |
| Cayman2015 | 10009177 | p38 MAPK (Phospho-Thr180/Tyr182) Polyclonal Antibody | 1 ea | 6300 |
| Cayman2015 | 10009178 | MEK1/2 (Phospho-Ser218,222) Polyclonal Antibody | 1 ea | 6500 |
| Cayman2015 | 10009179 | ERK/MAPK (Phospho-Thr202/Tyr204) Polyclonal Antibody | 1 ea | 6500 |
| Cayman2015 | 10009180 | β-Catenin (Phospho-Ser33,37) Polyclonal Antibody | 1 ea | 6500 |
| Cayman2015 | 10009181 | CREB (Phospho-Ser133) Polyclonal Antibody | 1 ea | 6300 |
| Cayman2015 | 10009195 | O-2545 (hydrochloride) | 1 mg | 2016 |
| Cayman2015 | 10009195 | O-2545 (hydrochloride) | 10 mg | 14896 |
| Cayman2015 | 10009195 | O-2545 (hydrochloride) | 5 mg | 8512 |
| Cayman2015 | 10009195 | O-2545 (hydrochloride) | 500 μg | 1064 |
| Cayman2015 | 10009197 | Flavopiridol | 10 mg | 1036 |
| Cayman2015 | 10009197 | Flavopiridol | 25 mg | 2408 |
| Cayman2015 | 10009197 | Flavopiridol | 5 mg | 686 |
| Cayman2015 | 10009197 | Flavopiridol | 50 mg | 4340 |
| Cayman2015 | 10009199 | Thiobarbituric Acid | 1 ea | 840 |
| Cayman2015 | 10009200 | TBA Acetic Acid | 1 ea | 350 |
| Cayman2015 | 10009201 | TBA Sodium Hydroxide | 1 ea | 280 |
| Cayman2015 | 10009202 | TBA Malondialdehyde Standard | 1 ea | 350 |
| Cayman2015 | 10009203 | TBA SDS Solution | 1 ea | 280 |
| Cayman2015 | 10009209 | PI-103 | 1 mg | 322 |
| Cayman2015 | 10009209 | PI-103 | 10 mg | 1932 |
| Cayman2015 | 10009209 | PI-103 | 25 mg | 3626 |
| Cayman2015 | 10009209 | PI-103 | 5 mg | 1288 |
| Cayman2015 | 10009210 | PIK-75 (hydrochloride) | 1 mg | 154 |
| Cayman2015 | 10009210 | PIK-75 (hydrochloride) | 10 mg | 1232 |
| Cayman2015 | 10009210 | PIK-75 (hydrochloride) | 25 mg | 2702 |
| Cayman2015 | 10009210 | PIK-75 (hydrochloride) | 5 mg | 700 |
| Cayman2015 | 10009215 | 9-OxoOTrE | 100 μg | 2618 |
| Cayman2015 | 10009215 | 9-OxoOTrE | 25 μg | 728 |
| Cayman2015 | 10009215 | 9-OxoOTrE | 250 μg | 5824 |
| Cayman2015 | 10009215 | 9-OxoOTrE | 50 μg | 1386 |
| Cayman2015 | 10009222 | Sphingosine Kinase Inhibitor 2 | 10 mg | 854 |
我們公司zui大優(yōu)勢是強(qiáng)大的采購，
1：基本什么都能進(jìn)口，血清，抗體，耗材，還有部分限制進(jìn)口的，
2： 貨品全，現(xiàn)經(jīng)營過700多個品牌，基本所有生物試劑耗材都可以進(jìn)口，特別是冷偏的產(chǎn)品那就更有優(yōu)勢，
3：提供加急服務(wù)，一般1-2周到貨，超過時限加急費(fèi)全免
4：價格公道，絕大部分價格有優(yōu)勢，當(dāng)然不能保證100%產(chǎn)品都是,因?yàn)橐馕吨鴽]有服務(wù).
5：良好的信譽(yù)，大部分客戶我們提供貨到付款服務(wù)，客戶包括清華，北大 交大 復(fù)旦，中山等100多所大學(xué)，ROCHE，阿斯利康，國藥 ，fisher等500多家公司
6：我們還是santa,Advanced Biotechnologies Inc;Athens Research & Technology, bangs, BBInternational, crystalchem, dianova, FD Neurotechnologies, Inc. FormuMax Scientific, Inc; Genebridege; Glycotope Biotechnology GmbH; iduron; Innovative Research of America； Ludger ； neuroprobe; omicronbio; Polysciences; prospecbi; QA-BIO；quickzyme；RESEARCH DIETS, INC；sterlitech；sysy；TriLink BioTechnologies, Inc；worthington-biochem;zyagen;......幾十家國外公司授權(quán)代理
7：我們還從事invitrogen，qiagen; abcam ;sigma;neb; roche;merck; rnd; BD; GE; pierce; BioLegend....等*批發(fā)
